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I Introduction  
 
I.1 Economic importance of grapevine 
Grapevine (Vitis species) is the main cultivated fruit crop in the world and the most important 
in economic terms. Contrary to other fruit crops grapevine is not only used as a fruit in its 
multiple uses (fresh fruit, fruit juice, dried fruit, etc) but it is the basis for the production of 
high value-added products such as wine and spirits. Because of these multiple uses, grapevine 
has been a part of human culture since the establishment of agricultural societies thousands of 
years ago (International Grape Genome Program white paper, 2002). European grapevine 
production covers approximately 5.5 million hectares of the member states, accounting for 
68% of the total world production. From an economic viewpoint, sustainable, high quality-
production is a direct consequence of the fitness of vines in the context of their available 
environmental resources (Vivier and Pretorius, 2002). Vitis vinifera is currently the major 
cultivated species because of its high quality for use in wine production (Ferreira et al., 2004). 
Viruses are major grapevine pathogens that cause heavy crop losses, amounting to several 
million Euros per year, and endanger the survival of infected plants; furthermore the 
establishment of new vineyards requires considerable investment, 20,000 to 30,000 Euros per 
hectare. The importance of the grapevine industry and the magnitude of the problems caused 
by these pathogens have generated widespread interest in developing novel approaches for 
disease control. 
Grapevine leafroll (GLR) is a graft-transmissible disease that can be caused by any of at least 
nine serologically distinct clostero-like viruses. These have been named Grapevine leafroll-
associated viruses (GLRaVs) 1–9 (Gugerli et al., 1984; Hu et al., 1990a; Zimmermann et al., 
1990; Boscia et al., 1995; Choueiri et al., 1996; Gugerli, 2003). Typical symptoms of GLR-
infected vines include downward curling and discoloration of fully expanded leaves toward 
the end of the growing season (Figure I-1) (Meng et al., 2005). All known GLRaVs showed 
flexible filamentous particles with a characteristic open structure. Within this complex, 
grapevine leafroll associated virus 2 and 3 (GLRaV-2 and -3), are one of the most 
economically damaging and widespread viral diseases of wine grapes world-wide (Bovey et 
al., 1980). Leafroll-induced yearly losses are estimated to be in the range of 10-15%, but over 
70% losses have been documented. 
Control of these viruses is economically important and up to date is achieved by the 
production and planting of healthy stocks, whose sanitary status is strictly controlled by 
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serological or molecular assays. Even if pathogen-free planting material is available, these 
plants can be re-infected in the field. Control of the virus itself by chemical or biological plant 
protection measures is difficult and the only chemical methyl bromide (methylbromide) that 
offers effective control of the nematode vectors is not only expensive but is of increasing 
concern to consumers due to possible secondary effect on human health and environment 
(Vivier and Pretorius, 2002). 
 
 
 
 
 
 
 
 
 
Figure I-1: Grape leafroll virus symptoms in grape foliage. 
 
I.2 Grapevine leafroll associated virus 2 
GLRaV-2 is member of the genus Closterovirus in the family Closteroviridae. In contrast to 
others grapevine leafroll-associated closteroviruses described so far, GLRaV-2 is 
transmissible to the herbaceous hosts Nicotiana benthamiana by inoculation of sap (Monette 
and Godkin, 1993; Boscia et al., 1995; Castellano et al., 1995; Goszczynski et al., 1996a, 
1996b). Virions of GLRaV-2 are confined in the phloem, flexuous, filamentous particles 
about 1400-1800 nm in length (Gugerli et al., 1984). A dsRNA of about 15 kb has been 
consistently isolated from GLRaV-2 infected tissues (Goszczynsky et al., 1996b). The coat 
protein (CP) of GLRaV-2 is approximately 22-25 kDa in zise (Zimmermann et al., 1990; 
Gugerli and Ramel, 1993; Boscia et al., 1995) which is considerable smaller than other 
GLRaVs (35-43 kDa) (Zee et al., 1987; Hu et al., 1990; Zimmermann et al., 1990; Ling et al., 
1997, 2004). The genetic organization of GLRaV-2 is shown in Figure I-2. 
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Figure I-2: Schematic representation of the genome of GLRaV-2. 
Identified domains are represented by boxes and designated: L1 and L2: two putative papain-like protease 
domains; MT: methyltransferase domain; HEL: helicase domain; RdRP: RNA-dependent RNA-polymerase; 
HSP70h: heat shock protein-70 homologue; CP: the major capsid protein; CPm: the minor capsid protein; open 
reading frame (ORF) 4, 7 and 8 are of unknown function. 
 
 
Within this genome structure, the most remarkable features are: 
• ORF6 encodes a polypeptide identified as the CP gene of GLRaV-2 based on 
sequence comparison with other closteroviruses. 
• ORF1b encodes a 460 amino acid polypeptide with a molecular mass of ~52 kDa. 
Database searches showed a significant similarity to the RdRP domains of positive-
strand RNA viruses. 
• ORF3 encodes a 600 amino acid polypeptide with a molecular mass of ~65 kDa. 
homologous to the HSP70h cellular heat shock protein. This protein is highly 
conserved among closteroviruses and is involved in virion assembly and transport 
(Alzhanova et al., 2001). 
GLRaV-2 isolates induces the same type of ultrastructural modifications in the herbaceous 
host and Vitis, consisting primarily of membrane proliferation, formation of inclusion bodies 
and virus particles aggregates. Inclusion bodies are made up of clusters of membranous 
vesicles with fibrillar content, surrounded by a single membrane, intermixed with loose 
aggregates of virus particles (Castellano et al., 2000). The dsRNA-containing cytoplasmic 
vesicles that accumulate in the cytoplasm of infected cells arise primarily by proliferation of 
the endoplasmic reticulum (Martelli et al., 2002). 
 
 
I.3 Grapevine leafroll associated virus 3 
GLRaV-3 is a widespread agent of leafroll (Rosciglione and Gugerli, 1986). This virus 
belongs to the genus Ampelovirus in the family Closteroviridae (Martelli et al., 2002). It is 
limited to the phloem and transmitted in a semi-persistent manner by several species of 
mealybugs and soft-scale insects (Gugerli, 2003). GLRaV-3 does not destroy infected vines 
but cause a decline in both yield and quality of grapes with symptoms such as delayed 
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L1         MT                                 HEL     RdRP             HSP70h       55k         CPm     CP    21k  20k   7k  
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20k   4k 
ripening, reduced yield and depressed berry sugar content that reduces wine quality (Mannini 
and Credi, 2000). It is easily transmitted by grafting and propagation material but is not 
transmissible by sap inoculation. Rootstocks are symptom-less carriers of leafroll virus and 
have probably contributed significantly to the current level of virus infection in established 
plantings. Initial virus levels can be minimized through the use of certified virus-free 
rootstock and scion material and virus indexing programmes are increasingly used to ensure 
that new vineyards are established using healthy plant material. Despite attempts to supply 
growers with healthy vines through virus indexing, nursery plants are often not 100% free of 
virus infection (Walker et al., 2004). 
GLRaV-3 has a positive-sense ssRNA genome of 17919 nt and is organized into 13 ORFs 
(Figure I-3). The major genetics components are: 
• ORF1b encodes a protein of 533 amino acids residues. Database searches revealed 
that this protein has a significant similarity to the supergroup 3 RdRP of positive-
strand RNA viruses.  
• ORF4 encodes a protein of 549 amino acids with a calculated molecular mass of ~59 
kDa and possess significant similarity to the HSP70 family of chaperones. 
• OFR6 encodes a protein of 313 amino acids with a calculated molecular mass of ~34 
kDa that potentially encodes the CP gene (Ling et al., 1998, 2000b). Functional 
evidence is only available for the CP, whose product, when expressed in bacteria, is 
recognized by antibodies binding to intact virus particles (Ling et al., 1997). 
 
 
 
 
 
 
 
Figure I-3: Schematic representation of the genome of GLRaV-3.  
Identified domains are represented by boxes and designated: L1, papain-like protease domain; MT, methyl-
transferase domain; HEL, helicase; RdRp, RNA-dependent RNA polymerase; ORFs 2 and 3 encodes small 
peptides with unknown function; HSP70, heat shock protein 70; 55K, unknown function; CP, coat protein; CPd, 
diverged coat protein; along with other five ORFs (8, 9, 10, 11 and 12) with unknown functions. 
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I.4 Resistance mechanisms to plant viruses 
I.4.1 Natural resistance to plant viruses 
Plants use a number of pathogen-induced defence pathways to prevent or control disease, and 
together these constitute the general or innate defence system. The earliest defence response 
against pathogens is the hypersensitive response, which is considered to be the main step 
leading to systemic acquired resistance (SAR). The latter is the most intensively studied 
pathogen-induced defence response, and provides broad-spectrum resistance against not only 
the initial pathogen challenge, but also against subsequent infection by a variety of other viral, 
fungal and bacterial pathogens (Campbell et al., 2002; Durrant and Dong 2004). 
The induction of this natural defence mechanism requires the specific recognition of the 
pathogen, and in many cases is based on matching resistance gene products from the plant 
(produced by the dominant resistance (R) genes) to the products of the pathogen avirulence 
(avr) genes (Goldbach et al., 2003). A growing number of mostly dominant resistance genes 
have been cloned and analyzed, leading to a better understanding of natural defence systems 
in plants. This has also allowed such genes to be transferred between species, e.g. the tobacco 
N gene, which confers resistance to Tobacco mosaic virus (TMV), has been transferred to 
tomato establishing TMV resistance in this species (Whitham et al., 1996). 
In other cases, pathogenesis-related (PR) proteins or defence peptides have been 
overexpressed, or plant metabolism has been modified to increase the production of 
antimicrobial compounds such as thionins, snakins, hevein- and knottin-like peptides, MBP1, 
IbAMP and so-called lipid transfer proteins (Veronese et al., 2003; Castro and Fontes, 2005; 
Pelegrini and Franco, 2005). Plant-derived ribosomal inactivating proteins have also been 
expressed in transgenic plants. These have a limited antifungal activity but also provide strong 
resistance against a broad range of plant viruses (Stirpe, 2004; Vivanco and Tumer, 2003).  
The disadvantage of natural, plant-derived resistance genes is that the resistance conferred on 
the plant is often short-lived since the pathogen can adapt rapidly to overcome it. 
 
I.4.2 Pathogen-derived resistance 
The concept of creating virus resistant crops by incorporating part of a viral genome into the 
genome of a host plant was first put forward by Hamilton (Hamilton, 1980). The first 
demonstration of this concept was provided by experiments using the Tobacco mosaic virus 
(TMV) coat protein sequence to transform tobacco plants (Powell-Abel et al., 1986). 
Subsequently, a number of transgenic crops tolerant or resistant to a range of viruses has been 
developed by expressing different viral sequences, including the viral genes encoding coat 
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proteins, nucleoproteins for minus-stranded RNA viruses, dysfunctional replicases or 
movement proteins (Goldbach et al., 2003). Transgenic grapevine plants expressing the coat 
protein of Arabis mosaic virus (ArMV), GLRaV-2 and 3, Grapevine fanleaf virus (GFLV) 
and Grapevine virus A (GVA) have been developed (Golles et al., 2000; Radian-Sade et al., 
2000; Spielman et al., 2000) and some of these are being evaluated for resistance in field 
trials. Of all the approaches, coat protein-mediated resistance has been used most frequently 
to obtain pathogen-mediated protection (Goldbach et al., 2003) and several transgenic lines 
are now cultivated commercially. 
Although protein-mediated resistance strategies have been successful under greenhouse and 
field conditions, there are some safety concerns reflecting the possibility that in planta 
recombination could produce wild type virus genomes or even completely novel viruses with 
unknown consequences (Borja et al., 1999; Canto et al., 2001). Therefore, the potential risks 
of pathogen-derived resistance make it less attractive for engineering virus resistance and 
novel approaches for engineering viral resistance are required. 
 
I.4.3 Antibody-based resistance against viruses 
The feasibility of antibody-based resistance has been demonstrated for plant and fungal 
viruses, and its application to other plant pathogens is becoming more established (Nölke et 
al., 2004, Zimmermann et al., 2006). The basis of antibody-based resistance is the 
neutralization of invading pathogens through interactions between high-affinity antibodies 
and critical pathogen proteins, thus preventing pathogen entry, replication and systemic 
spread. The first successful application of antibody-based resistance was reported by 
Tavladoraki et al. (1993). A scFv fragment specific for an isolate of Artichoke mottled crinkle 
virus (AMCV) was constructed from the parent monoclonal antibody selected from a panel 
raised against AMCV. The scFv was expressed in the plant cytosol and both transgenic 
protoplasts and plants were shown a reduction of infection and delay in symptom 
development to AMCV challenge. 
The success of antibody-based resistance depends on three major factors: 
• The selection of antibodies those are able to block a crucial step in the pathogen 
multiplication or transmission cycle, in combination with careful selection of the 
target molecule, appropriate design of the recombinant antibody format and selection 
procedures. 
• High levels of recombinant antibody accumulation, reflecting the design of the 
expression construct. 
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• Functionality of the antibody in the plant cell compartment where the pathogen life 
cycle is to be interrupted, reflecting the intrinsic properties of the recombinant 
antibody. 
 
For example this strategy was successfully used to engineer resistance against tomato spotted 
wilt virus (Prins et al., 2005), Tomato bushy stunt virus (Boonrod et al., 2004) and Cucumber 
mosaic virus (Villani et al., 2005). 
Antibody expression is therefore a powerful method for creating resistant plants, with the 
advantage that if the pathogen escapes the resistance, a second generation antibody that then 
counters the viral mutation can be developed.  
The aim of this thesis was to generate GLRaVs-specific scFvs using hybridoma and phage 
display technology and thereafter to express the selected candidates in the cytosol and phloem 
tissue of transgenic plants to evaluate if these recombinant antibodies could confer antibody-
based resistance in transgenic plants after virus inoculation. 
 
I.5 Recombinant antibody engineering 
Antibodies are complex glycoproteins that recognize and bind to target antigens with great 
specificity. This individual and specific binding activity allows antibodies to be used for a 
range of applications, including the diagnosis, prevention and treatment of disease (Chadd and 
Chamow, 2001). Traditional hybridoma technology (Köhler and Milstein, 1974) is limited to 
the production of full-size monoclonal antibodies of murine origin, but recombinant DNA 
methods now allow the production of derivatized molecules recognizing any target antigen 
and the fine-tuning of these recombinant antibodies to enhance their desirable properties 
(Kipriyanov and Little, 1999). Thus it is possible to design and express full-length 
recombinant antibodies and derivatives that are reduced in size, dissected into minimal 
binding fragments and rebuilt into multivalent, high-avidity reagents (Tomlinson and 
Holliger, 2000; Humphreys and Glover, 2001; Holliger and Hudson, 2005). Such derivatives 
include single chain Fv (scFv) fragments, bispecific scFvs, diabodies, minibodies, Fab 
fragments and F(ab’)2 fragments (Figure I-4). Because the antigen-binding surfaces of these 
small antibody fragments are unaltered, they can provide the same binding specificity as 
intact, full-size antibodies. 
ScFv fragments are a particularly popular antibody format (Bird et al., 1988). The size of 
theses molecules (30 kDa) is reduced to the antigen-binding part of the antibody, and they 
contain the variable domains of the heavy and light chain connected by a flexible linker 
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F(ab’)2 fragment Fab fragment
scFv fragment Diabody Bispecific scFv
linker 
N-terminus
IgG
S-S
Constant
region
C-terminus
Variable
region
Heavy 
chain
Light 
chain S-S
S-S
S-S
(usually 15-20 amino acids long, e.g. of the sequence (Gly4Ser)3, or 218 linker) (Whitlow et 
al., 1993). While most scFvs are predominantly monomeric some can also form higher 
molecular weight species, which can complicate selection and characterization (Griffiths et 
al., 1993). This tendency to dimerise has been exploited to create diabodies (Adams et al., 
2004) and triabodies (Todorovska et al., 2001; Bayly et al., 2002) by reducing the length of 
the linker. Moreover, in comparison with much larger Fab, F(ab’)2 and IgG forms of 
monoclonal antibodies from which they derived, scFvs have more rapid blood clearance and 
better tumour penetration (Holliger and Hudson, 2005; Wittel et al., 2005). scFvs can be 
conveniently produced in a variety of host, including bacteria (Hu et al., 2005), yeast (Fischer 
et al., 1999b; Emberson et al., 2005), and plant (Esteban et al., 2003; Galeffi et al., 2005).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure I-4: Schematic representation of an IgG molecule and various derived recombinant antibody fragments. 
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I.6 Phage display  
Phage display is an extremely powerful tool with applications in immunology, protein 
engineering, and ligand-receptor studies, among other. It allows large repertoires of molecules 
to be displayed on the surface of M13 phages and selected for specific characteristic, such as 
the selection of display antibody molecules that recognize specific antigens (de Bruin et al., 
1999).  
Antibodies were the first complex proteins to be successfully displayed on the surface of 
phages (McCafferty et al., 1990). This was achieved by fusing the coding sequence of the 
antibody variable (V) regions encoding a scFv fragment to the amino terminus of the M13 
phage gene encoding one of the phage coat proteins. 
Using the pIII structural protein the antibody is displayed using a phage vector. The genes 
encoding an antibody scFv fragment, are cloned in frame with gene III and downstream of the 
gene III signal sequence, which normally directs the adsorption protein to the bacterial 
periplasm. Here, the variable heavy (VH) and variable light (VL) domains will fold correctly, 
both stabilized by an intramolecular disulphide-bridge, and pair to form a functional scFv 
(Better et al., 1988; Skerra et al., 1988). Upon expression, the coat protein fusion will be 
incorporated into new particles that are assembled in the bacterium. Expression of the fusion 
product and its subsequent incorporation into the mature phage coat results in the binding 
structures being present on the phage surface, while its genetic material resides within the 
phage particle. This relation between genotype and phenotype allows enrichment of specific 
phages (Hoogenboom, 1997) and is the structural element that underpins all phage display 
technology (Willats, 2002). Selection of interesting members from the library based on the 
displayed antibodies binding specificity and affinity is generally performed over several 
rounds of selection and amplification in a process known as ‘panning’. Phages that display a 
relevant binding structure will be retained, while non-adherent phage will be washed away. 
Bound phages are recovered from the surface and used for reinfection of bacteria. 
Initially, phage vectors that carried all the genetic information required for the phage life 
cycle were used (McCafferty et al., 1990; Clackson et al.; 1991). Now, phagemids have 
become a more popular type of vector for display. Phagemids are small plasmid vectors that 
carry gene III with appropriate cloning sites and a phage packaging signal (Bass et al. 1990; 
Rader and Barbas, 1997). Additionally, they also contain an origin of replication and a 
resistance marker, therefore they can maintain itself as a plasmid and function as a bacterial 
expression vector if desired. Infection of the bacteria with a filamentous helper phage 
activates the phage origin of replication, resulting in single stranded phagemid DNA being 
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encapsulated into filamentous phage-like particles using a helper phage protein. A helper 
phage, such as M13KO7 has a defective packaging signal so the phagemid DNA is more 
efficiently replicated and packaged than the helper phage genome. Thus, the majority of 
phages produced contain the phagemid single-stranded DNA (Russel et al., 1986). Phagemids 
have high transformation efficiencies and are therefore ideally suited for generating very large 
repertoires. 
Additional, phagemids have been engineered to insert an amber stop codon incorporated 
between the cloned antibody fragment and the gene III. This format enables facile switching 
between expressions of membrane anchored fusion proteins in an E. coli suppressing strain 
such as TG1 and as soluble antibody fragments in non-suppressing E. coli strains such as 
HB2151 without subcloning. A goal of antibody engineering is to develop phage antibody 
display libraries of sufficient size and diversity to permit successful isolation of antibodies 
with desired specificities, including antibodies with high affinity and the desired 
pharmacokinetics. 
With phage display technology, we are now able to design repertoires of ligands from scratch 
and use the power of phage selection to select those ligands having the desired biological 
properties. Tailor-made antibodies may be synthesized and selected to acquire the desired 
affinity of binding and specificity for in vitro and in vivo diagnosis, for immunotherapy of 
human disease or for antibody-based resistance. Phage display is also a powerful tool for 
increasing antibody affinity to values not achievable using hybridoma technology and at the 
same time offers a new route for an effective display of scFv (Olea-Popelka et al., 2005; 
Wolfang et al., 2005;), Fab fragments (Hoet et al., 2005) and diabody fragments (Adams et 
al., 2004). 
 
I.6.1 Antibody phage display libraries 
The mammalian V-genes repertoires that encode antibody variable domains provide the raw 
material for phage antibody library construction. Libraries essentially fall into two categories 
depending on whether these genes are derived from animals immunised with the target 
antigen or from non-immunised animals. 
In the construction of repertoires from immune donors, IgG sequences are generally derived 
from the spleen B-cells of immunised animals. The repertoire of isolated V-genes are 
manipulated and packaged into phage library vectors. The rational is that some selection and 
affinity maturation of sequences with specificity for the antigen will have already occurred in 
vivo. 
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This method can generate antibodies with high affinity and specificity. Immune libraries have 
two major advantages: firstly, they are highly biased towards V-genes that encodes antibodies 
against the immunogen, which means that a relatively small (~105 clones) library can be 
successfully selected; and secondly, many of the genes will encode affinity matured 
antibodies. There are several drawbacks: firstly, there is little, if any, control over the immune 
response, which can often lead to no antibodies with the desired characteristics; secondly, 
tolerance mechanism make it difficult to isolate antibodies against self antigens and finally a 
practical shortcoming is that usually each new antigen specificity requires a new phage-
display library, which can take up to three months to make and is cost intensive. A variety of 
immune libraries have been generated, including mouse, human, rabbit, chicken, camel, cattle 
and sheep (Hoogenboom et al., 1998). 
The second type of phage display library are ‘single-pot’ libraries that depend on the source 
of immunoglobulin genes and are further discriminated in ‘naïve’ and ‘synthetic’ antibody 
libraries. The naïve libraries have a series of advantages over libraries from immunized 
donors: ideally, antibodies to any given antigen could be selected; no immunized donor is 
required (a particular advantage if human antibodies are required), antibodies can be isolated 
against self, non-immunogenic and toxic antigens and finally antibody generation takes less 
than two weeks. The major disadvantage are that much larger libraries must be cloned in 
order to isolate antibodies with affinities similar to those isolated from relatively small 
libraries made from immuno competent donors. They are made in essentially the same way as 
repertoires from immune donors using B-cells from diverse lymphoid sources including 
peripherical blood (Park et al., 2005), bone marrow, and tonsils (Vaughan et al., 1996; 
Okamoto et al., 2004). 
Theoretical studies have suggested, that the larger the library, the greater the chance of 
finding antibodies that bind to any given epitope. The affinity of antibodies selected from a 
naïve library is proportional to the size of the library, ranging from 106–7 M-1 for a small 
library, with 3x107 clones (Griffiths et al., 1993; Krebs et al., 1998; Griep et al., 1999; Villani 
et al., 2005), to 108–10 M-1 for a very large repertoire with 108-10 clones (Eeckhout et al., 2004). 
Synthetic or semi-synthetic libraries can be built artificially, by in vitro assembly of V-gene 
segments and D/J segments. V-genes may be assembled by introducing a predetermined level 
of randomization of complementary determining regions (CDRs) into germline V-gene 
segment (Ewert et al., 2004; Lee et al., 2004; van Wyngaardt et al., 2004; Hoet et al., 2005). 
Most natural structural and sequence diversity is found in the loop most central to the antigen 
combining site, the CDR3 of the heavy chain, while the five other CDRs have limited 
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variation (Clothia et al., 1989). This has therefore been the target for introduction of diversity 
in the first synthetic libraries. 
For most purposes, antibodies must bind their antigen tightly. Sufficient gain in apparent 
affinity may be achieved by simply constructing multivalent molecules (Hudson and Kortt, 
1999; Holliger and Hudson, 2005); however there will be situations in which in vitro affinity 
maturation of the selected antibodies is required. This diversity in the antibody genes is 
achieved using a variety of methods, chain shuffling (Klimka et al., 2000; Park et al., 2000), 
mutagenesis (Jermutus et al., 2001; Short et al., 2002), DNA shuffling (Jung et al., 1999; 
Huls et al., 2001) or rational design (Coulon et al., 2002; Kusharyoto et al., 2002). 
 
I.7 Antibody production in plants 
The first reports of a functional full-size recombinant antibody expressed in transgenic plants 
was described in 1989 (Hiatt et al., 1989) and 1990 (Düring et al., 1990). Since that time, 
plants have been engineered to express different classes of immunoglobulin including 
monotypic and chimeric IgG, IgM and IgA (Ma et al., 1994; Schillberg et al., 1999; Larrick et 
al., 2001; Sharp and Doran, 2001; Drake et al., 2003; Ramirez et al., 2003). 
In addition to full-size antibodies, various functional antibody derivatives have also been 
produced successfully in plants. These include Fab fragments (de Neve et al., 1993; De Wilde 
et al., 1998), scFvs (Tavladoraki et al., 1993; Kathuria et al., 2002; Ehsani et al. 2003; Galeffi 
et al., 2005; Olea-Popelka et al., 2005; Villani et al., 2005), bispecific scFvs (Fischer et al., 
1999c) and membrane-anchored scFvs (Schillberg et al., 2000; Vine et al., 2001). 
Accumulation of recombinant antibodies in the cytosol is attractive for several intracellular 
applications, such as engineering viral resistance. Although the cytosolic expression of single 
chain fragments is rather difficult by the reducing environment (De Jaeger et al., 2000), which 
would hinder the formation of the intrachain disulfide bonds of the variable domains of the 
heavy and light chains, cytosolic antibodies are generally unstable, exhibiting shorter half-
lives and low accumulation level (Cattaneo and Biocca, 1999; Schillberg et al, 1999). The 
ability of some scFv antibodies to accumulate in the cytosol appears to be dependent on their 
intrinsic properties. Most of the transgenic plants expressing scFv fragments in this specific 
compartment exhibited very low levels or at the detection limits. Nevertheless, some 
exceptions have been reported (De Jaeger et al., 1999; Nölke et al., 2005).  
Engineering viral resistance by cytosolic production of scFvs has been successfully 
demonstrated by Tavladoraki et al., 1993; Zimmermann et al., 1998; Xiao et al., 2000; 
Bajrovic et al., 2001; Boonrod et al., 2004; Prins et al., 2005 and Villani et al., 2005 (I.1.4.3). 
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The development of recombinant antibody engineering technologies and antibody production 
in plants seems almost uniquely flexible as a tool to protect crop plants because theoretically 
inhibitory antibodies can be generated that bind to any pathogen or protein involved in 
pathogenesis. 
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I.8 Aim of this thesis  
Transgenic plant technology offers the possibility to make grapevine inherently resistant to 
pathogen infection. The rational of this work is to generate pathogen-specific antibodies that 
inactivate major grapevine pathogens. Because of their economic importance for viticulture, 
the Closterovirus GLRaV-2 and the Ampelovirus GLRaV-3 were selected as target 
pathogens. The strategy followed was to select the coat proteins of theses viruses as target 
viral proteins and to generate and isolate specific single chain fragments that can bind and 
inactive viral particles by the use of phage display technology. A viral infection of a plant is a 
complex event consisting of key steps such as transmission by vector, encoting, viral genome 
replication, cell-to-cell movement and long-distance transport. The selection of the coat 
protein as a target for engineering virus resistant grapevine by antibody expression is based on 
the essential functions these proteins have in viral infectivity, replication and spread.  
ScFvs will be generated against the coat protein of GLRaV-2 and -3 by the use of genetic 
engineering and antibody technology. The cDNAs encoding these phage displayed antibodies 
will be characterised and expressed in tobacco in order to analyse their protein-protein 
detection in vivo. 
 
I.8.1 Generation of GLRaV-2 coat protein specific scFv fragments 
In this study the total RNA of the murine mAb R19 specific to GLRaV-2 coat protein were 
used for the amplification of the variable domains of the antibody heavy and light chains 
using reverse transcription and polymerase chain reaction. The variable antibody gene 
fragments will be assembled as scFv in a bacterial expression vector and the sequence and 
binding activity of the specific scFv fragment will be confirmed by ELISA. Furthermore, the 
selected scFv will be subcloned into a plant expression vectors containing the constitutive 
Cauliflower mosaic virus (CaMV) 35S promoter or the phloem-specific promoter of the 
Coconut foliar decay virus (CFDV). The functionality of the cytosolic transiently produced 
scFv fragment will be assessed by ELISA.  
Stable transformed tobacco lines accumulating GLRaV-2 coat protein specific scFv will be 
generated to investigate the ability of the expressed antibodies. 
 
I.8.2 Generation of GLRaV-3 coat protein specific scFv fragments 
GLRaV-3 coat protein will be bacterially expressed, affinity purified and used for mice 
immunization. A phagemid-scFv library will be constructed and used for the selection of scFv 
specific to GLRaV-3 coat protein by phage display technology. Specific scFvs are going to be 
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expressed, purified and tested for their reactivity and functionality to the specific target 
molecule by ELISA. The selected scFv will be characterized by basic proteins analysis 
method (SDS-PAGE and immunoblot) and affinity determination by surface plasmon 
resonance. Moreover, the functionality of the scFvs will be demonstrated by electrophoretic 
mobility shift assay (EMSA) and the binding to intact virus particles by immunogold electron 
microscopy (IEM). The putative epitope of the generated scFv fragment will be determined 
by epitope mapping. 
The selected scFv will be subcloned into a plant expression vectors and transiently produced 
in the plant cytosol using the constitutive 35S or the phloem-specific CFDV promoter. 
Accumulation levels and reactivity of the transiently produced scFv will be evaluated. Stable 
transformed N. benthamiana plants will be generated and characterized for the production and 
activity of the recombinant antibody fragment. 
 
A schematic overview of this thesis is presented in Figure I-5. 
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Figure I-5: Schematic outline of the thesis. 
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II Materials and Methods 
 
II.1 Materials 
 
II.1.1 Chemicals and consumables  
All chemical and solution used throughout this thesis were purchased from the following 
manufacturers: Amersham Pharmacia Biotech (Freiburg), Bio-Rad (München), British Biocell 
(Cardiff, England), Duchefa Biochemie (Haarlem, The Netherlands), Fluka (Neu-Ulm), Gibco 
BRL (Eggenstein), Merck (Darmstadt), Roche (Mannheim), Roth (Karlsruhe), Serva 
(Heidelberg), Sigma (Deisenhofen). The consumables were from: Amicon (Witten), Biozym 
(Hess. Oldendorf), Eppendorf (Hamburg), Greiner (Solingen), Kodak (Stuttgart), Millipore 
(Eschborn), Nunc (Bieberach), Schott Glaswerke (Mainz), Serva (Heidelberg), Stratagene 
(Amsterdam, The Netherlands), USB/Amersham (Braunschweig), Whatman (Bender & 
Hobein, Bruchsal) and Zeiss (Oberkochem). 
 
II.1.2 Buffer, media and solutions 
All standard solutions, buffers and media were prepared according to Sambrook et al. (1989), 
Ausubel et al. (1995) and Coligan et al. (1995). Compositions of non-standard solutions or 
buffers are listed at the end of the respective method section. Media for cultivating bacteria 
were sterilized by autoclaving (121°C/1-2 bar), all other solutions were sterile filtered 
(0.2 μm). Thermo labile components such as antibiotics were sterile filtered and added to the 
media after autoclaving and cooling to 50°C. 
 
II.1.3 Enzymes and reaction kits 
Restriction enzymes either purchased from New England Biolabs (Schwalbach) or Gibco 
BRL were used for DNA digestion. ExpandTM high fidelity DNA Taq polymerase from Roche 
was used for PCR amplification from cDNA libraries. Taq polymerase from Gibco BRL was 
used for amplification of mouse heavy and light chain fragments and for amplification of 
cloned DNA (check-PCR) (II.2.1.11). 
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The following kits were used: 
 
Kits                                                                                      Company 
Plasmid isolation kits (Mini, Midi, Maxi)  Qiagen (Hilden) 
QIAquick gel extraction kit  Qiagen 
QIAquick PCR purification kit  Qiagen 
MinEluteTM PCR purification kit Qiagen 
RNeasy mini kit  Qiagen 
SuperscriptTM preamplification system kit  GibcoBRL 
BCA protein assay kit  Pierce (Rockford) 
PCR DIG probe synthesis kit  Roche 
EZ-linkTM Activated Peroxidase Pierce (Rockford) 
ECL Advance Western blotting detection kit Amersham Biosciences 
 
 
II.1.4 Primary antibodies, secondary antibodies and substrates 
Polyclonal rabbit antibodies specific to GLRaV-2 CP and GLRaV-3 CP (BIOREBA, 
Switzerland) were used for capture ELISA (II.2.8.3). Mouse anti-c-myc tag monoclonal 
antibody (9E10) (ATCC clone number CRL-1729) was used for detection of scFv-fragments, 
immunoblot analysis (II.2.4.3) and ELISA (II.2.8.1). A mouse anti-his6 (Qiagen) antibody 
was used for detection of scFv fragments containing a C-terminal His 6tag in transient protein 
expression experiments (II.2.2.1). Alkaline phosphatase (AP) or horseradish peroxidase 
(HRP)-conjugated goat anti-mouse IgG (H+L, Fc) (Dianova) antibodies were used as 
secondary antibodies in immunoblot analysis (II.2.4.3) and ELISA (II.2.8.1). p-nitroblue 
tetrazolium chloride and 5-bromo-4-chloro-3-indolyl phosphate (NBT/BCIP) (Bio-Rad) as 
well p-nitrophenyl phosphate (pNPP) (Bio-Rad) were used as substrate for detection of 
immobilized proteins in immunoblot (II.2.4.3) and ELISA (II.2.8.1), respectively. 
 
II.1.5 Vectors 
II.1.5.1 Bacterial expression vectors 
pMAL c2X vector from New England Biolabs, containing the “tac” promoter was used for 
cloning the full length GLRaV-3 coat protein and also four truncated versions of the MBP-
GLRaV-3 coat protein (III.2.5.9.1) cDNAs. All the fusion proteins were then subsequently 
expressed and purified by one-step affinity purification for MBP using an amylose column) 
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(II.2.3.1). Construct MBP-58 LR-3 CP containing the first 58 amino acid of the MBP-
GLRaV-3 coat protein was kindly provided by Dr. P. Saldarelli (Dipartimento di protezione 
delle Piante e Microbiologia Applicata, Università degli Studi and Istituto di Virologia 
Vegetale- del C.N.R., Italy). 
pTYB1 plasmid from New England Biolabs, containing the T7 promoter was used for cloning 
the full length GLRaV-3 coat protein cDNA (II.2.3.1). 
 
pHENHi phagemid containing SfiI-BstEII, AscI-NotI cloning sites was used for cloning the 
heavy and light variable domains of the antibody respectively spaced by the modified 218 
poly-linker based on the 218-Whitlow linker (WHITLOW et al., 1993) for construction of the 
scFv.  
 
For bacterial expression (II.2.3.3), the scFv fragments were cloned into the pSynI vector 
(Amensdorfer et al., 1997). The pSynI vector contains a N-terminal pelB leader peptide that 
targets the expressed protein into the periplasmic space and a C-terminal His6 tag for 
purification via IMAC (Ni-NTA).  
 
pUC18 (Yanisch-Perron and Messing, 1985) containing the SCA24OmW cassette (Dr. Sabine 
Zimmermann, Institut für Biologie VII, RWTH, Aachen, Germany) (III.4.1.1) was used as an 
intermediate vector for cloning of the single chain scFvLR2cp-35 and scFvLR3cp-1 into the 
pTRA vector. 
 
II.1.5.2 Plant expression vector 
pTRA (Thomas Rademacher, Institut für Biology VII, RWTH Aachen, Germany) is a 
optimized plant expression vector containing the Cauliflower mosaic virus (CaMV) 35S 
promoter with duplicated enhancer region (35SS) or the phloem-specific promoter of the 
Coconut foliar decay virus (CFDV) and the pA35S untranslated region from Cauliflower 
mosaic virus (CaMV). There vectors were used to study the accumulation level and 
functionality of scFvs fragments in the plant cell cytosol or in the phloem tissue respectively. 
Schematic presentation of the vector maps are presented in the Appendices VII.2 
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II.1.6 Biological material 
II.1.6.1 Bacterial strains 
E. coli strains DH5α and XL1-Blue were used as a host cells for all intermediate cloning 
constructs. The strain BL21(λDE3) was used for expression of soluble scFv fragments 
(II.2.3.2). 
E. coli strain TG1 was used for generation of phage-displayed antibody libraries used in solid-
phase panning (II.2.7) (table II-1). 
Agrobacterium tumefaciens GV 3101::pMP90RK (gentr, kanr), rifr (Koncz and Schell, 1986) 
was used for agrobacterium-mediated gene transfer into tobacco leaves (Table II-1). 
 
Table II-1: Name, suppliers and genotypes of bacterial strains used throughout this thesis. 
Strain Source Genotype 
DH5α Ausubel et al., 1994 
F- (f80d Lac 2ΔM15) Δ(LacZYA-argF) U169end A1 rec1 
hsdR17(rk – mk +) deoR thi-1 supE44 gyrA96 relA1 λ- 
BL21(λDE3) Novagen F- ompT hsdSB (rB – mB -) gal dcm (DE3) 
XL1-Blue Stratagene recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F′ proAB laclIq ZΔM15 Tn10 (Tetr)] 
TG1 Stratagene supE thi-1 Δ(lac-proAB) Δ(mcrB-hsdSM) 5(rK - mK -) [F´traD36 proAB lacIq ZΔM15] 
Agrobacterium 
tumefaciens GV 
3101 
Koncz and 
Schell,1986 pMP90RK Gm
R, KmR, Rif R 
 
II.1.6.2 Plants 
Nicotiana tabacum cv. Petite Havana SR1 was used for transient protein expression after 
vacuum infiltration of recombinant agrobacteria (II.1.6.1). Nicotiana benthamiana was used 
for generation of stable transformed plants (II.2.2.4). 
 
II.1.6.3 Animals 
6-8 weeks old female BALB/c mice were used for immunization with MBP-GLRaV-3 coat 
protein fusion proteins (II.2.3.1). 
 
II.1.6.4 Hybridoma cell line mAb R19 
The cells of the hybridoma line mAb R19 secreting the GLRaV-2 specific monoclonal 
antibody (mAb) (class IgG2A) were used for isolation of total RNA (II.2.6.1.2) and was 
kindly provided by Dr. P. Saldarelli (Dipartimento di protezione delle Piante e Microbiologia 
Applicata, Università degli Studi and Istituto di Virologia Vegetale- del C.N.R., Italy). 
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II.1.6.5 Hybridoma cell line mAb LRE 
The specific GLRaV-3 coat protein mAb LRE (class IgA) was used to test the purity and 
integrity of the affinity purified full size MBP-GLRaV-3 coat protein and GLRaV-3 coat 
protein in immunoblot analysis (II.2.4.3) and was kindly provided by Dr. P. Saldarelli 
(Dipartimento di protezione delle Piante e Microbiologia Applicata, Università degli Studi 
and Istituto di Virologia Vegetale- del C.N.R., Italy). 
 
II.1.6.6 Phage 
M13KO7 helper phage (New England Biolab) is an M13 derivative which carries the 
mutation Met40IIe in gII, with the origin of replication from P15A and the kanamycin 
resistance gene from Tn903 both inserted within the M13 origin of replication. 
 
II.1.6.7 Viruses 
Reconstituted lyophilized material either from leaves extract of grapevine infected by 
GLRaV-3 (BIOREVA) or from N. benthamiana infected by GLRaV-2 (BIOREVA) was used 
for ELISA (II.2.8.3). 
 
II.1.7 Oligonucleotides 
Oligonucleotides used for sequence analysis and amplification of DNA are listed below. 
All oligonucleotides were synthesized by MWG-Biotech (Ebersberg). 
II.1.7.1 Oligonucleotides for PCR based analysis of recombinant bacterial clones 
• pTRA: 
forward pSS 5′: 5′ - GAC CCT TCC TCT ATA TAA GG – 3’ (20-mer) 
reverse pSS 3′: 5′ - C AC ACA TTA TTC TGG AGA AA – 5’ (20-mer) 
 
• pHENHi: 
pHEN forw VH: 5´- CAG GAA ACA GCT ATG AC - 3′ (17-mer) 
pHEN backwVL: 5′- GAA TTT TCT GTA GG - 3′ (14-mer) 
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II.1.7.2 Oligonucleotides used for synthesis of cDNA from total RNA (in 5´-3´ 
orientation) 
COH 30 (CH1 IgG1) GGC CAG TGG ATA GAC AGA 
COH 32 (CH1 IgG2a/2b) TAA CCC TWG ACC AGG CAT CC 
Mu PD 31 (CL1 κ) GCT GAT GCT GCA CCA ACT GTA TCC GTC GAC GCG GCC GCG ACT AGT 
Mu PD 32 (CL1 λ) TTT CCA CCT TCC TCT GAR GAG CTT GTC GAC GCG GCC GCG ACT AGT 
 
 
II.1.7.3 Sequences of murine VH domain specific forward primers (in 5′-3′ orientation) 
Name Overhang region Restriction sites (SfiI/NcoI) Binding region 
MPDVHF1 C ATG CCA TGA CTC GC G GCC CAG CCG GCC ATG GCC 
GAK GTR CAG CTT CAG GAG TCR 
GGA 
MPDVHF2 C ATG CCA TGA CTC GC G GCC CAG CCG GCC ATG GCC 
CAG GTG MAG CTG AWG GAR 
TCT GG 
MPDVHF3 C ATG CCA TGA CTC GC G GCC CAG CCG GCC ATG GCC 
GAG GTC CAG CTR CAR CAR TCT 
GGA CC 
MPDVHF4 C ATG CCA TGA CTC GC G GCC CAG CCG GCC ATG GCC 
CAG GTW CAG CTS CAG CAG TCT 
G 
MPDVHF5 C ATG CCA TGA CTC GC G GCC CAG CCG GCC ATG GCC 
SAG GTC CAR CTG CAG SAR YCT 
G 
MPDVHF6 C ATG CCA TGA CTC GC G GCC CAG CCG GCC ATG GCC 
GAG GTT CAG CTG CAG SAR YCT 
GGR 
MPDVHF7 C ATG CCA TGA CTC GC G GCC CAG CCG GCC ATG GCC 
GAR GTG AAG CTG GTG GAR TCT 
GGR 
MPDVHF8 C ATG CCA TGA CTC GC G GCC CAG CCG GCC ATG GCC 
GAG GTG AAG STY MTC GAG TCT 
GGA 
MPDVHF9 C ATG CCA TGA CTC GC G GCC CAG CCG GCC ATG GCC 
GAR GTG AAG CTK GAK GAG 
WCT GR 
MPDVHF10 C ATG CCA TGA CTC GC G GCC CAG CCG GCC ATG GCC 
GAV GTG MWG CTK GTG GAG 
TCT GGK 
MPDVHF11 C ATG CCA TGA CTC GC G GCC CAG CCG GCC ATG GCC 
GAG GTG CAR CTK GTT GAG TCT 
GGK 
MPDVHF12 C ATG CCA TGA CTC GC G GCC CAG CCG GCC ATG GCC 
SAG GTY CAG CTK CAG 
CAG TCT GGA 
MPDVHF13 C ATG CCA TGA CTC GC G GCC CAG CCG GCC ATG GCC 
CAG ATC CAG TTG GTG CAG TCT 
GGA 
MPDVHF14 C ATG CCA TGA CTC GC G GCC CAG CCG GCC ATG GCC 
CAG GTS CAC STG RWG SAG TCT 
GGG 
MPDVHF15 C ATG CCA TGA CTC GC G GCC CAG CCG GCC ATG GCC 
CAG GTT ACT CTR AAA GWG TST 
GGC C 
MPDVHF16 C ATG CCA TGA CTC GC G GCC CAG CCG GCC ATG GCC 
GAT GTG AAC TTG GAA GTG TCT 
GG 
Note: degeneracy codes: K= G or T; M = A or C; S = C or G; R = A or G; W = A or T 
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II.1.7.4 Sequences of murine VL domain specific forward primers (in 5′-3′ orientation) 
Name Overhang region Restriction sites (AscI) Binding region 
MPDVLF1 CAT GCC ATG ACT CGC GGC GCG CCT GAC ATT GTG MTG WCH CAG TCC CCA 
MPDVLF2 CAT GCC ATG ACT CGC GGC GCG CCT GAC ATT CAG ATG ATT CAG TCT CC 
MPDVLF3 CAT GCC ATG ACT CGC GGC GCG CCT GAC ATT GTT CTC WHC CAG TCT CC 
MPDVLF4 CAT GCC ATG ACT CGC GGC GCG CCT GAC ATT GTG MTG WCH CAG TCT CAA 
MPDVLF5 CAT GCC ATG ACT CGC GGC GCG CCT GAT RTT KTG ATG ACC CAR RCK GCA 
MPDVLF6 CAT GCC ATG ACT CGC GGC GCG CCT GAT RTT KTG ATG ACC CAR RCK CCA 
MPDVLF7 CAT GCC ATG ACT CGC GGC GCG CCT GAC ATT GTG ATG ACC CAR BHT G 
MPDVLF8 CAT GCC ATG ACT CGC GGC GCG CCT GAT ATT KTG ATG ACC CAR AYT CC 
MPDVLF9 CAT GCC ATG ACT CGC GGC GCG CCT RAM ATT GTG MTG ACC CAA TYT CCW 
MPDVLF10 CAT GCC ATG ACT CGC GGC GCG CCT SAA AWT GTK CTS ACC CAG TCT CCA 
MPDVLF11 CAT GCC ATG ACT CGC GGC GCG CCT GAY ATY CAG ATG ACM CAG WCT AC 
MPDVLF12 CAT GCC ATG ACT CGC GGC GCG CCT GAY ATY CAG ATG ACH CAG WCT CC 
MPDVLF13 CAT GCC ATG ACT CGC GGC GCG CCT GAC ATT GTG ATG ACT CAG GCT AC 
MPDVLF14 CAT GCC ATG ACT CGC GGC GCG CCT CAR SYT GTK STS ACT CAG KAA T 
MPDVLF15 CAT GCC ATG ACT CGC GGC GCG CCT CAR SYT GTK STS ACT CAG KCA T 
Note: degeneracy codes: K= G or T; M = A or C; S = C or G; R = A or G; W = A or T 
 
 
II.1.7.5 Sequences of murine VH domain specific backward primers (in 5′-3′ 
orientation) 
Name Overhang region Restriccion sites  (BstEII) Binding region 
MPDVHB1 CTA GTG GTA CTC CAC GGC GCG CCT MRG AGA CDG TGA SMG TRG TC 
MPDVHB2 CTA GTG GTA CTC CAC GGC GCG CCT MRG AGA CDG TGA SRG TRG TG 
MPDVHB3 CTA GTG GTA CTC CAC GGC GCG CCT MRG AGA CDG TGA SCA GRG TC 
MPDVHB4 CTA GTG GTA CTC CAC GGC GCG CCT MRG AGA CDG TGA STG AGG TT 
MPDVHB5 CTA GTG GTA CTC CAC GGC GCG CCT MRG AGA CDG TGA STG ARA TT 
Note: degeneracy codes: K= G or T; M = A or C; S = C or G; R = A or G; W = A or T 
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II.1.7.6 Sequences of murine κ VL domain specific backward primers (in 5′-3′ 
orientation) 
Name Overhang region Restriccion sites (SalI/NotI) Binding region 
MPDVLB1 CT AGT GGT ACT CCA C GC GGC CGC GTC GAC AGC MCG TTT CAG YTC CAR YTT 
MPDVLB2 CT AGT GGT ACT CCA C GC GGC CGC GTC GAC AGC MCG TTT KAT YTC CAR YTT 
MPDVLB3 CT AGT GGT ACT CCA C GC GGC CGC GTC GAC AGC MCG TTT BAK YTC TAT CTT TGT 
MPDVLB4 CT AGT GGT ACT CCA C GC GGC CGC GTC GAC AGC MCG AGC MCG TTT TAT TTC CAA MKT 
MPDVLB5 (λ) CT AGT GGT ACT CCA C GC GGC CGC GTC GAC CTG RCC TAG GAC AGT SAS YTT GGT 
Note: degeneracy codes: K= G or T; M = A or C; S = C or G; R = A or G; W = A or T 
 
II.1.7.7 Oligonucleotides used for sequencing DNA (in 5′-3′ orientation) 
Universe GTT GTA AAA CGA CGG CCA GT 
Reverse (P4) ACA CAG GAA ACA GCT ATG AC 
pHEN forward GCC GCT GGA TTG TTA TTA CTC GC 
pHEN backward TTT CAA CAG TCT ATG CGG CCC C 
pSS 5′ ATC CTT CGC AAG ACC CTT CCT CT 
pSS 3′ AGA GAG AGA TAG ATT TGT AGA GA 
malE forward CGC CAG GGT TTT CCC AGT CAC GAC 
 
 
II.1.7.8 Oligonucleotides used for the generation of the truncated versions of the 
MBP-GLRaV-3 coat protein (in 5′-3′ orientation) 
pMAL_CP3-f CCG GAA TTC GGA TCC ATG GCA TTT GAA CTG AAA 
pMAL_CP3-del1-r CAT TGG CTG CAG GTC GAC TTA CGC TGG TGG CTG CCT AGG 
pMAL_CP3-del2-r CAT TGG CTG CAG GTC GAC TTA TGT GAG AGT CTC AGA TTC 
pMAL_CP3-del4-r CAT TGG CTG CAG GTC GAC TTA TTT CCC TGG CTC GTT AAT 
pMAL_CP3-del5-r CAT TGG CTG CAG GTC GAC TTA TTC GGC GCC CAT AAC CTT 
malEcoRIForLR3 TGA GAA TTC ATG GCA TTT GAA CTG AAA TTA G 
CP3-3b CGG CGC CCA TAA CCT TCT TAC A 
 
 
II.1.8 Matrices and membranes 
Amylose resin from New England Biolabs was used for the purification of the full size MBP-
GLRaV-3 coat protein (II.2.3.1) and truncated MBP-GLRaV-3 coat protein versions 
(II.2.3.1). 
Ni-NTA agarose matrix from Bio-Rad was used for purification of scFv fragments containing 
a C-terminal His6 tag by immobilized metal ion affinity chromatography (IMAC) (II.2.3.3). 
HybondTM-C nitrocellulose membrane (0.45 μm) from Amersham Life Science and Whatman 
no.1 paper from Whatman (Maidstone, England) were used in immunoblot analysis (II.2.4.3). 
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II.1.9 BIAcore reagents 
Sensor chip CM5, surfactant P20, 2-(2-pyridinyldithio) ethanolamine hydrochloride (PDEA), 
amine-coupling kit containing N-hydroxysuccinimide (NHS), N-ethil-N´-(3-
diethilaminopropyl) carbodiimide (EDC), and ethanolamine hydroxychloride were obtained 
from Pharmacia Biosensor AB. For all experiments (II.2.8.5) degassed HBS buffer was used. 
 
II.1.10 Equipment and applications 
Cameras and scanner: MP4 (Polaroid, Cambridge, MA, USA), E.A.S.Y 429K camera 
(Herolab, Wiesloch), Arcus II Scanner with AGFA FotoLook 3.5 Software (AGFA, Köln), 
Fujifilm LAS-1000 (Fujifilm). 
Centrifuges: AvantiTM 30 and AvantiTMJ-25 (Beckman, California, USA), Biofuge A 
(Heraeus, Hanau), Sigma 3-10 and Sigma 4-10 (Sigma, St. Louis, Missouri, USA), RC5C and 
RC5B plus (Sorval instruments, Du Pont, Bad Homburg). Rotors: F0650, F2402H, JLA 
10.500 and JA 25.50 (Beckman), #1140 and #11222 (Sigma), RLA-300, SS-34 and GS-3 (Du 
Pont). 
Chromatography equipment: ÄKTA explorer 10xT (Amersham Pharmacia Biotech), Gel 
filtration XK26 column 26 mm inside diameter, 20 cm length (Amersham Pharmacia 
Biotech), 150 ml super-loop (Amersham Pharmacia Biotech) and UNICORN control, 
evaluation and documentation software (Amersham Pharmacia Biotech). 
DNA gel electrophoresis apparatus: wide mini and mini cells for DNA agarose 
electrophoresis and power supplies (Bio-Rad). 
DNA-sequencing machine: ABI Prism 3730 Genetic Analyzer (Applied Biosystems, 
Foster, CA, USA). 
Electron Microscope: Philips EM 400T 
Electroporation apparatus: “Gene pulserTM”, “Pulse controller” unit, Extender unit (Bio-
Rad) and 0.2 cm cuvettes (Bio-Rad). 
InnovaTM 4340 incubator shaker (New Brunswick Scientific, Nürtingen). 
PCR Thermocyclers: Primus and Primus 96 plus (MWG-Biotech). 
Photometers: Eppendorf biophotometer with Printer DPU 414 (Eppendorf, Hamburg), and 
multi-channel spectrophotometer Spectromax 340 (Molecular Devices, Sunnyvale, 
California). 
Probe sonicator: Bandelin Sonoplus sonicator UW2070 with Titan Microtip MS72 
(Bandelin Electronic, Berlin)  
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Protein gel electrophoresis and electroblotting equipment: Mini-PROTEAN IIITM 
electrophoresis system (Bio-Rad), Mini Trans-Blot Cell (Bio-Rad), Gel Air, Dryer (Bio-Rad). 
Software: Windows NT 4.0 operating system (Microsoft); Microsoft Office 2000 
(Microsoft); Adobe Photoshop 6.0 (Adobe); Chromas; Origin 6.0 (Data analysis and technical 
graphics, Microcal Software, Inc.); Align IR, version 1.2 (LI-COR); GCG (Wisconsin 
Package TM of Genetic Computer Group). 
Speed-Vac centrifuge: Eppendorf Concentrator 5301 (Eppendorf)  
Surface plasmon resonance: BIACORE® 2000 (BIACORE®, Uppsala, Schweden), 
Windows NT 4.0 operating system (Microsoft) and Software (BIAControl 1.3 and 
BIAEvaluation 3.0). 
UV-Transilluminators: wavelength 302 nm and UVT-20M (Herolab). UV-chamber (Bio-
Rad). 
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II.2 Methods 
All experiments related to the genetic engineering were performed according to the 
regulations of “S1-Richtlinien” and were officially approved by the Regierungspräsidium des 
Landes NRW” (RP-Nr.: 23.203.2 AC 12, 21/95) and “BGA” [AZ 521-K-1-8/98:AI3-
04/1/0866/88 (S1) and 55.8867/-4/93 (greenhouse)]. 
 
General recombinant DNA techniques, i.e. PCI (phenol/chloroform/isoamyl alcohol) and CI 
(chloroform/isoamyl alcohol) extraction, DNA precipitation, restriction enzyme digestion, 
DNA ligation, DNA agarose gel electrophoresis, were performed according to the standard 
protocols described in Sambrook et al. (1989) and Ausubel et al. (1995). 
 
II.2.1 Recombinant DNA technology 
II.2.1.1 Preparation of electrocompetent E. coli cells 
Electrocompetent E. coli were prepared from the following strains, DH5α, BL21(λDE3), 
XL1-blue, and TG1 as described by Dower et al. (1988). A single bacterial colony from an 
LB plate was inoculated in 5 ml LB-broth and cultured o/n at 37°C. Three ml of fresh o/n 
culture was transferred into 500 ml of LB broth. The cells were cultured at 37°C for 3-4 hours 
until the mid-log phase (OD600nm = 0.5-0.8). Then the cells were placed on ice for 15-20 min 
and harvested by centrifugation (3000g/4°C/10 min). Cells were washed three times with 
sterile water and resuspended in ice-cold 10% (v/v) glycerol to a 300-fold concentration of the 
original culture volume (>1010 cells/ml). 40 μl aliquots were stored at -80°C. 
 
II.2.1.2 Transformation of E. coli by electroporation 
Electrocompetent cells (II.2.1.1) were thawed on ice and mixed with 1 pg to 300 ng of DNA 
in sterile dH2O. The cell/DNA mixture was transferred into a prechilled electroporation 
cuvette (0.2 cm) and assembled into a safety chamber. After application of the pulse 
(25 μF, 2.5 kV, 200 Ω), the cells were diluted in 1 ml of SOC medium and incubated at 37°C 
with shaking for 1 h. Finally, 100 μl of the cells were plated onto LB agar containing 
appropriate antibiotics and incubated o/n at 37°C. 
 
II.2.1.3 Preparation of electrocompetent Agrobacterium cells 
A single colony of Agrobacterium tumefaciens strain GV3101 grown on a YEB agar plate 
containing 100 μg/ml rifampicin (Rif) and 25 μg/ml kanamycin (Km) (YEB-Rif-Km) was 
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inoculated in 5 ml of YEB-Rif-Km medium in a 100 ml Erlenmeyer flask and incubated at 
28°C for two days with shaking (250 rpm). One ml of the culture was transferred into 100 ml 
of YEB-Rif-Km medium and cultivated at 28°C for 15-20 h with shaking (250 rpm) until the 
OD600nm reached 1-1.5. The cells were chilled on ice for 15 min and spun down by 
centrifugation (4,000g/4°C/5 min). The culture medium was decanted and the cells were 
washed three times with 10 ml of dH2O by centrifugation and resuspended in 500 μl of sterile 
10% (v/v) glycerol. 45 μl-aliquots of the suspension were dispensed into prechilled 
microcentrifugation tubes, frozen immediately in liquid nitrogen and stored at -80°C. 
 
YEB-Rif-Km medium: 
                                      Nutrient broth 0.5% (w/v) 
                                      Yeast extract 0.1% (w/v) 
                                      Peptone 0.5% (w/v) 
                                      Sucrose 0.5% (w/v) 
2 mM MgSO4, 100 μg/ml rifampicin and 25 μg/ml kanamycin were added after autoclaving 
and cooling. 
 
II.2.1.4 Transformation of Agrobacterium by electroporation 
0.2-1.0 μg of plasmid DNA (II.2.1.8) in sterile dH2O was added to a thawed aliquot of 
electrocompetent A. tumefaciens cells (II.2.1.3) and incubated on ice for 3 min. The cell/DNA 
mixture was transferred into a prechilled electroporation cuvette (0.2 cm) and assembled into 
a safety chamber. After application of the pulse (25 μF, 2.5 kV, 200 Ω), the cells were diluted 
in 1 ml of SOC medium in a 4.0-ml tube and incubated at 28°C with shaking (250 rpm) for 1 
h. Finally, 1-10 μl of the cells were plated on YEB agar containing 100 μg/ml rifampicin 
(Rif), 25 μg/ml kanamycin (Km) and 100 μg/ml carbenicillin (Carb) (YEB-Rif-Km-Carb) and 
incubated at 28°C for 2-3 days. As a control transformation of A. tumefaciens cells with H2O 
was performed. 
 
II.2.1.5 Determination of the efficiency of recombinant bacteria transformation 
Efficiency of transformation of each new batch of competent cells was measured by test 
transformations with known concentrations of supercoiled pUC18 plasmid for E. coli. The 
following transformation rates were obtained: electrocompetent E. coli >108/μg pUC18 and A. 
tumefaciens >103/μg pSSH1. 
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II.2.1.6 Culturing of E. coli and glycerol stock preparation 
Individual colonies of all strains were obtained by plating the pertaining strain on LB agar 
plates. Strains carrying an F′ factor were spread on M9 plates. Incubation was performed at 
37°C. The plates were stored at 4°C for short periods (less than 2 weeks). LB medium 
containing the suitable antibiotics and 2% (w/v) glucose was inoculated with a single 
recombinant colony of E. coli and grown o/n at 37°C with vigorous shaking (225 rpm). 
Glycerol stocks were prepared by mixing 600 μl of a fresh overnight culture with 600 μl of 
40% (v/v) sterile glycerol. Bacterial glycerol stocks were stored at -80°C. 
 
II.2.1.7 Growth of recombinant A. tumefaciens and preparation of glycerol stocks 
Single colonies of A. tumefaciens were examined for the presence of plasmids by control PCR 
(II.2.1.11). Positive colonies were inoculated in 10 ml of YEB-Rif-Km-Carb medium and 
cultivated at 28°C for 2-3 days with vigorous shaking at 250 rpm. The culture was transferred 
to 50 ml Falcon tubes and agrobacteria cells were pellet by centrifugation at 4000g for 10 min 
at 15°C. The cells were resuspended in 0.5 ml YEB Rif-Km-Carb medium and 0.5 ml 
glycerol stock media (GSM). The suspension was aliquoted (100μl) and stored at -80°C for 
further experiments. 
 
Glycerol stock media (GSM): 
                                      Tris-HCl, pH 7.4 25 mM 
                                      Glycerol l5% (v/v) 
                                      MgSO4 100 mM 
 
II.2.1.8 Isolation of plasmid DNA from E. coli 
Recombinant plasmid DNA was purified with the Qiagen plasmid DNA Mini-and Midiprep 
kits according to the manufacturer’s instructions based on the alkaline lysis method 
(Sambrook et al., 1989). Quality and yield of plasmid DNA was examined by reading the 
absorbance at 260 nm and 280 nm in a spectrophotometer according to Müller et al. (1993) 
and Sambrook et al. (1996). The integrity of DNA was verified by a control restriction digest 
followed by agarose gel electrophoresis (II.2.1.9). Isolated plasmid DNA was stored at -20°C. 
 
II.2.1.9 Agarose gel electrophoresis 
Plasmid DNA (II.2.1.8) and PCR-fragments (II.2.1.12) were separated in 0.8-1.2% (w/v) 
agarose gels. Preparation of agarose gels and electrophoresis of the samples were carried out 
as described by Sambrook et al. (1989). Ethidium bromide was added to the gel solution and 
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TBE electrophoreses running buffer prior to the experiment. Known amounts of DNA 
molecular markers such as 1 kb ladder and 100 bp ladders were used for evaluation and 
determination of DNA concentration and size. The DNA bands were visualised directly upon 
illumination with a UV transilluminator at 302 nm. Documentation of the DNA gels was 
performed by using a black and white E.A.S.Y 429K camera (Herolab). 
 
II.2.1.10 Preparative agarose gel electrophoresis 
Preparative gel electrophoresis was used for large scale purification of a particular DNA 
fragment from (II.2.1.8) a mixture of DNA fragments after restriction enzyme digestion. The 
agarose containing the DNA fragment of interest was excised from the gel on an UV 
transilluminator with a sterile scalpel. The DNA extraction was performed with QIAquick Gel 
extraction kit according to the manufacturer’s guidelines. The concentration of recovered 
DNA was measured by spectrophotometer (II.2.1.11) or determined by agarose gel 
electrophoresis (II.2.1.9) and was used in further experiments. 
 
II.2.1.11 Quantification of nucleic acids 
The amount of RNA or DNA in a sample was estimated by measuring the OD260nm. The 
OD260nm of one corresponds to ~50 μg/ml of double stranded DNA, ~40 μg/ml of single 
stranded DNA and RNA and ~20 μg/ml of single stranded oligonucleotides. Purity of the 
nucleic acid was ascertained by the OD260/OD280 ratio of the measured optical density, which 
is 1.8 for pure DNA and 2.0 for pure RNA.  
 
 
II.2.1.12 PCR amplification 
For rapid identification of recombinant E. coli and agrobacteria control PCR was carried out 
to detect plasmids as described by Jesnowski et al. (1995). 
The optimal annealing temperature (Tp) of the primers was experimentally optimised or 
calculated based on the empiric formula (Wu et al., 1991): 
Tp = {22 + 1,46 [2X (G + C) + (A + T)]} 
 
 
 
PCR reactions were carried out in a total volume of 50 μl as described below: 
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X 35 
Components  Volume Final concentration 
10X PCR buffer  
50 mM MgCl2  
10 mM dNTPs  
10 pmol forward Primer  
10 pmol backward primer  
Template DNA  
Taq DNA polymerase (5U/μl)  
dd H2O  
5 μl 
1.5 μl  
1 μl 
0.5-1 μl 
0.5-1 μl 
0.5-5 μl 
0.25 μl 
to 50 μl 
1X 
1.5 mM 
0.2 mM each 
10 pmol 
10 pmol 
10-100 ng 
1.25 units 
 
Amplification was carried out under the following conditions: 
 
5 min 95°C  initial denaturation 
1 min 94°C denaturation 
1 min 55°C primer annealing 
1 min 72°C primer extension 
5 min 72°C final extension 
 
The annealing temperature and the time for denaturation were changed according to Tp value 
of primers and the length of the target gene. The performance of each PCR reaction was 
checked by running 5 μl of each reaction on agarose gels (II.2.1.9) with appropriate DNA 
markers. 
 
II.2.1.13 DNA sequencing 
BigDye® Terminator v3.1 Cycle Sequencing Kit (ABI) was used for performing fluorescence-
based cycle sequencing reactions using plasmid DNA or PCR fragments as templates. The 
reaction products were purified using Montage SEQ sequencing reaction cleanup kits® 
(Millipore) and run on an ABI Prism 3730 DNA analyser. 
 
II.2.1.14 Sequence analysis 
Chromas software package and Align IR, version 1.2 (LI-COR) were used for displaying the 
chromatogram files from automated DNA sequencer. The sequences were edited and exported 
for further with the Wisconsin Package TM of Genetic Computer Group (GCG). 
II.2.2 Generation and characterisation of transgenic plants 
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II.2.2.1 Preparation of recombinant A. tumefaciens 
100 ml of YEB-Km-Rif-Carb medium was inoculated with 100 μl of the glycerol stock from 
the selected recombinant agrobacteria carrying a plant expression vector. The culture was 
grown o/n at 28°C with shaking at 250 rpm. Next day the cells were pelleted by centrifugation 
at 5000 g for 10 min at 15°C and transferred into 250 ml of induction medium and cultivated 
o/n at 28°C with shaking at 250 rpm. Agrobacteria cells were centrifuged 
(4000g/15°C/15 min) and resuspended in 50 ml of MMA buffer and kept at RT for 2 h. The 
OD600nm was measured after 1:10 dilution and the cell suspension was adjusted to an OD600nm 
of 1. 100 ml of the diluted cell suspension was used for vacuum infiltration of plant leaves 
(II.2.2.1). 
 
Induction medium: 
                       YEB medium, pH 5.6 
                       MES 10 mM 
 
2 mM MgSO4, 25 μg/ml kanamycin, 100 μg/ml rifampicin, 100 μg/ml carbenicillin and 
20 μM acetosyringone were added after autoclaving and cooling. 
 
MMA solution: 
                       MS-salts (Murashige & Skoog, basic salt mixture) 0.43% (w/v) 
                       MES, pH 5.6 10 mM 
                       Sucrose 2% (w/v) 
                       Acetosyringone was added directly before use 200 μM 
 
II.2.2.2 Transient assay in tobacco leaves by vacuum infiltration 
Growth of recombinant A. tumefaciens (II.2.1.7) and vacuum infiltration of tobacco leaves 
were performed as described by Kapila et al. (1996) and Vaquero et al. (1999). 
 
II.2.2.3 Vacuum infiltration of intact leaves 
Young N. tabacum cv. Petite Havana SR1 leaves (4 leaves for each construct) were placed in 
100 ml of recombinant agrobacteria suspension in a “Weck” glass and a continuous vacuum 
(60- 80 mbar) was applied for 15-20 min. The applied vacuum was released rapidly; the 
leaves were briefly rinsed in tap water and kept on wet Whatman paper no. 1 with adaxial side 
upwards. The plastic tray was sealed with saran wrap and placed at 22°C with a 16 h 
photoperiod for 60 h. Leaves were weighed, frozen in liquid nitrogen and stored at -80°C until 
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analysis. As control, leaves were infiltrated with agrobacteria suspension, which did not 
contain the plant expression vector plasmid. 
 
II.2.2.4 Agrobacterium-mediated stable transformation Nicotiana benthamiana 
Stable transformation of N. benthamiana was performed with the help of Dr. Flora Schuster 
(RWTH Aachen, Institute für Biology VII). Transgenic N. benthamiana were generated by 
leaf disc transformation using recombinant A. tumefaciens transformed with pTRA plasmid 
carrying the cDNAs encoding the heavy and light chains scFvLR3cp1 and scFvLR2cp3-5 
(II.2.1.3). Transgenic T0 plants were regenerated from transformed callus (Fraley et al., 1983; 
Horsch et al., 1985).  
Briefly, wild type plants were grown on MS medium in “Weck” glasses and the youngest 
leaves (length up to 2 cm) were used for transformation. The recombinant agrobacteria 
suspension was prepared as described above (II.2.2.1) and the OD600nm was adjusted to at least 
1.0 after dilution in MMA buffer. 
The leaves were cut into 5-8 pieces and transferred into “Weck” glasses containing 50-100 ml 
of recombinant agrobacteria suspension and incubated at RT for 30 min. The leaf pieces were 
then transferred onto sterile pre-wetted Whatman filters in petri dishes closed with saran wrap 
and incubated at 23-25°C in the dark for two days. Following washing with distilled water 
containing 200 μg/ml Cefotaxime sodium (Duchefa), leaf pieces were transferred onto MS-II 
plates and incubated at 25°C in the dark for three days and with a 16 h photoperiod for 2-3 
weeks. 
After shooting, the shoots were removed, transferred onto MS-III plates and incubated at 
25°C with a 16 h photoperiod for 10-14 days until roots developed. The small plants were 
transferred into “Weck’’ glasses containing MS-III medium and incubated at 25°C in 16 h 
light rhythm for 2 weeks until transferred into soil. The young leaves from regenerated 
transgenic plants were used for immunoblot analysis of expressed scFvs (II.2.4.3). 
MS medium:  
                     MS-salts 0.43% (w/v) 
                     Myo-Inosite 0.1% (w/v) 
                     Sucrose 2% (w/v) 
                     Thiamin-HCl 0.4 mg/l 
                     ddH2O add to 1000 ml 
The pH was adjusted to 5.8 with 1 N NaOH (for preparation of solid medium, 0.8% (w/v) 
agar was added). The solution was autoclaved and 500 μl of vitamin (Duchefa) solution were 
added upon cooling to 55°C. 
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MS-II medium: 
                     MS medium supplemented with: 
                     6-Benzylaminopurin (BAP) (Duchefa) 1 mg/l 
                     α-Naphtalenacetic acid (NAA) (Sigma) 0.1 mg/l 
Solution was autoclaved, then and Bialaphos (3 mg/l) and Claforan (250-500 mg/l) were 
added. 
 
MS-III medium: 
                           Autoclaved MS medium supplemented with: 
                           Bialaphos 3 mg/l 
                           Claforan 200-500 mg/l 
 
II.2.2.5 Growth of N. benthamiana 
Tobacco plants were grown in ED73 standard soil (Patzer, Sinntal-Jossa) with 0-30% (v/v) 
sand under the following conditions: 16 h artificial light, 25°C (or higher depending on the 
outside temperature), 10000 Lux (plus the sun light) and 70-90% humidity. To prevent 
pollination from other plants, flowers were covered with plastic bags with micro pores. 
Mature, dried seeds were stored in paper bags at RT. 
 
II.2.2.6 Preparation of total soluble proteins from plant leaves 
For the extraction of transiently expressed scFv in vacuum infiltrated tobacco leaves (II.2.2.3) 
or in stable transformed N. benthamiana plants (II.2.3.4), frozen leaves were ground in liquid 
nitrogen to a fine powder with a mortar and pestle. Total soluble proteins were extracted using 
2 ml of extraction buffer per gram leaf material. Cell debris was removed by two rounds of 
centrifugation (16000g/4°C/30 min) and the supernatant was used for expression analyses by 
immunoblot (II.2.4.3) and capture ELISA (II.2.8.3). 
 
Extraction buffer: 
                          Tris-HCl, pH 7.5 200 mM 
                          EDTA 5 mM 
                          DTT 0.1 mM 
                          Tween 20 0.1% (v/v) 
 
 
 
 
 
II Material and Methods 
____________________________________________________________________________________________________ 
 35
II.2.3 Expression and purification of recombinant proteins 
II.2.3.1 Bacterial expression and purification of full length MBP-GLRaV-3 coat 
protein and truncated MBP-GLRaV-3 coat protein versions 
MBP-GLRaV-3 coat protein and four truncated versions of the GLRaV-3 coat protein 
(III.2.5.9.1) comprising the first 78, 98, 148 or 161 amino acids (MBP-78 LR-3 CP, MBP-98 
LR-3 CP, MBP-148 LR-3 CP, MBP-161 LR-3 CP, respectively) C-terminally fused to MBP 
were expressed based on the manufacturer recommendations (New England Biolabs). 
The plasmid DNAs (II.2.1.8) were transformed separately into E. coli strain BL21(λDE3) and 
a single colony harbouring recombinant plasmid DNA was inoculated in 10 ml of fresh rich 
broth medium containing 1.5% (w/v) glucose and cultivated o/n at 37°C with vigorous 
shaking. The following day, the cells were used for inoculation of 1 litre rich broth medium 
containing ampicillin (100 µg/ml). The culture was grown to an OD600nm of 0.5-0.7. 
Expression of recombinant protein was then induced by addition of IPTG to a final 
concentration of 0.3 mM and incubated for 3 additional hours at 37°C. The cells were 
harvested by centrifugation (20 min/5000 g/4°C). The supernatant was discarded and the 
pellet was frozen at -20°C o/n. The next day, cells were thawed on ice, resuspended in ice-
cold column buffer (10 ml) and sonicated on ice 3 times for 2 min (cycle 9, power 70%, and 
1 min intervals). Cell debris and insoluble components were removed by centrifugation 
(30000 g/20 min/4°C) and the supernatant subjected to amylose affinity chromatography. 
The crude extract was applied to a pre-equilibrated amylose matrix. Unbound protein was 
washed with 20-30 matrix volumes of ice-cold column buffer. The different recombinant 
proteins were eluted in four fractions of 1 matrix volume with elution buffer. Ten µl from 
each step was tested by immunoblot analysis (II.2.4.3) and SDS-PAGE (II.2.4.2). Protein 
concentration was determined using the Pierce BCA protein assay (II.2.4.1). 
 
 
Rich broth medium: 
                         Tryptone 10 g 
                         Yeast extracts 5 g 
                         NaCl 5 g 
                         Glucose 2 g 
 
Column buffer: 
                          Tris-HCl, pH 7.4 20 mM 
                          NaCl 200 mM 
                          EDTA 1 mM 
                          DTT 1 mM 
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Elution buffer: 
                         Tris-HCl, pH 7.4 20 mM 
                         NaCl 200 mM 
                         EDTA 1 mM 
                         DTT 1 mM 
                         Maltose 10 mM 
 
II.2.3.2 Bacterial expression and purification of full length GLRaV-3 coat protein 
The pTYB1 bacterial expression vector carrying the full length GLRaV-3 coat protein cDNA 
was used to transform BL21(λDE3) E. coli electrocompetent cells (II.2.1.2). One colony was 
grown in 10 ml of LB medium o/n at 37°C. The following day, the cells were used for 
inoculation of 1 litre LB medium containing ampicillin (100 µg/ml). The culture was grown 
to an OD600nm of 0.6 - 0.7. Expression of recombinant protein was then induced by addition of 
IPTG to a final concentration of 0.3 mM and incubated o/n at 15°C. After o/n induction the 
cells were harvested by centrifugation (10 min/5000 g/4°C), resuspended in ice cold cells 
lysis buffer and then sonicated (2 x 2 min at 70% power, cycle 9, 1 min pause). Cell debris 
and insoluble components were removed by centrifugation (20000 g/30 min/4°C) and the 
clarified extract loaded onto a chitin column. Unbound protein was washed with 20-30 matrix 
volumes of column buffer. The full length GLRaV-3 coat protein was eluted in 5 fractions of 
1 matrix volume with elution buffer. To determine the yield and purity of the full length 
GLRaV-3 coat protein, 10 µl from each step were run in a SDS-PAGE (II.2.4.2) and analyzed 
by immunoblot analysis (II.2.4.2). 
Column buffer: 
                          Tris-HCl, pH 7.4 20 mM 
                          NaCl 500 mM 
                          EDTA 1 mM 
 
Cleavage buffer: 
                         Tris-HCl, pH 7.4 20 mM 
                         NaCl 500 mM 
                         EDTA 1 mM 
                         DTT 50 mM 
 
The affinity purified MBP-GLRaV-3 coat protein and the full lenght GLRaV-3 coat protein 
was kindly provided by Dr. P. Saldarelli (Dipartimento di protezione delle Piante e 
Microbiologia Applicata, Università degli Studi and Istituto di Virologia Vegetale- del 
C.N.R., Italy). 
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II.2.3.3 Large scale production and purification of soluble scFv by IMAC 
For large scale expression, scFv cDNAs were subcloned into the prokaryotic expression 
vector pSyn using NcoI/NotI restriction sites. Recombinant pSyn plasmids were transformed 
into E. coli strain BL21(λDE3). A single recombinant colony was inoculated in 10 ml of 2YT 
medium containing 1 % (w/v) glucose and 100 µg/ml ampicillin and cultivated at 37c with 
shaking (180 rpm).  
Three ml of the o/n culture were transferred into 500 ml of 2YT media containing 0.1% (w/v) 
glucose and 100 µg/ml ampicillin and grown at 37°C until the OD600nm reached 1.0 - 1.1. 
Expression of scFv fragments was induced by addition of IPTG to a final concentration of 1 
mM for 4 hours at 28°C. The culture was centrifuged (4000 g/4°C/20 min) and the pelleted 
bacteria were resuspended in 10 ml of resuspension buffer (30 mM Tris, 20 % (w/v) sucrose, 
pH 8.0). EDTA was added to a final concentration of 1 mM. The suspension was incubated at 
4°C for 10 min with gentle agitation followed by centrifugation at (8000 g/4°C/20 min). The 
supernatant S1 was removed and kept on ice. The pellet was resuspended in 9 ml of cold 
5 mM MgSO4 and incubated at 4°C for 8-9 min on a rotatory shaker. EDTA was added to a 
final concentration of 1 mM and the suspension was agitated for 3 more minutes followed by 
centrifugation at 8000 g/4°C/20 min. The supernatant (S2) was mixed with the first 
supernatant (S1) and dialyzed against PBS prior to IMAC affinity purification. 
Ni-NTA-agarose was added in a disposable 10 ml column and equilibrated with 10-20 
volumes of wash buffer. Imidazol and sodium chloride were added into the dialyzed 
periplasmic fraction to a final concentration of 10 mM and 500 mM, respectively. The sample 
was passed through the pre-equilibrated Ni-NTA matrix. The column was washed with 20 
volumes of wash buffer and the proteins were eluted in three fractions with 700 µl of elution 
buffer. Collected fractions were immediately dialyzed against citrate buffer (pH 4.5) to 
remove imidazol and salt. To control the yield and purity of dialyzed scFv fragments 5 µl 
were run in a SDS-PAGE (II.2.4.2). The concentration was determined using the Pierce BCA 
protein assay (II.2.4.1). 
Column buffer: 
                          Tris-HCl, pH 7.4 20 mM 
                          NaCl 500 mM 
                          Imidazol 10 mM 
 
Elution buffer: 
                         Citrate buffer, pH 4.5 100 mM 
                         Imidazol 250 mM 
                         EDTA 1 mM 
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II.2.4 Protein analysis 
II.2.4.1 Quantification of proteins 
The concentration of purified protein was determined by BCA assays (Pierce). The Pierce 
BCA protein assay is a detergent-compatible formulation based on bicinchoninic acid (BCA) 
for the colorimetric detection and quantification of proteins (Smith et al., 1985; Sorensen and 
Brodbeck, 1986). This method combines reduction of Cu+2 to Cu+1 by proteins in an alkaline 
medium with the sensitive and selective colorimetric detection of the cuprous cation (Cu+1) 
using bicinchoninic acid (Wiechelman et al., 1988). Concentration measurements were done 
according to the manufacturer’s instructions, using BSA as standard. 
 
II.2.4.2 SDS-PAA gel electrophoresis and Coomassie brilliant blue staining 
Protein samples were separated by sodium dodecylsulphate (SDS) polyacrylamide gel 
electrophoresis (stacking gel: T = 4%, C = 2.6%, pH 6.8; separating gel: T = 12%, C = 2.6%, 
pH 8.8) (Ausubel et al., 1995) in SDS running buffer. Before loading onto the gel, protein 
samples were denaturated in the presence of SDS and β-mercaptoethanol. The proteins were 
separated electrophoretically with 20 V/cm for 1 hour. Protein bands were revealed by 
staining with Coomassie brilliant blue R-250 (Serva) or transfer to nitrocellulose membrane 
for immunoblot analysis (II.2.4.3). Proteins were detected after incubating the gel for 30 min 
in Coomassie staining solution at RT under constant rocking. Coomassie staining was 
removed by incubating in destaining solution until the protein bands was clearly visible. 
 
SDS-PAGE running buffer: 
                                  Tris-HCl, pH 8.3 125 mM 
                                  Glycin 960 mM 
                                  SDS 
 0.5% (w/v) 
Coomassie staining solution: 
                                  Coomassie brilliant blue G-250 0.25% (w/v) 
                                  Methanol 50% (v/v) 
                                  Glacial acetic acid 
 9% (v/v) 
Coomassie distaining solution:  
                                  Methanol 10% (v/v) 
                                  Glacial acetic acid 10% (v/v) 
 
II.2.4.3 Immunoblot analysis 
Separated proteins (II.2.4.2) were transferred from an SDS-PAA gel to a HybondTM-C 
nitrocellulose membrane (0.45 μm) (Ausubel et al., 1995). After blotting the membrane was 
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blocked with PBS buffer containing 3% (w/v) skim milk powder (MPBS). As primary 
antibody either anti c-myc or anti his6 (II.1.4) were used in a dilution of 1:5000 in 1xPBS. 
Binding of the primary antibody was detected by addition of the secondary polyclonal 
antibody coupled to alkaline phosphatase (AP) or to horseradish peroxidase (HRP). Both, 
primary and secondary antibodies were diluted in blocking buffer. The target protein was 
finally revealed by addition of substrate NBT/BCIP dissolved in AP buffer or ECL Advance 
Western blotting detection Kit (Amersham Biosciences) and exposured to Fujifilm LAS-
1000. 
PBS buffer (pH 7.3): 
                           NaCl 137 mM 
                           KCl 2.7 mM 
                           Na2HPO4x2H2O 8.1 mM 
                           KH2PO4 1.5 mM 
Transfer buffer: 
                           Tris-HCl, pH 8.3 25 mM 
                           Glycin 92 mM 
                           Methanol 20% (v/v) 
 
AP buffer: 
                           Tris-HCl, pH 9.6 100 mM 
                           NaCl 100 mM 
                           MgCl2 5 mM 
 
II.2.4.4 Horseradish peroxidase coupling to scFvLR3cp-1 
Coupling of scFvLR3cp-1 to the activated peroxidase was realized with EZ-LinkTM Activated 
Peroxidase kit. The coupling protocol was performed following the specifications of the 
manufactures. Different dilution of the labelled single chain fragment (1:500-1:5000) were 
incubated against a fixed concentration of MBP-GLRaV-3 coat protein to determine the 
optimal dilution of the antibody on immunoblot analysis resulting in the best signal at a 
1:3000 dilution. ECL Advance Western blotting detection kit was used as a detection system.  
 
II.2.5 Immunization of mice 
The treatment and maintenance of laboratory animals was approved by the 
‘Regierungspräsidium des Landes NRW’ (RP-Nr.: 23.203.2 AC 12, 21/95) and supervised by 
Dr. Hirsch as responsible biosafety officer at the Institut für Biologie I, RWTH Aachen. 
Three female mice (Balb/c) were immunized with 50 μg of MBP-GLRaV-3 coat protein 
mixed with 40μl GEBRU’s adjuvant. Two further injections into the tail vein were given at 
biweekly intervals with the same amount of antigen and 20 μl GEBRU’s adjuvant per mouse. 
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The final boost was performed 4 days prior to sacrifice. After the last boost, blood was taken 
from the tail vein using a 26 gauge needle (1-2 μl) and a capillary for picking up blood. The 
blood was diluted 1000-fold with PBS for estimation of antibody titers by direct ELISA 
(II.2.8.2). 
 
II.2.5.1 Determination of antisera titers by ELISA 
The determination of polyclonal antibody titer from sera of immunized mice was performed 
by direct ELISA (II.2.8.2) using MBP-GLRaV-3 coat protein as antigen. To determine the 
titer of GLRaV-3 coat protein-specific antibodies, 5 μg/ml of the full length GLRaV-3 coat 
protein expressed in the IMPACTTM system were coated to ELISA plates (II.2.3.1). 1XPBS 
was included as negative control. Antigens were coated at o/n 4oC and blocked with 1XPBS 
buffer containing 3% (w/v) skim milk powder (MPBS). Serial dilutions of sera (1:1000-
1:1024000) in blocking buffer were added to the coated plates and incubated at 37°C for 1.5 
hours. After three washes with PBST bound antibodies were detected by addition of 1:5000 
diluted AP-labelled goat anti-mouse polyclonal antibodies in blocking buffer and p-
nitrophenyl phosphate (pNPP) as substrate (Sigma). ELISA plates were incubated at 37°C for 
1 h followed by measurement of the OD at 405 nm. 
 
II.2.6 Construction of phage displayed scFv libraries and scFvLR2cp-35 
II.2.6.1 Isolation of total RNA from spleen cells 
Spleens from immunised mice (II.2.5) showing an adequate titer (II.2.5.1) were removed and 
dissected. Spleenocytes were prepared by disrupting the spleens through a meshing net and 
washed twice with RPMI 1640 solution (Sigma-Aldrich). The cells were homogenized in 
1xPBS, aliquoted to not more then 1x108 cells and subjected to total RNA isolation using 
TRIZOL extraction reagent (GibcoBRL) according to the manufacturer’s protocol to obtain 
high yield and pure RNA. 
 
II.2.6.2 Isolation of total RNA from cells hybridoma line mAb R19  
5-10x106 cells of hybridoma line R19 were resuspended in 5 ml of TRIZOL extraction 
reagent (GibcoBRL) and total RNA was purified following the specification of the 
manufacturer’s. 
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II.2.6.3 First strand cDNA synthesis 
First-strand cDNA was synthesised from 5 μg of total RNA using ‘SuperscriptTM 
preamplification system kit’ (GibcoBRL) and gene specific primers COH 30, COH 32, MuPD 
31, MuPD 32 (I.1.7.2) that bind to the constant region of mouse IgG1, IgG2a/2b, κ and λ, 
respectively. cDNA synthesis was performed according to the manufacturer’s instructions. 
 
II.2.6.4 Construction of scFv libraries from immunized mice 
Mouse heavy and light chain variable regions were amplified by PCR using primers specific 
to murine IgG1, IgG2a/2b heavy chain λ and κ light chain (II.1.7.3). For each forward primer 
separate PCR reactions were performed whereas backward primers were used as a cocktail. 
PCR reactions were carried out in a total volume of 50 μl by adding 10 pmol of each primer 
and 1/10 to 1/16 dilution of the first strand cDNA reaction (II.2.6.2) under the following 
conditions: initial denaturation at 95°C for 5 minutes followed by 35 cycles at 94°C for 1 min, 
55°C for 1 min, 72°C for 1 min and a final elongation for 10 min at 72°C. 
Heavy (VH) and light (VL) chain fragments were gel purified using “QIAquick gel extraction 
kit” (Qiagen) (II.2.1.10) and digested with SfiI and BstEII, or AscI and NotI enzymes, 
respectively. pHENHi phagemid DNA was digested with SfiI and BstEII or AscI and NotI and 
gel purified. 200 ng of purified vector were ligated with a five fold molar excess of purified 
fragments. Ligation products were electroporated into electrocompetent E. coli DH5α cells 
(II.2.1.2) to create the sublibraries. The scFv fragment libraries were constructed by excising 
VH or VL fragments with the respective enzymes and ligating them into the linearised pHENHi 
containing VL or VH fragments and electroporated into electrocompetent E. coli TG1 cells 
(II.2.1.2). 
 
II.2.6.5 Construction of scFvLR2cp-35 from the hybridoma cell line R19 
The cDNA encoding the heavy chain variable domain of scFvLR2cp-35 was amplified with a 
repertoire of 16 forward primers forming four different mixes containing 4 primers each 
(MPDVHB1-4, MPDVHB5-8, MPDVHB9-12 and MPDVHB13-16) (II.1.7.3). For the 
amplification of the light chain variable region the same procedure was applied for the 
forward primers (II.1.7.4), preparing four different mixes containing: MPDVLB1-4, 
MPDVLB5-8, MPDVLB9-12 and MPDVLB13-15. Backward primers, PCR conditions for 
heavy and light chain amplification and the construction of the mini library was performed as 
described above in II.2.6.4. 
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II.2.6.6 BstNI fingerprinting 
The variability of the generated scFv fragment libraries from immunized mice (II.2.5) was 
tested by restriction with BstNI. PCR-amplified scFv fragments from 26 randomly selected 
recombinant E. coli colonies were digested with 5 U BstNI at 60oC for 2 h. This method was 
first described in phage display protocols by Marks et al. (1992) and Hoogenboom et al. 
(1996). Digested fragments were separated in a 2% (w/v) agarose gel (II.2.1.10) and the 
variability of the library was estimated. 
 
II.2.7 Phage displayed antibody selection 
Phage particles were rescued from the scFv libraries by superinfection with helper phage 
M13KO7 (Clackson et al., 1991). Phage titers were determined by addition of phage dilutions 
to exponentially growing E. coli strain TG1. For isolation of phages exposing antigen-specific 
antibodies panning procedures were performed. The full length GLRaV-3 coat protein 
(10 μg/ml) was immobilized o/n to a 4 ml immunotubes. To exclude unspecific binding, 
1012 phages were preincubated with in 2% (w/v) MPBS for 30 min at RT. Then the phage 
solution was added to the antigen-coated immunotubes and incubated for 30 min under 
rotation and then 1.5 h without movement. Phages that showed no or low affinity for the 
immobilized antigen were washed away by 1XPBS containing 0.05% (v/v) Tween20 
followed by PBS. Each washing step was performed 20 times by filling the tube with 4 ml of 
solution and decanting immediately. Phages with affinity to the antigen were eluted from the 
tube by addition of 1 ml of 100 mM triethylamine (freshly made) while rotating for 8-10 min 
followed by neutralisation with 1 M Tris-HCl (pH 7.4). Nine ml of log phase E. coli TG1 
cells were infected with eluted phages and plated on 2x YT agar plates containing 2% (w/v) 
glucose and 100 μg/ml ampicillin. The plates were incubated o/n at 37oC. Cells were scraped 
off the agar by adding 5 ml of 2x YT medium containing 15% (v/v) glycerol and stored at      
-80oC for a new round of selection. 
The total eluted phage titer indicating the successful binding and elution of phages was 
determined after each round of panning by addition of dilutions to exponentially growing E. 
coli TG1. An increasing titer of eluted phages in subsequent round of pannings indicated the 
enrichment of clones, which bind most strongly to the target antigen. 
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II.2.8 Characterisation of scFv fragments 
II.2.8.1 Soluble expressions of scFv fragments and direct ELISA 
Screening of scFv fragment libraries was performed after the third round of panning by small 
scale induction of scFv expression from pHENHi phagemid vector in ELISA plates. 120 
recombinant clones of E. coli strain TG1 were randomly selected and inoculated in 100 μl of 
2xTY containing 100 μg/ml ampicillin and 1% (w/v) glucose in microtiter plates. The plates 
(master plates) were grown overnight at 37oC. The next day, cells were transferred from the 
master plate to a second microtiter plate containing 125 μl 2x TY with 100 μg/ml ampicillin, 
and 0.1% (w/v) glucose. Recombinant bacteria were grown at 37oC until the OD600nm reached 
0.8-1. Expression of soluble scFv fragments was induced at 30oC for 16-24 h by addition of 
IPTG to a final concentration of 1 mM. The cells were removed by centrifugation and the 
supernatant was used for soluble ELISA. 
A high binding ELISA plate was coated o/n with 10 μg/ml of the bacterially purified MBP-
GLRaV-3 coat protein, MBP-ArMV-repas to exclude cross reactivity against maltose and 
PBS, at 4oC. After blocking with 2% (w/v) MPBS the supernatant was applied to the plate and 
incubated for 2 h at RT. Bound scFv fragments from the soluble expression were detected 
using 1:5000 diluted anti c-myc monoclonal antibody 9E10 and 1:5000 diluted AP-
conjugated goat anti mouse polyclonal antibody. ELISA readings were performed at OD405nm 
after 10 min incubation at 37oC with pNPP. 
 
II.2.8.2 Direct ELISA of selected scFv fragments 
Direct ELISA was performed by coating 5 μg/ml of bacterial purified antigen (MBP-GLRaV-
3 coat protein) and a truncated MBP-GLRaV-3 coat protein version containing the first 58 
amino acids of the GLRaV-3 coat protein C-terminally fused to MBP. The plate was blocked 
for 2 h at RT with 2% (w/v) MPBS. Finally, several concentrations of the affinity purified 
scFv fragment (II.2.3.3) were applied and incubated at RT for 2 h. Bound scFv fragments 
were detected with 9E10 monoclonal antibody and the 1:5000 diluted HRP-conjugated goat 
anti mouse polyclonal antibody. ELISA readings (OD405nm) were performed after 1 hour 
incubation with ABTS substrate at 37 oC. 
 
II.2.8.3 Capture ELISA analysis using soluble scFv fragments 
Capture ELISA was performed by coating polyclonal rabbit IgG antibodies specific to 
GLRaV-3 coat protein or GLRaV-2 coat protein (1.5 µg/ml). The plate was blocked for 2 h at 
RT with 2% (w/v) MPBS, then incubated either with leaf extracts from grapevines infected by 
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GLRaV-3 or with N. benthamiana infected by GLRaV-2 (II.1.6.6). Finally, affinity purified 
scFv produced in E. coli (II.2.3.3) or transiently expressed in N. tabacum (II.2.2.2) were 
applied in serial dilution and incubated at RT for 2 h. The bound scFvs were revealed by 
addition of 1:5000 diluted 9E10 monoclonal antibody and GAMHRP polyclonal antibody. 
ELISA readings (OD405 nm) were performed after 1 hour incubation with ABTS substrate at 
37oC. 
 
II.2.8.4 Electrophoretic mobility shift assay (EMSA) 
Varying amounts of MBP-GLRaV-3 coat protein were incubated for 1 hr at RT with 1 µg of 
affinity purified scFv specific to GLRaV-3 coat protein. Then, the electrophoretic mobility 
was compared to the electrophoretic mobility of purified antigen and scFv alone. Samples 
were loaded on a native 9% non-reducing PAGE pH 9 and run at 100 V for 5 hours. Proteins 
were visualized by Coomassie brilliant blue staining (II.2.4.2). 
 
II.2.8.5 Characterization of scFv fragments by surface plasmon resonance 
A biomolecular interaction analysis of purified scFv3cp-1 to the corresponding antigen MBP-
GLRaV-3 coat protein was done by surface plasmon resonance (SPR) on a BIAcore 2000. All 
injected samples were diluted in HBS buffer (10 mM HEPES, 150mM NaCl, 3.4 mM EDTA, 
0.05% (v/v) Surfactant P20) and subjected to centrifugation prior to injection 
(14000 rpm/10 min/4oC) to remove insoluble components. The antigen, MBP-GLRaV-3 coat 
protein at a concentration of 0.10 μM was immobilized on a CM5-rg sensor chip (Pharmacia) 
using the amine coupling kit (BIAcore). The immobilization of proteins on the chip was 
performed at a flow rate of 5 µl/min. The carboxyl groups on the sensor surface were 
activated with an injection of a solution containing 100 mM EDC/NHS (N-Ethyl-N’-
(Dimethylaminopropyl)-Carbodimide-Hydrochloride, 400 mM N-Hydroxyl-Succinimide). 
After each binding experiment the surface was regenerated with 15-20 µl of 1.2 M Guanidine 
HCl followed by 30 sec injections of HBS. The data were analyzed using the BIAevaluation 
(3.0) software. 
 
II.2.8.6 Epitope mapping 
II.2.8.6.1 PEPSCAN analysis 
For PEPSCAN analysis a set of nine 13-mer peptides spanning the N-region of the GLRaV-3 
coat protein (each peptide overlaps with the previous peptide by 11 amino acids) were 
synthesized on a membrane (Jerini AG, GMBH). Binding of the affinity purified scFvLR3cp-
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1 to the previously described peptides was tested as described for immunoblot analysis 
(II.2.4.3) but using a HRP labeled secondary antibody. The membrane was developed by 
reaction with ECL Advance Western blotting detection Kit (Amersham Biosciences) and 
exposured to Fujifilm LAS-1000. 
 
II.2.8.7 Electron microscopy 
Electron microscope grids with a Pioloform-carbon support film were floated for 5 min on 
drops containing purified GLRaV-3 particles, washed and blocked afterwards with 0.1% 
(w/v) bovine serum albumin (Sigma) in phosphate buffer (1xPBS, pH 7.2). A scFv (with a 
concentration of 3 μg/μl) recognizing the coat protein of the virus was diluted 1:50 with 
1xPBS-T and incubated with the virus particles for 1.5 h at RT. After washing (1xPBS-T), a 
primary antibody anti c-myc was applied in a dilution of 1:500 in 1xPBS-T. Samples were 
decorated with gold-labelled goat anti-mouse IgG (10 nm gold particles, British Biocell, 
United Kingdom) by floating the grid on a 1:50 1xPBS-T dilution of the antibody for 2 h at 
RT. Finally, the grids were extensively washed (once with 1xPBS-T, and twice with distilled 
H2O) and the sample stained with five drops of 2% (w/v) uranyl acetate. Electron microscopy 
was carried out using a PHILIPS EM 400T electron microscope at the Institute of 
Neuropathology, University Hospital, RWTH Aachen. 
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III Results 
 
The rationale of this work was to generate single chain fragment variable (scFv) antibodies 
that specifically recognize grapevine leafroll associated viruses 2 and 3 (GLRaV-2 and -3) by 
recombinant DNA technology. Consequently the result section is divided in two parts: the 
first (III.1) covers the generation and characterization of an scFv fragment that specifically 
react to the coat protein of GLRaV-2. The variable regions of the antibody heavy and light 
chains of the mouse mAb R19 were amplified from mRNA isolated from the R19 hybridoma 
cell line for the subsequent generation of the scFv fragment. The in vitro characterization by 
SDS PAGE and capture ELISA were carried out. Moreover, the specific scFv fragment was 
subcloned into a plant expression vector and transiently produced in the plant cytosol. 
The second part (III.2) comprises the generation of scFvs binding to the GLRaV-3 coat 
protein by phage display technology using a biased antibody gene repertoire. Briefly, the 
procedure included the use of affinity purified GLRaV-3 coat protein for animal 
immunization, phagemid-scFv library construction and subsequent selection of GLRaV-3 coat 
protein specific scFvs by phage display technology. The in vitro characterization of one 
selected scFv was performed by protein analysis methods (SDS-PAGE, immunoblot analysis, 
ELISA, EMSA) and the determination of the affinity constant was performed by surface 
plasmon resonance analysis. Furthermore, the putative binding epitope on the GLRaV-3 coat 
protein was determined. Finally, stable transformed N. benthamiana plants producing 
functional scFvs in the cytosol were generated. 
 
III.1 Generation and characterization of a GLRaV-2 specific scFv antibody 
III.1.1 Total RNA isolation from hybridoma cells 
The hybridoma cell line R19 producing the GLRaV-2 coat protein specific monoclonal 
antibody (mAb) R19 was propagated and the cells were used for total RNA isolation 
(II.2.6.1.2). The integrity and quality of the purified sample was evaluated by gel 
electrophoresis (Figure III-1). 
The RNA extraction showed two discrete bands for the ribosomal RNA 18S and 28S 
population. The mRNA was present as a characteristic smear between these bands indicating 
the good quality of the extraction. No DNA contamination was observed. The total amount of 
purified total RNA from 5.106 hybridoma cells ranged between 25 to 50 μg. 
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Figure III-1: Analysis of total RNA isolated from the hybridoma cell line R19. 
Total RNA (II.2.6.2) was isolated from hybridoma cell line R19 and separated on a 1.2% (w/v) agarose gel 
(II.2.1.9) containing 2.4 M formaldehyde. The major ribosomal RNA species (28S and 18S rRNA) are indicated: 
2μl of total RNA were loaded into the gel. 
 
 
III.1.1.1 First strand cDNA synthesis and PCR amplification of variable antibody 
domains 
Total RNA isolated from the hybridoma cell line R19 was used for PCR amplification of the 
antibody variable heavy (VH) and variable light (VL) fragments. Two μg of total RNA was 
reversely transcribed to synthesize first strand cDNA using oligo(dT) primer to hybridize to 
the 3´ poly(A) tails, which are found in the vast majority of eukaryotic mRNAs. This cDNA 
template was used for the subsequent PCR reactions using a mixture of primers specific to 
murine IgG1, IgG2a/2b heavy chain and κ light chain (II.2.1.8). 
In total eight PCR reactions were prepared (II.2.6.3.1). Four PCR products of the expected 
size (400 to 450 bp) were obtained for the antibody heavy chain and two for the light chain 
(Figure III-2). 
 
 
 
 
 
 
 
 
 
 
 
Figure III-2: PCR amplification products of antibody VH and VL chains using murine specific primer IgG1; 
IgG2a/b and κ. 
Ten μl of the PCR products (II.2.1.12) were separated on a 1.2% (w/v) agarose gel (II.2.1.9) for IgG1, IgG2a/b, 
κ and λ amplified products, respectively. H1-4: cocktail containing a mixture of MPDVHF1 to 4 primers, H5-8: 
cocktail containing a mixture of MPDVHF5 to 8 primers, H9-12: cocktail containing a mixture of MPDVHF9 to 
12 primers, H13-16: cocktail containing a mixture of MPDVHF13 to 16 primers. L1-4: cocktail containing a 
mixture of MPDVLB1 to 4 primers, L5-8: cocktail containing a mixture of MPDVLF5 to 8 primers, L9-12: 
cocktail containing a mixture of MPDVLF9 to 12 primers; L13-15: cocktail containing a mixture of MPDVLF13 
to 15 primers. M: 1 kb DNA ladder (II.2.6.3). 
IgG1 IgG2a/2b κ
450 bp 
H1-4      H5-8        H9-12      H13-16         M           L1-4       L5-8          L9-12     L13-15 
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III.1.1.2 Cloning of the scFvLR2cp-35 and sequence analysis  
The amplified products obtained for both the antibody VH and VL domains were pooled, 
separated and purified from an agarose gel (II.2.1.9). The gel-purified antibody VH fragments 
were digested with SfiI and BstEII restriction enzymes and the antibody VL fragments with 
AscI and NotI, ligated separately into the pHENHi vector (II.1.5.1) and transformed into 
electrocompetent DH5α cells, resulting in construction of antibody variable heavy and light 
domains mini sublibraries. To verify the presence of the inserts, plasmid minipreps were 
performed (II.2.1.8) followed by restriction analysis of ten randomly selected ampicillin 
resistant E. coli DH5α for both VH and VL mini sublibraries, respectively. Four clones out of 
ten carried a fragment of the expected size ranging between 400-450 bp for the VH and all 10 
for the VL mini sublibrary (data not shown). 
The four and ten positive selected clones for VH and VL, respectively, were sequenced 
(II.2.1.12) demonstrating that they presented an open reading frame for the VH and VL 
domains. All VH and VL  domains showed identical nucleotide sequences in the CDR and 
frameworks region and no heterogeneity was observed at the 5’ primer-binding region that 
span the first eight amino acid residues (data not shown). Therefore, for the construction of 
the specific scFv fragment, the VL fragment from clone number 5 of the VL mini sublibrary 
was directly recovered by double digestion with the corresponding restriction enzymes and 
cloned into the linearized pHENHi vector containing the VH fragment from clone number 3 of 
the VH sublibrary resulting in scFvLR2cp-35. The cDNA of scFvLR2cp-35 was sequenced 
(II.2.1.12) and Table III-1 presents the amino acid length and the deduced molecular weights 
of the scFvLR2cp-35. The sequence of the scFvLR2cp-35 is shown in Figure III-3. 
 
Table III-1: Sequence analysis of scFvLR2cp-35. 
Designation of scFv Amino acid length1 Deduced MW (Da) 
scFvLR2cp-35 277 30015 
1: The His6 tag and c-myc tag are included for the calculation of the length and MW. 
 
Sequence comparison with the germline gene sequences listed in the IMGT database (The 
international ImMunoGenetics database) indicated that the VH region of the scFvLR2cp-35 
had the highest homology with the gene AF290969. The antibody VL region shows the 
highest homology to the germline gene sequence AJ235956 as indicated in Table III-2. 
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During the immunization process, the antibody VH and VL domains accumulated a total of six 
amino acid mutations each. 
Table III-2: V-gene family, germline deviation and extent of somatic mutation of scFvLR2cp-35. 
The amino acid differences observed in the primer region are indicated between brackets. The sequences 
alignment was performed using the IMGT database (http://imgt.cines.fr). 
 
Mouse IgG Family Closest germline 
gene sequence 
Difference from germline
(amino acids) 
scFv H L H L H L 
scFvLR2cp-35 IGHV5 IGKV1 AF290969 AJ235958 6(1) 6(3) 
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Figure III-3: Amino acid sequence of scFvLR2cp-35. 
Framework regions and complementary determining regions (CDRs) were determined according to Kabat and 
Wu (1991). The amino acid sequence of the CDRs, the 218* linker, c-myc and His6 tag are shown in single 
letter code. Amino acid residues were colored by residues as follows, orange: G, P, T and S; red: H, K and R; 
blue: F, W and Y; green: I, L, M, and V. 
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III.1.2 Generation and characterization of bacterial produced scFvLR2cp-35 
III.1.2.1 Generation of the bacterial expression construct and bacterial expression 
To characterize the functionality of scFvLR2cp-35 the corresponding cDNA was subcloned 
into the bacterial expression vector pSyn (II.1.5.1) for expression and purification of soluble 
scFv fragments (Figure III-4). The pSyn vector contains a pelB signal peptide that directs the 
recombinant proteins into the bacterial periplasm. The biochemical milieu in the periplasmic 
space of E. coli facilitates the formation of intramolecular disulfide bonds and the correct 
folding of the recombinant proteins (Kipriyanov and Little, 1999). The vector contains a C-
terminal c-myc tag as a marker for detection in immunoblot analysis (II.2.4.3) and a C-
terminal His6 tag for IMAC purification of the recombinant proteins (II.2.3.2). The 
scFvLR2cp-35 cDNA was subcloned using NcoI and SalI restriction enzymes and the correct 
insertion of the scFv cDNA was confirmed by sequencing (II.2.1.12). Expression of 
scFvLR2cp-35 into the periplasmic space was achieved by the addition of IPTG to a final 
concentration of 1 mM at 28°C using E. coli strain BL21(λDE3) and the recombinant protein 
was purified by IMAC as described in II.2.3.2. 
 
 
 
 
Figure III-4: Schematic diagram of the scFvLR2cp-35 expression cassette in pSyn. 
scFvLR2cp-35 was subcloned into the pSyn vector using NcoI/SalI restriction enzymes. Plac: lac promoter; 
pelB: pelB leader peptide sequence; c-myc: myc epitope for scFv detection; His6: His6 tag for purification. 
 
The result of SDS-PAGE and immunoblot analysis of the elution fractions of the affinity 
purified scFvLR2cp-35 are shown in Figure III-5 (A) and (B), respectively, and revealed the 
presence of a band of approximately 32 kDa corresponding to the calculated molecular weight 
of 30 kDa. Some other co-eluted bands were also present on the Coomassie stained SDS-PAA 
gel. The most prominent co-eluted bands run at the molecular size of 26 and 28 kDa. None of 
theses co-eluted proteins were detected by immunoblot analysis demonstrating that these 
proteins were not degraded forms of the scFvLR2cp-35 but unrelated bacterial contaminants. 
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Figure III-5: SDS-PAGE and immunoblot analysis of affinity purified, bacterial produced scFvLR2cp-35. 
The scFvLR2cp-35 cDNA (II.2.6.3) was subcloned into the pSyn vector and expressed in the E. coli strain 
BL21(λDE3) upon induction with IPTG. The periplasmic expressed scFv was purified by IMAC (II.2.3.3). 
Protein were separated on a 12 % (w/v) SDS-PAA gel (II.2.4.2) and stained with Coomassie brilliant blue (A) 
(II.2.4.2) or blotted onto nitrocellulose membrane (B) (II.2.4.3). Immunodetection of scFvLR2cp-35 was done 
using 1:5000 diluted 9E10 monoclonal antibody and GAMAP polyclonal antibody (1:5000). Detection was 
carried out with NBT/BCIP for 1 min at RT. 
M: 5 μl of Prestained Protein Marker. E1, E2: 10 μl of elution fraction; E3, E4: 5 μl of elution fraction. 
 
 
After purification, the elution fraction E1 and E2 were dialyzed overnight in citrate buffer (pH 
4.5) and the final protein concentration was determined by BCA protein assay kit (II.2.4.1) 
and SDS-PAGE (II.2.4.2) using a scFv of known concentration as a standard (data not 
shown). The amount of the purified scFvLR2cp-35 ranged between 150-250 μg per L culture 
volumes. Slight deviations were observed depending on the batch of preparation. A step-wise 
elution of the scFvLR2cp-35 from the column by increasing the concentration of imidazole 
was performed to minimize the contaminants present in the elution fractions. But there was no 
significant improvement in the purity of the fractions (data not shown). However, the purity 
of scFvLR2cp-35 was sufficient for performing the subsequent characterization. 
 
III.1.2.2 Reactivity of affinity purified scFvLR2cp-35 to virus particle 
To examine the specific binding of the affinity purified scFvLR2cp-35 to GLRaV-2 particles 
a capture ELISA was performed. Several concentrations of the scFv fragment were incubated 
on a high binding microtiter plate coated overnight with polyclonal rabbit IgG specific to 
GLRaV-2 coat protein followed by the addition of extracts from N. benthamiana infected by 
GLRaV-2 (II.1.6.7). ELISA result demonstrated specific binding of scFvLR2cp-35 to the 
virus particles present in the infected material (Figure III.6). No cross-reactivity to non-
infected N. benthamiana was observed verifying the functionality and specificity of bacterial 
produced and affinity purified scFvLR2cp-35.  
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Figure III.6 Reactivity of affinity purified scFvLR2cp-35 to an extract from N. benthamiana leaves infected or 
non-infected by GLRaV-2 in capture ELISA (II.2.8.3). 
1.5 μg/ml of polyclonal rabbit IgG specific to GLRaV-2 coat protein were coated overnight onto a microtiter 
plate and blocked for 2 h at RT with 3% skim milk-PBS (MPBS), then leaf extract from GLRaV-2 infected or 
non-infected N. benthamiana were added. Finally, several concentrations of affinity purified scFvLR2cp-35 (3.5 
– 1000 ng) were applied followed by addition of 1:5000 diluted 9E10 monoclonal antibody and GAMHRP 
polyclonal antibody. ELISA reading (OD405nm) were performed after 1 h incubation with ABTS substrate at 
37oC. 
 
 
III.1.3 Transient expression of scFvLR2cp-35 in tobacco leaves 
III.1.3.1 Cloning of scFvLR2cp-35 into the plant expression vector pTRA 
To study the accumulation level and functionality of scFvLR2cp-35 in the plant cell cytosol, 
the corresponding cDNA was subcloned into the plant expression vector pTRA containing the 
doubled enhanced constitutive 35S promoter from the Cauliflower mosaic virus (CaMV) 
(Figure III-7A) or the phloem-specific promoter of the Coconut foliar decay virus (CFDV), 
respectively (Figure III-7B). The scFv must be expressed in the cytosol because this is the 
plant cell compartment where the virus is most vulnerable. 
The scFvLR2cp-35 cDNA fragment was digested with NcoI and SalI from the pSYN vector 
and subcloned into the pUC18 derivate to introduce it downstream of the TMV 5’ 
untranslated region (omega (Ω) leader) and upstream of a c-myc tag and His6 tag. The 
complete cassette was then excised by digestion with EcoRI and XbaI and cloned into the 
pTRA vector upstream the pA35S untranslated region containing either the enhanced 35S 
promoter resulting in the final construct pTRA-35SS:scFvLR2cp-35 or CFDV promoter 
resulting in pTRA-CFDV:scFvLR2cp-35. The correct sequence for both construct was 
confirmed by sequence analysis (II.2.1.12) and the plasmid DNA was used for electroporation 
of competent Agrobacterium tumefaciens (II.2.1.4). The obtained recombinant clones were 
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analyzed for the presence of the cDNA insert by colony PCR (II.2.1.11) with vector-specific 
primers (II.1.7.1) and glycerol stocks (II.2.1.7) were prepared for both recombinant A. 
tumefaciens strains. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure III-7: Strategy for cloning scFvLR2cp-35 cDNA into the plant expression vector pTRA. 
P35S: 35S promoter from CaMV with duplicated enhancer; Ω: omega leader region of TMV RNA; pA35S: 3' 
UTR of CaMV; CFDV: phloem specific promoter from Coconut Foliar Decay Virus; scFvLR2cp-35: scFv 
specific to GLRaV-2 coat protein; c-myc: myc epitope for detection; His6: his-6 tag for purification. 
 
III.1.3.2 Transient expression of scFvLR2cp-35 in tobacco leaves 
Transient expression experiments were performed of the scFv stability in the plant cell 
cytosol because the procedure is fast and reliable to evaluate protein production, there is no 
transgene integration and protein expression is not affected by position effects (Kapila et al., 
1996). Glycerol stocks of recombinant agrobacteria transformed with pTRA-
35SS:scFvLR2cp-35 or pTRA-CFDV:scFvLR2cp-35 were grown and used for agro-
infiltration of N. tabacum cv. Petite Havana SR1 leaves (II.2.2.3). Total soluble proteins were 
extracted from four infiltrated leaves after three days of incubation at 26oC and accumulation 
levels and integrity of scFvLR2cp-35 were analyzed by immunoblot analysis. 
The expression levels of the scFvLR2cp-35 were below detection limits of the immunoblot 
analysis for both constructs indicating low accumulation of scFvLR2cp-35 in the plant cell 
cytosol. Therefore, a capture ELISA using GLRaV-2 infected N. benthamiana material was 
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performed to check the binding specificity and to quantify the amount of transiently produced 
scFv. 
 
 
III.1.3.3 Functionality analysis of transiently produced scFvLR2cp-35  
The antigen specificity of transiently produced scFvLR2cp-35 to GLRaV-2 particles was 
evaluated by capture ELISA. Several dilutions of total soluble protein plant extract containing 
the transiently produced scFvLR2cp-35 driven either by the constitutive CaMV 35S or the 
phloem-specific CFDV promoter were incubated on high binding microtiter plates coated 
overnight with polyclonal rabbit IgG specific to GLRaV-2 coat protein followed by the 
addition of extracts from N. benthamiana infected by GLRaV-2 (II.1.6.7). 
ELISA results confirmed significant binding to GLRaV-2 particles for both transiently 
produced scFvLR2cp-35 samples indicating that scFvLR2cp-35 was produced and functional 
in the plant cytosol under the control of 35S and the CFDV phloem-specific promoter (Figure 
III-8). ScFv accumulation levels ranged between 2.2 and 2.9 μg per g fresh leaf tissue for the 
cytosolic construct produced with the constitutive 35S promoter and approximately 10-fold 
lower for the scFv transiently produced with the phloem-specific promoter when compared by 
capture ELISA with bacterially expressed scFvLR2cp-35 diluted in non-infiltrated plant 
extract as standard (data not shown). Due to the tissue specificity of the phloem-specific 
CFDV promoter the scFv accumulates to lower levels when using the pTRA-
35SS:scFvLR2cp-35 construct leading to lower OD values as indicated by the capture ELISA. 
No cross-reactivity to the wild type tobacco extract was observed. 
In contrast to the immunoblot analysis (III.1.3.2) the higher sensitivity of the ELISA 
procedure enabled detection of transiently produced scFvLR2cp-35 demonstrating its 
specificity and functionality. 
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Figure III-8: Capture ELISA (II.2.8.3) of transiently produced scFvLR2cp-35 in the plant cytosol under the 
control of the CaMV 35S (dark blue) or CFDV promoter (fuchsia). 
1.5 μg/ml of polyclonal rabbit IgG specific to GLRaV-2 coat protein were coated overnight onto a microtiter 
plate and blocked for 2 h at RT with MPBS, then the leaf extract of GLRaV-2 infected or non-infected N. 
benthamiana were added. Finally, serial dilution of plant extract containing the transiently produced scFvLR2cp-
35 were applied and incubated for 1 hour at RT. Bound scFv fragments were detected by addition of 1:5000 
diluted 9E10 monoclonal antibody and GAMHRP polyclonal antibody (1:5000). ELISA reading (OD405nm) were 
performed after 1 h incubation with ABTS substrate at 37oC. 
 
 
III.1.4 Stable production of scFvLR2cp-35 in N. benthamiana plants 
Since GLRaV-2 can be mechanically transmitted to N. benthamiana, bioassay studies using 
stable transformed plant expressing scFvLR2cp-35 can be performed. Consequently, forty-
nine and thirty-eight independent transgenic N. benthamiana lines were generated by leaf disc 
transformation using recombinant A. tumefaciens (II.2.2.4) carrying the pTRA-
35SS:scFvLR2cp-35 or pTRA-CFDV:scFvLR2cp-35 construct, respectively. Regenerated T0 
plants for each of the two constructs were screened for accumulation of recombinant protein 
by immunoblot analysis of the crude extract of the total soluble leaf protein (II.2.2.6). 
Immunoblot analyses revealed that the expression levels of the scFvLR2cp-35 were below 
detection limits for both constructs (data not shown). Therefore, a capture ELISA using 
GLRaV-2 infected N. benthamiana material was carried out to analyse the accumulation 
levels of scFvLR2cp-35 in the regenerated T0 plants. Unfortunately, ELISA results were 
negative for both construct indicating that scFvLR2cp-35 accumulation levels were below 
detection limits in stable transformed T0 plants (data not shown).  
A second stable transformation was performed and 33 transgenic N. benthamiana lines were 
generated and tested for both constructs. Again the capture ELISA result was negative 
demonstrating accumulations levels below detection limits. Therefore, it was decided not to 
perform bioassays because it would be impossible to correlate potential observed biological 
effects with scFv accumulation levels. 
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III.2 Generation and characterization of GLRaV-3 specific scFv antibodies 
 
III.2.1 Bacterial expression and purification of GLRaV-3 coat protein 
III.2.1.1 GLRaV-3 coat protein C-terminally fused to MBP  
The full-length GLRaV-3 coat protein cDNA was cloned in frame to the 3’ end of the maltose 
binding protein (MBP) sequence between the EcoRI and HindIII sites into the pMAL c2X 
vector (II.1.5.1) for cytosolic expression of the recombinant GLRaV-3 coat protein. The 
plasmid DNA was used for transformation in E. coli strain BL21(λDE3) (II.2.3.1) and 
recombinant protein expression was induced by adding 0.3 mM of IPTG for 3 hours at 37oC 
(II.2.3.1). 
The size of the produced and affinity purified (II.2.3.1) recombinant fusion protein 
corresponded with the expected molecular weight of the MBP-GLRaV-3 coat protein fusion 
(77.5 kDa) (Figure III-9A). To confirm its identity the affinity purified protein was analyzed 
by immunoblot (II.2.4.3) (Figure III-9B) using a GLRaV-3 coat protein specific monoclonal 
antibody (mAb LRE) for detection. The immunoblot analysis revealed that intact MBP-
GLRaV-3 coat protein fusions were purified but degradation products were observed running 
between 40 and 72 kDa. The yield of the affinity purified full-size MBP-GLRaV-3 coat 
protein was approximately 12.5 mg per liter culture medium. Affinity purified MBP-GLRaV-
3 coat protein was used for mice immunization, titer determination (III.2.2) and scFv 
characterization (III.2.3). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure III-9: SDS-PAGE and immunoblot analysis of affinity purified MBP-GLRaV-3 coat protein. 
Affinity purified MBP-GLRaV-3 (II.2.3.1) coat protein obtained from the pMAL expression system was 
analyzed in a 12% (w/v) SDS-PAA gel (II.2.4.2) followed by Coomassie brilliant blue staining (A) (II.2.4.2) or 
blotted onto nitrocellulose membrane followed by immunoblot analysis (B) (II.2.4.3). Immunodetection was 
carried out with mAb LRE as primary antibody in a dilution of 1:1000 dilution followed by 1 hour incubation 
with GAM-FcHRP (1:5000). Detection was carried out using ECL Advance Western blotting detection kit (II.1.3). 
Line 1, 2: 2 μl and 0.5 μl, respectively, of affinity purified MBP-GLRaV-3 coat protein. M: 5 μl PageRulerTM 
Prestained Protein Ladder. 
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III.2.1.2 Full-length GLRaV-3 coat protein 
To avoid-cross reactivity against MBP during antibody titer determination and to select only 
scFvs specific to GLRaV-3 coat protein epitopes during the panning procedure, the full-length 
coat protein cDNA was cloned into the pTYB1 vector (II.1.5.1) via NdeI and XhoI sites. The 
pTYB1 vector contains the IPTG inducible T7 promoter and the target protein is C-terminal 
fused to a self-cleavable intein tag in where a chitin binding domain allows affinity 
purification of the fusion precursor on a chitin column. DTT is used to promote specific self-
cleavage which releases the target protein from the chitin bound intein tag. The plasmid DNA 
was transformed into the E. coli strain BL21(λDE3) (II.2.3.2) and the protein expression was 
induced by adding 0.4 mM of IPTG overnight at 16oC. 
The purity and integrity of the affinity purified GLRaV3 coat protein was checked by SDS-
PAGE revealing a prominent band of the expected size of 36 kDa (Figure III-10A). This band 
was also recognized by immunoblot analysis using the coat protein specific mAb LRE 
(II.1.6.5) (Figure III-10B) confirming the identity of the purified protein. In addition some 
minor bands were also detected running at approximately 21 and 27 kDa indicating the 
presence of degradation products of the full-length GLRaV-3 coat protein as confirmed by 
immunoblot analysis. The yield of the affinity purified full-size GLRa-3 coat protein was 
around 2.5 mg per litre culture medium. 
The purified full-length coat protein was used for antibody titer determination (III.2.2) and for 
panning based selection by phage display (III.2.4.1) but neither for mice immunization nor 
scFv characterization (III.2.3.2) since the affinity purified full-length GLRaV-3 coat protein 
was not available at that time point or the concentration was to low respectively. 
 
 
 
 
 
 
 
 
 
Figure III-10: SDS-PAGE and immunoblot analysis of purified GLRaV-3 coat protein. 
The affinity purified full-length GLRaV-3 coat protein was separated on a 12% (w/v) SDS-PAA gel and either 
stained with Coomassie brilliant blue (A) (II.2.4.2) or blotted onto nitrocellulose membrane followed by 
immunoblot analysis (B) (II.2.4.3). Immunodetection was carried out with mAb LRE as primary antibody in a 
dilution of 1:1000 followed by HRP conjugated GAM secondary antibody in a dilution of 1:5000 during 1 hour. 
Detection was performed using ECL Advance Western blotting detection kit (II.1.3). A, B: 5 μl and 2 μl, 
respectively, of affinity purified GLRaV-3 coat protein. 
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III.2.2 Immunization of mice with MBP-GLRaV-3 coat protein and antibody 
titer determination 
Affinity purified MBP-GLRaV-3 coat protein was used for immunization of three mice. 
Three boosts were performed injecting the recombinant protein every two weeks (II.2.5). 
After the third boost, polyclonal antibodies from blood tail vein serum were analyzed. The 
titer of specific antibodies raised against the coat protein was evaluated by direct ELISA 
(II.2.5.1) using the MBP-GLRaV-3 coat protein and the full-length GLRaV-3 coat protein 
expressed in the IMPACTTM system (III.2.3.2). This strategy is designed to avoid cross-
reactivity to antibodies generated during the immunization against the MBP domain. PBS was 
used as a negative control. The antibody titer refers to the highest dilution at which antigen-
specific binding is detected above an OD of 0.1. 
The titer for antibodies specific to the coat protein ranged between 1:140,000-150,000 (Figure 
III-11). In addition, cross-reactivity to MBP was also observed showing that the fusion 
partner elicited a response during the immunization. Nevertheless, the presence of specific 
polyclonal antibodies against the GLRaV-3 coat protein dominated the immune response.  
 
 
 
 
 
 
 
 
 
  
 
 
 
Figure III-11: Determination of polyclonal antibody titers from mouse antiserum by direct ELISA (II.2.5.1). 
5 μg/ml of affinity purified MBP-GLRaV-3 coat protein or GLRaV-3 coat protein were coated onto a microtiter 
plate and block for 2 h at RT with MPBS. Serial dilutions of the sera in blocking buffer were added to the coated 
plates. Detection of the bound antibodies was performed with GAMAP polyclonal antibody (1:5000) for 1 hour 
followed by the addition of pNPP substrate at 37oC.  
 
 
 
 
 
III Results 
____________________________________________________________________________________________________ 
 60
28S 
18S 
1        2 
III.2.3 Phage display library construction 
III.2.3.1 Total RNA isolation from spleen cells of immunized mice 
The mouse showing the highest antibody titer (1:140,000) against GLRaV-3 coat protein was 
euthanized and total RNA was purified from spleen cells and separated on a 1.2% (w/v) 
agarose gel containing 2.4% of formaldehyde (Figure III-12). Two distinct bands of the 
ribosomal RNA population corresponding to the 28S and 18S rRNA were clearly observed 
and the mRNA was present as background smear indicating the good quality of the extraction. 
The concentration of the RNA was relatively low (0.2 μg/μl) probably due to losses during 
the extraction procedure. No DNA contamination was observed. Since the integrity and 
quality was verified the RNA was used for subsequent construction of the phagemid scFv 
library. 
 
 
 
 
 
 
Figure III-12: Analysis of total RNA isolated from the spleen cells of an immunized mouse. 
Total RNA (II.2.6.1) was isolated from spleen cells and separated on a 1.2% (w/v) agarose gel containing 2.4 M 
formaldehyde. The major ribosomal RNA species (28S and 18S rRNA) are indicated. 1: 2μl of total RNA; 2: 
4 μl of total RNA. 
 
II.2.3.2 First strand cDNA synthesis and PCR amplification of murine antibody heavy 
and light chain variable regions 
 
Total RNA isolated from a mouse immunized with MBP-GLRaV-3 coat protein was used for 
PCR amplification of the variable domains of antibody heavy (VH) and light chains (VL). Two 
μg of total RNA was reversely transcribed to synthesize first strand cDNA using a set of gene 
specific primers which bind to the constant region of antibody heavy and light chains, 
respectively (II.1.7.3-II.2.6.2).  This cDNA template was used for the subsequent PCR 
amplification reactions using primers specific to murine IgG1, IgG2a/2b heavy chain λ and κ 
light chain (II.1.8). In total 47 PCR reactions were prepared, 14 out of 16 potential products 
were amplified using the primer combination for IgG1, 15 out of 16 for IgG2a/b, 12 out of 13 
for κ and both λ were successfully generated. VH and VL PCR products with the expected size 
ranging between 400 to 450 bp were obtained (Figure III-13) and used for subsequent 
cloning. 
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Figure III-13: PCR amplification products of antibody VH and VL chains using murine specific primer. 
Number under the lines indicates the PCR product sample separated on a 1.2% (w/v) agarose gel (II.2.6.4). Lines 
1-16 (A); 1-16 (B); 1-13 (C) and 1-2 (D) indicate the different murine phage display variable (MPDV) primers 
(II.2.1.7.3) used for the amplification of the IgG1 (A), IgG2a/b (B), κ (C) and λ (D), respectively. M: 100 bp 
DNA ladder (II.2.6.3). 
 
 
 
III.2.3.3 Construction of phagemid scFv library 
The amplified PCR products for the antibody VH and VL domains were pooled, separated and 
purified from an agarose gel (II.2.1.9). The gel-purified antibody VH fragments were digested 
with SfiI and BstEII and the antibody VL fragments with AscI and NotI and ligated into the 
pHENHi vector resulting in the construction of separate variable heavy and light chain 
sublibraries. For the construction of the phagemid scFv library of the GLRaV-3 coat protein 
immunized mice, the VL fragments were recovered from the VL sublibrary with the 
corresponding restriction enzymes and cloned into the linearized pHENHi vector containing 
the VH fragments. The cloning strategy is shown in Figure III-14. 
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Figure III-14: Schematic presentation showing the cloning procedure used for the generation of the phagemid 
scFv library. 
The VH and VL PCR amplification mixes (II.2.6.4) were separately digested with SfiI/BstEII or AscI/NotI, 
respectively, and ligated into the pHENHi vector. Then, the VL domains were excised by digestion with 
AscI/NotI and subcloned into the pHENHi vector containing the VH fragment. pelB: pelB leader peptide; c-myc: 
myc epitope for the scFv detection; His6 tag for purification: 218*: 218 linker. 
 
The cloning efficiency for the VH and VL sublibraries and final scFv library was estimated by 
PCR amplification of randomly selected colonies using pHEN specific primers (II.1.7.1). The 
PCR products were analyzed on a 1.2% (w/v) agarose gel. Figure III-15 shows as an example 
25 individual colonies randomly selected from the GLRaV-3 coat protein scFv library, 
demonstrating that the percentage of positives clones carrying the full-size fragment of 900-
950 bp was 92%. 
 
 
 
 
 
Figure III-15: PCR amplification of randomly selected colonies of the mouse derived GLRaV-3 coat protein 
scFv library. 
1-25: PCR amplification products (II.2.6.4) of 25 individual colonies (II.2.1.12) separated on a 1.2% (w/v) 
agarose gel (II.2.1.9). M: 100 bp ladder. C(+): scFvODC3 was used as positive control. 
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Table III-3 summarizes the results obtained from the calculation of the cloning efficiency. 
The number of independent clones for the VH and VL sublibraries was 7.5x105 and 6x106, 
respectively, and the percentage of positives clones carrying the correct fragment were 95% 
and 90% for VH and VL chain sublibraries. Finally, the percentage of full-size clones in the 
final GLRaV-3 coat protein library was 92% with a number of 5.8x106 independent clones. 
 
Table III-3: Summary of the number of independent clones and cloning efficiency of the GLRaV-3 coat protein 
library for VH, VL and for the scFv library, respectively.  
 
Fv library size 
(cloning efficiency %) Antigen 
H L 
scFv library size 
(cloning efficiency %) 
GLRaV-3 CP 7.5x105 (95%) 6x106 (90%) 5.8x106 (92%) 
Note: the cloning efficiency is indicated in brackets.  
 
To determine the variability of the generated scFvs, PCR-amplified scFv fragments were 
subjected to restriction with BstNI (II.2.6.4). The restriction fragment length polymorphism 
(RFLP) obtained from 26 randomly selected colonies indicated that approximately 84% of 
them had different patterns (Figure III-16). These results confirmed that the construction of 
GLRaV-3 coat protein scFv library was successful resulting in a diverse repertoire. Therefore, 
the phagemid scFv library was subsequently used for solid phase phage panning. 
 
 
 
 
Figure III-16: Analysis of murine scFv fragments after BstNI digestion. 
PCR-amplified scFv fragments (II.2.6.4) of 26 randomly selected colonies (II.2.1.12) from the GLRaV-3 coat 
protein scFv library were digested with BstNI (II.2.6.6) and analyzed on a 2% (w/v) agarose gel (II.2.1.9). M: 
100 bp ladder. 
 
III.2.4 Selection and characterization of GLRaV-3 coat protein specific scFvs 
 
III.2.4.1 Solid phase panning against recombinant full-length GLRaV-3 coat protein 
The phagemid scFv library was panned three times against 10 μg/ml of full-length GLRaV-3 
coat protein immobilized on the surface of immunotubes (II.2.7). For each round of panning 
1010 phages were incubated with 3% (w/v) of MPBS to avoid non-specific binders in the 
following round of panning. After each round of panning randomly selected colonies were 
analyzed by PCR for the presence of the full-size scFv inserts using vector-specific primers 
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(II.1.7.1). To visualize the diversity of the selected colonies a BstNI fingerprint analysis was 
performed after the third round of panning. 
Table III-4 shows that there was a 1508-fold enrichment of selected phages displaying coat 
protein specific scFvs after the third round of panning. Between the first and the second round 
of panning the presence of phagemid carrying the full-size scFv insert was increased from 
79% to 81.5%. After the third round the percentage of phages containing full-size scFv cDNA 
reached 96%. The BstNI fingerprint obtained from 26 colonies after the third round indicated 
the presence of at least 3 different patterns suggesting an enrichment of specific clones (data 
not shown). 
 
Table III-4: Enrichment of specific selected phages against GLRaV-3 coat protein antigen through panning. 
Enrichment was calculated by dividing the ratio of recovered number of phages to the input number of phages 
for each round by the same ratio from the preceding round. Total enrichment is obtained by dividing the ratio of 
recovered number of phages to input number of phages of round 3 by the same ratio from round 1. Enrichment 
of round 1 is considered as one. 
 
scFv 
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      7x10
7
      7x10
-3
 13 
 
 
III.2.4.2 Selection and characterization of specific scFv-fragments against MBP 
GLRaV-3 coat protein 
A soluble expression of 120 randomly selected colonies after the third panning round was 
performed to select specific phages against the antigen. The expression of soluble scFv 
fragments was achieved by the addition of 1 mM IPTG. The specificity of the selected scFv 
fragments was tested by direct ELISA (II.2.8.2) against MBP-GLRaV-3 coat protein. To 
avoid selection of scFvs cross-reacting against the MBP-fusion partner or the linker, the 
active site of Arabic mosaic virus (ArMV) replicase (a non-related 18 kDa protein) fused to 
maltose binding protein (MBP-ArMV-repas) was used as a control. PBS was used as negative 
control. 
Thirteen scFv fragments showed specific binding to the GLRaV-3 coat protein without cross-
reacting to MBP or the linker between ArMV-repas and the MBP (data not shown). To verify 
the presence of a full-length scFv fragments including the C-terminal c-myc and the His6 
tags, the 13 positive clones were PCR-amplified and digested with BstNI restriction enzyme. 
All of them presented a full-size insert of approximate 1 kb and the RFLP pattern indicated 
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the presence of three different clones (data not shown) confirming the previous profile 
obtained after the third round of panning. 
Soluble expression of scFv fragments in microtiter plates is a suitable method for growing of 
large numbers of clones for preliminary screening, but the cultures do not aerate uniformly, so 
the level of scFv expression is not normalized. To overcome the differences between 
individual clones based on expression in microtiter plates, all 13 selected specific scFvs were 
subjected to a medium scale periplasmic expression. A direct ELISA (II.2.8.2) using 
bacterially expressed MBP-GLRaV-3 coat protein was performed. MBP-ArMV-repas and 
PBS was used as controls. All 13 scFv fragments bound specifically to the GLRaV-3 coat 
protein (Figure III-17). Since these scFvs did not show any binding to MBP-ArMV-repas 
specificity to the fusion partner MBP can be excluded. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure III-17: Binding of selected murine scFv fragments to MBP-GLRaV-3 coat protein, MBP-ArMV-repas or 
PBS in direct ELISA. 
10 μg/ml of MBP-GLRaV-3 coat protein or MBP-ArMV-repas were coated onto microtiter plates (II.2.8.1). 
Periplasmic supernatant was added in 2% (w/v) MPBS to a final volume of 100 μl. Bound scFvs were detected 
by addition of 1:5000 diluted 9E10 monoclonal antibody and GAMAP polyclonal antibody. ELISA readings 
(OD405 nm) were performed after 10 min incubation with pNPP substrate at 37oC. 
 
 
III.2.4.3 Sequence analysis of GLRaV-3 coat protein specific scFv fragments  
All 13 specific scFv fragments characterized by ELISA were sequenced (II.2.1.12). They 
belong to three different sequence groups. The most abundant sequence was represented by 
clone scFvLR3cp-1 presented nine times followed by scFvLR3cp-2 and scFvLR3cp-6 which 
were present twice each.  
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One clone of each group (scFvLR3cp-1, scFvLR3cp-2 and scFvLR3cp-6) presenting the 
highest binding signal in direct ELISA (III.2.3.2) was selected and further analyzed. All three 
scFvs had an open reading frame encoding proteins between 28 and 30 kDa. The sequence 
alignment (Figure III-18) of the three different scFv fragments with the consensus sequence 
of the Kabat database indicated that the variable antibody heavy and light chain fragments 
belong to murine IgG. Table III-5 shows the amino acid length and the molecular weights of 
three scFv fragments. 
 
Table III-5: Summary of amino acid length and molecular weight of murine derived GLRaV-3 coat protein 
specific scFv fragments. 
 
Designation of scFvs Amino acid length1 Deduced MW (Da) 
scFvLR3cp-1 271 29303 
scFvLR3cp-2 273 29409 
scFvLR3cp-6 272 28943 
1: The His6 tag and c-myc tag are including for the calculation of the length and MW. 
 
The sequence alignment of scFvLR3cp-1, -2 and -6 with the nearest germline V-gene 
segments listed in the IMGT database showed that the heavy and light chain variable domains 
of selected scFvLR3cp’s were members of the family I and IV of murine VH and family I, IV 
and VI of the κ light chain, respectively. Differences were observed from the nearest germline 
V-gene segments (Table III-6) and will be further discussed in the discussion section. 
 
Table III-6: V-gene family, germline deviation and extent of somatic mutation of the three scFvs binding to 
GLRaV-3 coat protein.  
The amino acid differences observed in the primer region are indicated in brackets. The sequences alignment 
was performed using the IMGT database (http://imgt.cines.fr). 
 
Mouse IgG Family Closest germline  gene sequence 
Difference from germline 
(Amino acids) 
scFvs H L H L H L 
scFvLR3cp-1 IGHV4 IGKV6 V00774 J00569 3(2) 3(1) 
scFvLR3cp-2 IGHV1 IGKV1 AF304558 AJ235953 19(1) 5(1) 
scFvLR3cp-6 IGHV1 IGKV4 OF304551 AJ235938 17(0) 9(4) 
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Figure III-18: Alignment of the amino acid sequence of the GLRaV-3 specific scFv fragments. 
Framework regions and complementary determining regions (CDRs) were determined according to Kabat and 
Wu (1991). ‘*’: indicates positions which have a single, fully conserved residue; ‘-‘: no amino acids at that 
position; ‘:’ or ‘.’ different amino acid. The complementary determining regions, the 218* linker, c-myc and 
His6 tag amino acid sequence shown in single letter code have been indicated. Amino acid residues were colour 
coded as follows, orange: G, P, T and S; red: H, K and R; blue: F, W and Y; green: I, L, M, and V. 
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The results obtained from the sequence analysis of the thirteen scFv fragments confirmed that 
all contained the specific element of a scFv including the CDRs and the framework regions. 
 
III.2.5 Bacterial expression and characterization of GLRaV-3 coat protein 
specific scFvs 
III.2.5.1 Cloning of scFvLR3cp-1, -2 and -6 into the bacterial expression vector pSyn 
To enable bacteria expression GLRaV-3 coat protein specific scFv fragments scFvLR3cp-1,   
-2 and -6 in more detail the corresponding cDNAs were subcloned into the expression vector 
pSyn (Figure III-4) downstream of the pelB signal sequence using NcoI and NotI restriction 
sites. The correct subcloning of the scFv cDNAs was confirmed by sequencing (II.2.1.12) and 
the protein accumulation of the recombinant scFvs into the periplasmic space was achieved 
by 1 mM IPTG at 28°C using E. coli strain BL21(λDE3). 
 
III.2.5.2 Bacterial expression and purification of GLRaV-3 specific scFvs 
ScFvLR3cp-1 cloned into the pSyn bacterial expression vector was induced for expression 
and purified by IMAC as described in II.2.3.2. Analysis of the elution fractions by SDS-
PAGE (Figure III-19A) revealed the presence of a band of approximately 30 kDa which 
agreed well with the calculated molecular mass of 29.3 kDa. Other contaminating bands were 
also observed, the most dominant ones being approximately ~62 kDa and 26 kDa. The 
immunoblot analysis of the elution fractions revealed a band at the expected size for the 
scFvLR3cp-1 (Figure III-19B) and confirmed the identity of the 26 kDa band as a degradation 
product of the scFv. None of the other proteins that co-eluted with the scFvLR3cp-1 were 
detected in the immunoblot analysis indicating that these contaminants were not multimeric 
forms of the scFv but unrelated bacterial proteins. 
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Figure III-19: SDS-PAGE and immunoblot analysis of affinity purified bacterial produced scFvLR3cp-1. 
scFvLR3cp-1 was subcloned into the pSyn vector (II.1.5.1) and expressed in the E. coli strain BL21(λDE3) 
(II.1.6.1) upon induction with IPTG. The periplasmic expressed scFv was purified by IMAC (II.2.3.3). Proteins 
were separated on a 12 % (w/v) SDS-PAA gel and either stained with Coomassie brilliant blue (A) (II.2.4.2) or 
blotted onto nitrocellulose membrane (B) (II.2.4.3). Immunodetection of scFvLR3cp-1 was done using 1:5000 
diluted 9E10 monoclonal antibody and GAMAP polyclonal antibody (1:5000). Detection was carried out with 
NBT/BCIP for 1 min at RT. P: 
 10 μl of pellet; O: 10 μl of periplasmic extract; FT : 10 μl of flow through ; W1, W2 : 10 μl of wash fractions; E1, 
E2, E3 : 10 μl of elution fractions. 
 
After purification, scFvLR3cp-1 was dialyzed overnight in citrate buffer (pH 4.5) and the 
final concentration was determined by BCA protein assay kit (II.2.4.1) and SDS-PAGE 
(II.2.4.2) using a scFv of known concentration as a standard (data not shown). The yield of 
purified scFv ranged between 2.5-4 mg/L culture volume. Slight deviations were observed 
depending on the batch of preparation.  
Expression of scFvLR3cp-2 and -6 was achieved by the addition of IPTG to a final 
concentration of 1 mM at 28°C and IMAC purified. Under these conditions 90% of the 
recombinant scFvs were produced as insoluble inclusions bodies (data not shown). Several 
modifications were employed to improve solubility. First the IPTG concentration was reduced 
to 0.1mM; second the bacterial growth and induction temperatures were decreased from 37°C 
and 28°C to 25°C and 18°C,  respectively, for longer induction periods.  
All attempts to purify soluble scFvLR3cp-2 and -6 using these parameters gave no 
improvement in the purification yield. The average yield of soluble scFv was between 0.02 
and 0.04 mg per liter culture volume (data not shown). These results suggest that the kinetics 
of insoluble antibody fragment formation was not affected by the different conditions used 
during the expression of these scFvs.   
Since the purification of scFvLR3cp-2 and -6 resulted in very low yields of soluble protein, 
only scFvLR3cp-1 showing the highest level of expression was selected for further 
characterization. 
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III.2.5.3 Reactivity of affinity purified scFvLR3cp-1 to MBP-GLRaV-3 coat protein 
The binding of affinity purified scFvLR3cp-1 to MBP-GLRaV-3 coat protein was analyzed 
by direct ELISA (II.2.8.2). Several concentrations of the scFvLR3cp-1 (0.14 - 73 ng) were 
subjected to a high binding microtiter plate coated with 5μg/ml of MBP-GLRaV-3 coat 
protein. As a control a truncated version containing the first 58 amino acids of the GLRaV-3 
coat protein C-terminally fused to maltose binding protein (MBP-58 LR-3 CP) was used 
(III.1.5.7.1). 
The result shown in Figure III-20 confirmed that the scFvLR3cp-1 binds highly specific to the 
recombinant coat protein of GLRaV-3 and did not bind to the MBP. Since the scFv did not 
bind to the truncated MBP-58 LR-3 CP it was concluded that the binding epitope is not 
located within the first 58 amino acids of the GLRaV-3 coat protein (see III.2.4.9).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure III-20: Reactivity of affinity purified scFvLR3cp-1 to MBP-GLRaV-3 coat protein and MBP-58 LR-3 CP 
in direct ELISA (II.2.8.2). 
5 μg/ml of MBP-GLRaV-3 coat protein and MBP-58 LR-3 CP (II.2.3.1) were coated o/n onto a high binding 
microtiter plate. Several concentration of scFvLR3cp-1 (0.14 - 73 ng) were added in 2% (w/v) MPBS to a final 
volume of 100 μl. The bound scFv was revealed by addition of 1:5000 diluted 9E10 monoclonal antibody and 
GAMHRP polyclonal antibody. ELISA readings (OD405 nm) were performed after 1 hour incubation with ABTS 
substrate at 37oC.  
 
III.2.5.4 Reactivity of affinity purified scFvLR3cp-1 to viral particles 
Specific binding of scFvLR3cp-1 to GLRaV-3 particles was characterized by capture ELISA 
using infected grapevine material (II.2.8.3). Extract from grapevine leaves infected by 
GLRaV-3 (II.1.6.7) were incubated on high binding microtiter plate coated overnight with 
polyclonal rabbit IgG antibodies specific to GLRaV-3 coat protein. Then several 
concentrations of affinity purified scFvLR3cp-1 were added. 
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The ELISA result demonstrated a high binding specificity of the selected scFv to the viral 
particles present in the infected grapevine material (Figure III-21). No cross-reactivity was 
observed against non-infected grapevine extract used as a control.  
The binding of scFvLR3cp-1 to the GLRaV-3 particles from infected plants was lower 
compared to the direct ELISA (Figure III-20) using the recombinant MBP-GLRaV-3 coat 
protein. The lower OD values observed in capture ELISA (Figure III-21) could be due to 
lower amounts of GLRaV-3 particles present in the infected grapevine material. 
Unfortunately, the amount of GLRaV-3 particles present in the infected material could not be 
quantified by SDS-PAGE (II.2.4.2) to confirm this observation. The concentration of viral 
particles present in the sample seemed to be low to resolve distinct band for a proper 
quantification. 
 
 
 
 
 
 
 
 
 
 
 
Figure III-21: Reactivity of affinity purified scFvLR3cp-1 to extract from grapevine leaves infected and non-
infected by GLRaV-3 in capture ELISA (II.2.8.3). 
1.5 μg/ml of polyclonal rabbit IgG specific to GLRaV-3 coat protein were coated overnight onto a microtiter 
plate and blocked for 2 h at RT with MPBS, then leaf extract from GLRaV-3 infected or non-infected grapevine 
were added. Finally, several concentrations of affinity purified scFvLR3cp-1 (2.5 – 625 ng) were applied 
followed by addition of 1:5000 diluted 9E10 monoclonal antibody and GAMHRP polyclonal antibody (1:5000). 
ELISA reading (OD405nm) were performed after 1 h incubation with ABTS substrate at 37oC. 
 
 
III.2.5.5 Electrophoretic mobility shift assay  
The functionality of the affinity purified scFvLR3cp-1 against GLRaV-3 coat protein was 
tested in solution by electrophoretic mobility shift assay (EMSA). This biochemical 
characterization is based on the formation of stable antibody:antigen complexes that migrate 
slower through polyacrylamide gels than free antigen and antibody fragments, respectively 
(II.2.8.4). One μg of affinity purified scFvLR3cp-1 was incubated with MBP-GLRaV-3 coat 
protein in a molar ratio of 1:0.40 and 1:0.20 (scFv:antigen) for 1 h at 37°C. In parallel one μg 
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1      2       3  4       
of MBP-GLRaV-3 coat protein and scFvLR3cp-1 alone were also incubated under the same 
condition. The different samples were then loaded on a native 9% (w/v) non-reducing PAA 
gel and Coomassie stained (Figure III-22).  
 
 
 
 
  
 
 
 
Figure III-22: Functionality analysis of affinity purified scFvLR3cp-1 to MBP-GLRaV-3 coat protein antigen by 
EMSA (II.2.8.4). 
scFvLR3cp-1/MBP-GLRaV-3 coat protein complex formation was analyzed on a native 9% (w/v) non-reducing 
PAA gel followed by Coomassie brilliant blue staining (II.2.8.4). 1: 1 μg scFvLR3cp-1; 2: 1 μg MBP:GLRaV-3 
coat protein; 3: 1 μg scFvLR3cp-1 + 1 μg MBP:GLRaV-3 coat protein; 4: 1 μg scFvLR3cp-1 + 0.5 μg 
MBP:GLRaV-3 protein.  
 
 
The interactions between the scFv and the antigen resulted in the formation of a complex of 
higher molecular weight that migrate slower (lane 3, marked with a circle) than the 
scFvLR3cp-1 (lane 1, blue arrow) or MBP-GLRaV-3 coat protein alone (lane 2, red arrow). 
Moreover, the band intensity of this complex decreased when the same concentration of the 
scFv fragment was incubated with a lower amount of antigen (lane 4). This result 
demonstrated that scFvLR3cp-1 and MBP-GLRaV-3 coat protein interact and form stable 
complexes confirming the specificity of the scFv to the antigen. 
 
 
III.2.5.6 Determination of the affinity constant by surface plasmon resonance analysis 
The kinetic of scFvLR3cp-1 binding to the GLRaV-3 coat protein was studied by surface 
plasmon resonance analysis. The measurement was made on a low capacity binding surface 
prepared by immobilising the antigen to the sensor surface using amine-specific coupling. 
Different concentrations of scFvLR3cp-1 (0.56 - 72.5 nM) were injected and their binding to 
the MBP-GLRaV-3 coat protein acting as a ligand (II.2.8.5) was measured as an increase in 
the refraction index. This change is transformed into a sensorgram (Figure III-23) plotted as 
response units (RUs) versus time, which is a continuous, real-time monitoring of the 
association and dissociation of the interacting molecule (Harding and Chowdhry, 2001). 
When the affinity purified scFvLR3cp-1 fragment was injected, the sensorgram revealed that 
the association to the GLRaV-3 coat protein was very slow (ka = 4.89 x 104) but the 
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dissociation was relatively fast (kd = 1.98 x 10-3). The dissociation constant (KD) determined 
from the ratio of theses two kinetics constants (kd/ka) was 4 x 10-8 M. This study demonstrated 
that the selected scFvLR3cp-1 binds in soluble form to the antigen with a high affinity 
constant.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure III-23: Affinity constant determination of scFvLR3cp-1 by surface plasmon resonance (II.2.8.5). 
Overlay of sensorgrams showing the binding of various concentration of scFvLR3cp-1 to MBP-GLRaV-3 coat 
protein immobilized on the sensor chip. The changes in the RU were measured after 180 seconds of sample 
injection. 
 
 
III.2.5.7 Electron microscopy analysis of GLRaV-3 coat protein specific scFvLR3cp-1 
Immunogold electron microscopy (IEM) studies were performed to verify the binding of the 
affinity purified scFvLR3cp-1 to intact virus particles. Purified GLRaV-3 particles were 
directly absorbed on electron microscopy grids followed by the addition of the GLRaV-3 coat 
protein specific scFv antibody fragment. Immunogold analysis revealed that scFvLR3cp-1 
binds uniformly over the entire surface of the virus particle (Figure III-24A). No decoration 
was observed in the negative control (Figure III-24B). This result confirmed that the epitope 
is accessible and exposed on the surface of the GLRaV-3 virions. 
 
 
 
 
 
III Results 
____________________________________________________________________________________________________ 
 74
B
A
 
 
 
 
 
 
 
 
 
Figure III-24: Immunogold labelling (II.2.8.7) of GLRaV-3 particles decorated with scFvLR3cp-1.  
Virus particles were trapped on microscope grids, washed and blocked afterwards with 0.1% (w/v) BSA. 
Panel A: The virus particles were subsequently incubated with scFvLR3cp-1 (60 μg/ml) and 9E10 monoclonal 
antibody (1:500) and decorated with 10 nm goat anti-mouse IgG H+L gold conjugated (1:50). 
Panel B: Negative control. The same procedure as in A but without scFvLR3cp-1. 
Bar: 200nm 
 
III.2.5.8 Analysis of scFvLR3cp-1 binding to MBP-GLRaV-3 coat protein by 
immunoblot 
Since preliminary electron microscopy studies (III.2.4.7) confirmed that scFvLR3cp-1 
recognized epitopes located over the entire surface of the virus particles, an immunoblot 
analysis (II.2.4.3) was performed to determine if the denatured GLRaV-3 coat protein antigen 
could be recognized as well by this scFv fragment. Therefore, one μg of the fusion protein 
MBP-GLRaV-3 coat protein was separated on a 12% (w/v) SDS-PAA gel, electroblotted to a 
nitrocellulose membrane and blocked for 1 hour with MPBS and subsequently incubated with 
scFvLR3cp-1 followed by 9E10 monoclonal antibody and GAMAP polyclonal antibody. 
Detection was performed according to II.2.4.3.  As shown in Figure III-25, the immunoblot 
analysis revealed the presence of a band at the expected size of 77.5 kDa for the bacterially 
purified MBP-GLRaV-3 coat protein confirming that scFvLR3cp-1 recognized the denatured 
antigen including some degradation bands. This result indicates that scFvLR3cp-1 is 
recognizing a linear epitope present on the surface of the viral coat protein. 
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Figure III-25: Immunoblot analysis of MBP-GLRaV-3 coat protein with affinity purified scFvLR3cp-1. 
One μg of bacterially purified MBP-GLRaV-3 coat protein (II.2.3.1) was separated on a 12% (w/v) SDS-PAA 
gel (II.2.4.2) and blotted onto nitrocellulose membrane for immunoblot analysis (II.2.4.3). Blotted MBP-
GLRaV-3 coat protein was incubated with scFvLR3cp-1 (3 μg/ml) for 1 hour followed by addition of a 1:5000 
dilution of 9E10 monoclonal antibody and 1:5000 dilution of GAMAP polyclonal antibody. Detection was carried 
out with NBT/BCIP for 1 min at RT.  
 
 
III.2.5.9 Epitope mapping of scFvLR3cp-1  
The binding epitope on the GLRaV-3 coat protein recognized by the scFvLRcp-1 was 
analyzed by two different approaches. The preliminary information about the scFv binding 
region was generated by studying the reactivity of scFvLR3cp-1 to the first 58, 78, 98, 148 or 
161 amino acids of the GLRaV-3 coat protein by ELISA and immunoblot analysis 
(III.2.4.9.2). To map this epitope more accurately a second approach based on a peptide 
scanning analysis was used (III.2.4.9.3). 
 
III.2.5.9.1 Generation, cloning and expression of truncated GLRaV-3 coat protein 
versions 
Four truncated versions of the GLRaV-3 coat protein comprising the first 78, 98, 148 or 161 
amino acids (MBP-78 LR-3 CP, MBP-98 LR-3 CP, MBP-148 LR-3 CP, MBP-161 LR-3 CP, 
respectively) C-terminally fused to MBP were generated by PCR (II.2.1.11) using the full-
length GLRaV-3 coat protein in pMAL as a template. To facilitate the cloning into the pMAL 
c2X vector, primers containing BamHI and SalI restriction sites were designed (II.1.7.8). The 
truncated MBP-58 LR-3 CP was generated by religation and filling in of SnaBI and HindIII 
digested GLRaV-3 coat protein in pMAL (II.1.5.1). The five truncated versions of the coat 
protein are summarized in table III-7.  
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Table III-7: Summary of the generated truncated versions of MBP-GLRaV-3 coat protein fusions.  
 
Clone name 
Number of amino acids 
belonging to the GLRaV-3 
coat protein 
Molecular weight of the MBP-
fusion (kDa) 
MBP-58 LR-3 CP 58 55.9 
MBP-78 LR-3 CP 78 50.9 
MBP-98 LR-3 CP 98 53 
MBP-148 LR-3 CP 148 57.5 
MBP-161 LR-3 CP 161 70.5 
 
  
DNA sequencing (II.2.1.12) revealed that the five truncated versions of the coat protein gene 
were in frame with the 3’ end of the MBP sequence. The plasmid DNAs were transformed 
separately into E. coli strain BL21(λDE3) and cytosolic expression was induced by adding 
IPTG to a final concentration of 0.3 mM for 3 hours at 37°C (II.2.3.1). 
The SDS-PAGE (II.2.4.2) analysis of the affinity purified MBP-truncated fusions showed 
high purity (Figure III-26) and the predicted molecular sizes of the truncated fusions of MBP-
GLRaV-3 coat protein, whereas MBP-78 LR-3 CP and MBP-98 LR-3 CP migrated slowler 
than expected according to the calculated molecular weight of 50.9 and 53 kDa, respectively. 
The yield of purified truncated MBP-GLRaV-3 versions ranged between 0.5-4 mg per liter of 
bacterial culture. Occasionally, degradation was observed for the MBP-161 LR-3 CP fusion 
protein (Figure III-26, line 4). The five purified MBP-GLRaV-3 coat protein truncated 
fusions were subsequently used for the identification of the initial scFvLR3cp-1 binding site 
by immunoblot analysis and ELISA. 
 
 
 
 
 
 
 
 
Figure III-26: SDS-PAGE analysis of affinity purified truncated MBP-GLRaV-3 coat protein fusions. 
MBP-GLRaV-3 coat protein and its affinity purified deleted versions were loaded on a 12% (w/v) SDS PAA gel 
followed by Coomassie brilliant blue staining (II.2.4.2) 1: 0.2 µl MBP; 2: 2 µl MBP-GLRaV-3 coat protein; 3: 2 
µl MBP-58 LR-3 CP; 4: 1 µl MBP-161 LR-3 CP; 5: 10 µl MBP-78 LR-3 CP; 6: 10 µl MBP-98 LR-3 CP; 7: 10 
µl MBP-148 LR-3 CP; M: 5 μl PageRulerTM Prestained Protein ladder. 
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III.2.5.9.2 Identification of the initial scFvLR3cp-1 binding site by immunoblot analysis 
and ELISA 
Approximately 1 μg of each of the MBP-truncated fusions were separated on a 12% SDS-
PAA gels, transferred to a nitrocellulose membrane (II.2.4.3) and analyzed by immunoblot 
using scFvLR3cp-1 for specific detection of the GLRaV-3 coat protein.  
Truncated versions MBP-78 LR-3 CP, MBP-98 LR-3 CP, MBP-148 LR-3 CP, MBP-161 LR-
3 CP were detected with similar intensities by scFvLR3cp-1 in immunoblot analysis (Figure 
III-27A). In contrast the first 58 amino acids were not detectable (see also result presented in 
section III.2.4.3) indicating that the epitope recognized by this scFvLR3cp-1 is located 
between amino acids 58 and 79 of the GLRaV-3 coat protein (Figure III-27B). This result was 
also confirmed by ELISA. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure III-27: Epitope mapping of affinity purified scFvLR3cp-1 with truncated fusions of the MBP-GLRaV-3 
coat protein antigen by immunoblot analysis and ELISA. 
(A) Approximately 1 μg of each of the affinity purified MBP-truncated fusions were separated on a 12% (w/v) 
SDS-PAA gel (II.2.4.2) and blotted onto nitrocellulose membrane (II.2.4.3). Immunodetection was done using 
1:3000 diluted scFvLR3cp-1 conjugated to HRP (II.2.4.4). Detection was carried out using ECL Advance 
Western blotting detection kit. 
 (B) Schematic representation of truncated forms of MBP-GLRaV-3 coat protein. Numbers on the left refer to 
the position of the corresponding MBP-truncated fusion in the immunoblot analysis (Figure III-27 A). Positive 
and negative reactions in immunoblot analysis and ELISA are indicated by a “+” and “–“, respectively. 1: MBP-
58 LR-3 CP; 2: MBP-161 LR-3 CP; 3: MBP-78 LR-3 CP; 4: MBP-98 LR-3 CP; 5: MBP-148 LR-3 CP; M: 5 μl 
PageRulerTM Prestained Protein ladder. 
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II.2.5.9.3 Determination of the putative epitope of scFvLR3cp-1 by PEPSCAN 
analysis 
To define the epitope determined by truncated GLRaV-3 coat protein formats more 
accurately, a second approach based on a peptide scanning analysis was performed. Scanning 
of overlapping peptides, derived from the amino acid sequence of the antigen, is a widely 
used tool for epitope mapping (Geysen et al., 1987). The entire antigen sequence is 
synthesized as linear 8 to 15meric peptides that are subsequently tested for binding of the 
antibody. The peptides are covalently bound to a Whatman 50 cellulose support via the C-
terminus and have usually an acetylated N-terminus leading to a higher stability and better 
presentation of the peptide on the membrane. These solid phase-bound peptides are used for 
binding studies directly on the membrane. 
For PEPSCAN analysis a set of nine 13-mer peptides spanning the amino acids 59 to 78 of 
the GLRaV-3 coat protein were synthesized on a membrane (II.2.8.6.2). This 19 amino acid 
region was identified as the reactive binding domain by immunoblot and ELISA analysis 
(III.2.4.9.2). Each peptide overlapped with the previous peptide by 11 amino acids. 
The reaction of scFvLR3cp-1 with the synthetic peptides covering the previously described 
region of amino acid produced a strong signal for peptides 3, 4, 6 and an intermediate signal 
for the peptide 5 (Figure III.28A). Alignment of these peptide sequences revealed the 
AQEPPRQ sequence from the GLRaV-3 coat protein as the putative epitope (Figure III-28B).  
This study confirms that scFvLR3cp-1 binds to the linear epitope AQEPPRQ comprising the 
amino acids 69 to 75 of the GLRaV-3 coat protein. 
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                           B 
Peptide number Peptide sequence reactivity 
1  VFATAALATAAQE - 
2    ATAALATAAQEPP - 
3      AALATAAQEPPRQ + 
4        LATAAQEPPRQPP + 
5          TAAQEPPRQPPAQ + 
6            AQEPPRQPPAQVA + 
7 EPPRQPPAQVAEP - 
8   PRQPPAQVAEPQE - 
9     QPPAQVAEPQETD - 
Consensus 
sequence AQEPPRQ 
 
 
Figure III-28: Determination of the putative binding epitope of scFvLR3cp-1 by peptide scanning analysis.  
(A) A set of nine 13-mer peptides covering 19 amino acids of the GLRaV-3 coat protein were synthesized on a 
membrane (II.2.8.6.1) and incubated with affinity purified scFvLR3cp-1 conjugated to HRP in a 1:3000 dilution 
(II.2.4.4). Detection was carried out using ECL Advance Western blotting detection kit. 
(B) The table presents the overlapping peptides used and their recognition by scFvLR3cp-1. Peptides positively 
recognized are indicated by a “+” and highlighted in dark blue. 
 
 
III.2.5.10 Reactivity of scFvLR3cp-1 to related GLRaVs 
To evaluate the reactivity of scFvLR3cp-1 to related viruses, a number of different GLRaVs 
from the Closteroviridae family were analyzed by direct ELISA (II.2.8.2). Several 
concentrations of the affinity purified scFvLR3cp-1 were incubated on a high binding 
microtiter plate, coated with extracts from grapevines leaves infected by GLRaV-1, GLRaV-
2, GLRaV-3, GLRaV-6 or GLRaV-7. 
The ELISA demonstrated that scFvLR3cp-1 recognized GLRaV-1, GLRaV-6 and GLRaV-7 
with similar intensities but did not cross-reacted to GLRaV-2 (Figure III-29). GLRaV-3 was 
used as positive control. No cross-reactivity against non-infected grapevine material used as 
negative control was observed.  
This study indicated that scFvLR3cp-1 possesses a broad specificity against at least four 
different GLRaVs from the Closteroviridae family. 
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Figure III-29: Reactivity of affinity purified scFvLR3cp-1 to GLRaV-1, GLRaV-2, GLRaV-3, GLRaV-6 and 
GLRaV-7 in direct ELISA. 
Leaf extract from GLRaV-1, GLRaV-2, GLRaV-3, GLRaV-6 and GLRaV-7 infected and non-infected grapevine 
material were coated o/n onto a microtiter plate and blocked for 2 h at RT with MPBS. Several concentrations of 
affinity purified scFvLR3cp-1 (3.90 – 1000 ng) were added in 2% (w/v) MPBS to a final volume of 100 μl. The 
bound scFv was revealed by addition of 1:5000 diluted 9E10 monoclonal antibody and GAMHRP polyclonal 
antibody. ELISA readings (OD405 nm) were performed after 1 hour incubation with ABTS substrate at 37oC 
 
 
There is no information available about the amino acid sequences of GLRaV-6 and 7 coat 
proteins but sequence comparison between GLRaV-3 and GLRaV-1 coat proteins indicate a 
sequence identity of 32.9% and sequence similarity of 51.8% at the amino acid level. Amino 
acid sequence comparison revealed the presence of three identical amino acids and a similar 
fourth amino acid generating a 57% of similarity between the GLRaV-3 epitope and GLRaV-
1 (Table III-8). This result strongly suggests that the cross-reactivity against GLRaV-1 is 
based on the presence of a similar epitope onto the coat protein of this ampelovirus.  
 
 
Table III-8: Amino acid sequence comparison of the GLRaV-3 epitope with the sequence of the GLRaV-1 coat 
proteins. 
The comparison was determined according to Henikoff and Henikoff (1992) using an amino acid substitution 
matrices from protein blocks. ‘⏐’: identity as above; ‘:’: similar amino acids at that position. The numbers at the 
extremes of the sequence indicate the position of the epitopes. 
 
Virus Alignment % similarity 
GLRaV-1 
GLRaV-3 
128-IFEPPKD-134 
 ⏐⏐⏐: 
69-AQEPPRQ-75 
57.14 
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III.2.6 Expression of scFvLR3cp-1 in plants 
III.2.6.1 Cloning of scFvLR3cp-1 into the plant expression vector pTRA 
To evaluate production and functionality of scFvLR3cp-1 in the plant cell cytosol, the 
corresponding cDNA was subcloned into pTRA plant expression vectors containing the 
constitutive CaMV 35S or the phloem-specific CFDV promoter, respectively. The same 
cloning strategy as for scFvLR2cp-35 (III.1.3.1) was followed for the cloning of this specific 
scFv fragment into the pTRA vectors. Two different constructs were generated: pTRA-
35SS:scFvLR3cp-1 contains the double enhanced constitutive CaMV 35S promoter and the 
pTRA-CFDV:scFvLR3cp-1 contains the phloem-specific CFDV promoter. 
The correct sequence for both construct was confirmed by sequence analysis (II.2.1.12) and 
the recombinant DNA was transformed into competent A. tumefaciens by electroporation 
(II.2.1.4). Six independent colonies from each transformation were analyzed for the presence 
of the cDNA insert by colony PCR (II.2.1.11) using vector-specific primers (II.1.7.1) and 
glycerol stocks (II.2.1.7) were prepared for both constructs. 
 
III.2.6.2 Transient expression of scFvLR3cp-1 in tobacco leaves 
Inoculates of recombinant agrobacteria transformed with pTRA-35SS:scFvLR3cp-1 or 
pTRA- CFDV:scFvLR3cp-1, respectively,  were grown and used for agro-infiltration of N. 
tabacum cv. Petite Havana SR1 leaves (II.2.2.3). Total soluble proteins were extracted as 
described (II.2.2.6). Accumulation levels and integrity of scFvLR3cp-1 were analysed by 
immunoblot. A distinct band of approximately 30 kDa (Figure III-30A), corresponding to the 
expected size of the scFvLR1cp-1 was observed for the expression cassette driven by the 35S 
promoter. No significant variation in accumulation level was detected among the different 
leaves. The scFv accumulation levels ranged between 40-60 μg per g fresh weight when 
compared with bacterial produced scFvLR3cp-1 diluted in non-infiltrated plant extract as 
standard (data not shown). Transient production of this scFv fragment expressed under the 
control of the CFDV promoter (Figure III-30b) reached values between 1-4 μg per g fresh 
weight. The variation in production levels between both promoters correlated with the 
difference obtained with the GLRaV-2 coat protein specific scFvLR2cp-35 (III.1.3.1). This 
result demonstrated that scFvLR3cp-1 could be successfully produced to high levels in the 
plant cytosol. 
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Figure III-30: Immunoblot analysis of transiently produced scFvLR3cp-1 in tobacco leaves. 
Total soluble protein extracted from infiltrated leaves (II.2.2.6) were resolved on a 12% SDS-PAA gel (II.2.4.2) 
and blotted onto nitrocellulose (II.2.4.3). The accumulated scFv fragments were detected by a 1:5000 dilution of 
the 9E10 as primary antibody and with a 1:5000 dilution of a goat anti-mouse polyclonal antibody conjugated to 
alkaline phosphatase followed by addition of NBT/BCIP for 1 min at RT. 
(A): pTRA-35SS:scFvLR3cp-1. 1-2: 10 μl of total soluble protein from two different tobacco leaves 
accumulating scFvLR3cp-1 in the cytosol; WT: wild type tobacco extract. 
(B): pTRA-CFDV:scFvLR3cp-1. 3: 10 μl of total soluble protein from tobacco leaves accumulating scFvLR3cp-
1 in the phloem tissue;  
WT: wild type tobacco extract. M: 5 μl of Prestained Protein Marker. 
 
 
 
III.2.6.3 Analysis of transiently produced scFvLR3cp-1 by capture ELISA 
Transiently produced scFvLR3cp-1 was analyzed by capture ELISA to evaluate the antigen 
binding activity to GLRaV-3 particles present in infected grapevine material (II.1.6.7). ELISA 
results (Figure III-31) showed a high binding reactivity against the antigen for both transiently 
produced scFvLR3cp-1 samples compared to the wild type tobacco extract, confirming the 
functionality of the plant produced scFv fragment. The binding reactivity of scFvLR3cp-1 
transiently produced with the phloem-specific promoter was 10-fold lower compared to the 
production of the same scFv fragment driven by the constitutive CaMV 35S promoter as 
previously describe for scFvLR2cp-35 (section III.1.3.3). No cross-reactivity to the wild type 
tobacco extract was observed. 
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Figure III-31: Capture ELISA (II.2.8.3) of scFvLR3cp-1 produced in tobacco leaves under the control of the 
CaMV 35S or CFDV promoter. 
Serial dilutions of transiently produced cytosolic scFvLR3cp-1 driven by the 35S are indicated in blue or in red 
if the transiently produced scFv was under the control of the CFDV promoter. 1.5 μg/ml of polyclonal rabbit IgG 
specific to GLRaV-3 coat protein were coated overnight onto a microtiter plate and blocked for 2 h at RT with 
MPBS, then leaf extract from GLRaV-3 infected or non-infected material were added. Finally, serial dilutions of 
plant extract containing the transiently produced scFvLR3cp-1 were applied and incubated for 1 hour at RT. 
Bound scFv fragments were detected by addition of 1:5000 diluted 9E10 monoclonal antibody and GAMHRPO 
polyclonal antibody (1:5000). ELISA reading (OD405nm) were performed after 1 h incubation with ABTS 
substrate at 37oC. 
 
 
III.2.6.4 Generation and characterization of stable transformed N. benthamiana 
plants producing scFvLR3cp-1 
Since functional scFvLR3cp-1 could be transiently produced at high levels in the plant cell 
cytosol, the pTRA-35SS:scFvLR3cp-1 vector encoding the cytosolic targeted scFvLR3cp-1 
was stably transformed into N. benthamiana by Agrobacterium-mediated gene transfer 
(II.2.2.4). Thirteen regenerated T0 plants were screened for accumulation of recombinant 
proteins by immunoblot analysis of the total soluble leaf protein from crude extract (II.2.2.6). 
Immunoblot analyses revealed that three out of thirteen T0 analysed plants accumulated 
detectable levels of cytosolic scFvLR3cp-1 (data not shown). The three lines (4, 6 and 8) were 
selected and self pollinated for establishment of homozygous lines. The seed from each of the 
three selected T0 plants were sown on MSIII plates (II.2.2.4). Ten BASTA resistant T1 plants 
from line 4, two plants from line 6 and 22 from line 8 were transferred to soil in the 
greenhouse. The plants were screened for accumulation of recombinant protein by 
immunoblot analysis of the crude extract of total soluble leaf protein (II.2.2.6). 80% of the 
analyzed plants were positive, producing scFvLR3cp-1 in the range of 15-60 μg per gram leaf 
material (data not shown). These accumulation levels were similar to the parental lines. 
Finally, the transgenic T1 plant with the highest accumulation of cytosolic scFvLR3cp-1 (line 
8/20) was selected for further analysis. Seeds of this line were germinated in the greenhouse 
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and young leaves of the T2 plants were collected. Total soluble protein from leaves of six 
plants was extracted for analysis of recombinant protein accumulation by immunoblot 
analysis. The results are illustrated in Figure III-32. The recombinant scFv antibody fragment 
migrated according to the expected size of approximately 30 kDa. No visible degradation was 
observed. The accumulation levels ranged between ~18-70 μg per gram fresh tissue when 
compared with several concentration of scFv standard diluted in wild type plant extract (data 
not shown).  
 
 
 
 
 
 
 
 
Figure III-32: Immunoblot analysis of transgenic T2 N. benthamiana plants producing cytosolic scFvLR3cp-1. 
Total soluble protein (II.2.2.6) extracted from stable transformed N. benthamiana plants (II.2.2.4) were resolved 
on a 12% SDS-PAA gel (II.2.4.2) and blotted onto nitrocellulose (II.2.4.3). The produced scFvLR3cp-1 was 
detected by 1:5000 dilution of 9E10 as primary antibody and revealed with 1:5000 dilution of goat-anti mouse 
antibody conjugated to alkaline phosphatase followed by addition of NBT/BCIP for 3 min at RT.  
1-6: 10 μl of total soluble protein from transgenic T2 N. benthamiana (line 8/20-1 to -6) producing cytosolic 
scFvLR3cp-1; M: prestained protein marker; WT: wild type tobacco extract. 
 
A capture ELISA to evaluate the specific binding of stable produced scFvLR3cp-1 to 
GLRaV-3 particles was performed. The results demonstrated high binding reactivity of the 
stable produced scFvLR3cp-1 against the antigen (data not shown). The obtained result was 
comparable to the previous performed capture ELISA when transiently produced scFvLR3cp-
1 under the control of the 35S promoter was used (Figure III-31). 
 
In summary, the results from stable produced scFvLR3cp-1 in transgenic N. benthamiana 
lines were consistent to those obtained from the transiently produced assay. This study 
demonstrated that scFvLR3cp-1 accumulated to high levels in the plant cytosol of stable 
transformed N. benthamiana plants retaining the functionality in this reducing environment. 
Since N. benthamiana can not be infected by GLRaV-3, GLRaV-1, GLRaV-6 or GLRaV-7, 
bioassays studies could not be performed. Therefore pTRA-35SS:scFvLR3cp-1 and pTRA-
CFDV:scFvLR3cp-1 constructs were transferred for grapevine transformation to the Centrum  
Grüne Gentechnik, Neustadt-Germany. The transformation process is ongoing. 
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IV Discussion  
 
Viticulture and wine making have been part of human culture for thousand of years. Increased 
production efficiency and improved fruit quality has traditionally been based on the 
modification of management and growing conditions of specific genotypes which have 
generally been kept constant by vegetative multiplication. Today the limitations of this 
approach are obvious with increased input costs and practices, some of which are not 
sustainable, and include the use of chemicals with the potential negative secondary effects on 
human health and the environment (International Grape Genome Program white paper). 
Grapevine Leafroll-associated virus 2 and 3 (GLRaV-2 and 3) are one of the most widespread 
graft-transmissible diseases-affecting grapevines. The degeneration of the vascular system of 
the plants produces a reduction in the berry yields, delayed maturity and causes a poor 
pigmentation of the berries (Meng et al., 2005). All these have negative influence on the vine 
produced.  
The feasibility of antibody-based resistance has been demonstrated for plant viruses (for a 
recent review, see Nölke et al., 2004; Zimmermann et al., 2006). It has been shown that plants 
that express antibodies binding to viral coat proteins gain a degree of protection against the 
virus in question (Tavladoraki et al., 1993; Prins, et al., 2005; Villani et al., 2005). 
 
Recombinant antibodies such as full-length (Voss et al., 1995; Schillberg et al., 1999) and 
scFvs (Tavladoraki et al., 1993; Zimmermann et al., 1998; Xiao et al., 2000; Bajrovic et al., 
2001; Boonrod et al., 2004; Prins et al., 2005 and Villani et al., 2005) have been successfully 
used in this approach. ScFv is the minimum recombinant antibody with antigen binding 
activity, and since it is encoded by a single structural gene it can be more easily produced in 
plants than the complete antibody. Therefore, the rationale of this work was to generate scFvs 
by recombinant DNA technology that specifically recognize and inactivate the coat protein of 
the GLRaV-2 and 3 and therefore potentially inactivate virus disassembly and virus 
spreading. The constitutive expression of these scFvs may create virus resistant grapevine 
improving the farming system and reducing the use of environmental unfriendly chemical 
controls.  
In the present work, a specific GLRaV-2 coat protein scFv-fragment was generated from the 
mAb R19 and expressed in E. coli and its reactivity to GLRaV-2 viral particles was confirmed 
(III.1.2.2). Furthermore, the functionality of the scFv in the plant cell cytosol was tested by 
ELISA. 
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In addition, three specific scFv fragments that specifically bind to GLRaV-3 coat protein were 
isolated from a phage display library derived from immunized mice (III.2.4). One of these 
specific scFv was further characterized for its reactivity and functionality to GLRaV-3 coat 
protein by ELISA, EMSA, surface plasmon resonance analysis, electron microscopy and 
epitope mapping. The selected single chain fragment also recognized with high specificity at 
least four different members of the Closteroviridae family. The in vivo stability of this scFv 
was evaluated by transient expression in N. tabacum and stable transformed N. benthamiana 
plants.  
 
IV.1 GLRaV-2 coat protein specific scFv fragment 
IV.1.1 Generation of scFvLR2cp-35 specific to GLRaV-2 coat protein 
A set of degenerate primers were used for the amplification of the variable domains of the 
heavy and the light chains of the murine mAb R19 specific for GLRaV-2 coat protein. The 
restriction site for cloning of PCR inserts is generally placed in the 5’ primer at a position 
corresponding to encoded amino acid sequence in FR1.  The back primers are designed to 
correspond to the antisense strand in the J region. Several 3’ primers are used in combination 
with each 5’ primer. The advantage of priming in these specific areas is the sequence 
conservation in these regions. For cloning of the amplified DNA into the pHENHi vector, rare 
restriction sites are introduced within the PCR primer that are not normally presents in the 
mouse variable antibody domain. For the VH antibody fragment BstEII and SfiI site were 
introduced by PCR while AscI and NotI restriction sites were used for the VL. The VL and VH 
fragments of the mouse mAb R19 were amplified by more than one primer combination 
(III.1.1.2) and sequentially cloned into pHENHi vector generating the scFvLR2cp-35 which 
contains an open reading frame of 30 kDa and is in frame with the cloning module. 
Sequence alignment of the variable domains of this GLRaV-2 coat protein specific scFv 
fragment with the closest germline sequences showed one and three differences in the primer 
binding regions for the heavy and the light chains, respectively. The changes in these amino 
acids residues can be a result of the use of degenerated primers or an acquired mutation 
during affinity maturation. Changes in this region did not affect the binding of this scFv 
fragment to the GLRaV-2 coat protein, as confirmed by capture ELISA (III.1.2.2). 
Nevertheless, it is difficult to predict how these changes in the amino acid sequence could 
affect the level of scFvLR2cp-35 expression. 
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Additionally, the variable heavy and light chains of the scFvLR2cp-35 presented five and 
three mutations within the frameworks and CDR regions, respectively, with the closest 
germline gene as confirmed by sequence alignment. These internal variations may have arisen 
from somatic mutations or from errors introduced during PCR amplifications since low-
fidelity Taq polymerase was used to amplify the variable fragments (Eckert and Kunkel, 
1991). 
 
IV.1.2 Expression and purification of scFvLR2cp-35 in E. coli 
The most used approach for obtaining functional antibody fragments is to imitate the situation 
in the eukaryotic cell for secreting a correctly folded antibody. In E. coli, the secretion 
machinery directs proteins carrying a specific signal sequence to the periplasmic space. 
Periplasmic expression has permitted the functional testing of a wide variety of antibody 
fragments with different binding properties (Kipriyanov and Little, 1999). The antibody 
fragments are usually correctly processed in the periplasm; they contain intramolecular 
disulfide bonds and are soluble (Kipriyanov and Little, 1999) the purification is as well easier, 
only 5% of E. coli proteins are present in this compartment. Therefore, cDNA encoding the 
scFvLR2CP-35 was subcloned into pSyn vector for bacterial expression. The expression of 
these scFv fragments was induced by addition of IPTG in E. coli BL21(DE3) strain and 
purified by IMAC. 
The level of purified scFvLR2cp-35 ranged between 150-250 μg/L culture volume. The SDS-
PAGE revealed that the elution fraction of this bacterially expressed scFv fragment presented 
contaminating proteins co-eluting with the protein of interest (Figure III-5). These 
contaminants presented a molecular weight of approximately 30 and 70 kDa and most likely 
correspond to that of bacterial chaperons that are involved in the proper folding of nascent 
proteins in E. coli (Gottesman et al., 2000).  
Levels of expression described in the literature for bacterial expression systems secreting scFv 
fragment into the periplasmic space give typical yields of 0.1-2 mg/l in shake flask cultures 
for many scFv fragments (Plückthun et al., 1996) and are related mostly with the primary 
structure of the antibody, in particular with some amino acids located in the antibody 
framework region 1 of the VH domain. The different combinations in the composition of 
amino acids especially in the first ten amino acids of this domain are frequently introduced by 
the primer mixture commonly used for the cloning of individual antibody libraries. This can 
produce severe effects on folding yields and stabilities of the antibodies thus obtained. Several 
researchers observed drastic effects of mutations affecting residue H6 on antibody 
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functionality and stability (Brégégère et al., 1997; Kipriyanov et al., 1997; de Haard et al, 
1998; Langedijk et al., 1998). H6 is either a glutamine (Gln) or a glutamate (Glu) residue in 
almost all VH sequences. Kipriyanov et al. (1997) and Brégégère et al. (1997) found that 
repair of a primer-induced Gln to Glu substitution markedly improved expression yield and 
shelf-life. de Haard et al. (1998) even found a complete loss of binding and severe in vivo 
folding problems caused by an amino acids exchange at position H6 towards Glu. Gln H6 is 
relatively permissive concerning the identity of the amino acids in positions H7 and H10, 
while Glu has more stringent requirements: H7 cannot be a proline residue, and H10 requires 
a positive phi torsion angle compatible only with a glycine residue in this position (Honegger 
and Plückthun, 2001). 
Assuming that scFvLR2cp-35 was not lost during the purification as confirmed by 
immunoblot analysis (data not shown), the low level of expression achieved by this GLRaV-2 
coat protein specific single chain antibody may be attributed to the presence of Glu at the H6 
position which requires more stringent conditions regarding the microenvironment in the first 
ten amino acids of the scFv fragment (Honegger and Plückthum, 2001). But it can not be 
excluded that the primary sequence of the antibody influences the folding efficiency of scFv 
fragments. Mis-folding of the protein in turn causes insoluble protein aggregates which may 
prove toxic to the bacterial host leading to low accumulation levels as was observed during 
scFvLR2cp-35 expression (data not shown) (Kipriyanov and Little, 1999). Therefore 
generalization can not be made. 
 
IV.1.3 Antigen binding activity of affinity purified scFvLR2cp-35 in capture ELISA 
The use of more than one primer combination (III.1.1.1) for the amplification of antibody 
variable region (VL and VH) from hybridoma cell lines, may lead in some rare cases to the 
amplification of non-functional variable regions (Nicholls et al., 1993; Kleimann et al., 1995). 
These hybridoma cells not only transcribe the desired monoclonal antibody cDNA, but also 
bear high levels of non-functionally rearranged mRNAs. These mRNAs represent 
pseudogenes and can greatly exceed the level of normal antibody mRNA. Due to a reading 
frame shift in the V–J recombination site, these pseudogene mRNAs cannot be translated into 
a functional protein (Carroll et al., 1988). The use of degenerate primers may also produce 
mismatches and PCR errors that will lead to point mutation (Eeckhout et al., 2000) or out-of-
frame clones, which can also contribute to a background of non-functional scFv molecules 
during the PCR amplification. Therefore, it is essential to demonstrate the specific binding 
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capacity of the scFv to the GLRaV-2 viral particles, even when the deduced antibody 
sequence seems reasonable. 
The binding activity of bacterially purified scFvLR2cp-35 to GLRaV-2 particles was tested 
by capture ELISA (III.2.3.2). Analysis of the specific binding of this affinity purified scFv 
fragment to its antigen indicated that scFvLR2cp-35 had high specific binding to extract from 
N. benthamiana leaves infected by GLRaV-2 and did not cross-reacted to non-infected plants. 
Therefore, the ELISA result confirmed that the specific binding activity of the bacterially 
expressed scFvLR2cp-35 originating from the mAb R19 is completely retained for the 
antigen. 
 
IV.1.4 Expression of scFvLR2cp-35 in plants 
In order to produce an efficient immunomodulation choosing the right plant cell compartment 
is a must. The antibody fragment should be targeted to the specific subcellular compartment 
where the antigen is vulnerable and inactivates the pathogen by binding to its surface or to 
proteins necessary for its spread or replication. GLRaV-2 like the rest of the grapevine 
leafroll-associated virus types replicate in the cytosol. 
The strategy of using recombinant antibodies to engineer resistance by cytosolic production of 
scFvs has been successfully demonstrated for plant viruses (Tavladoraki et al., 1993; 
Zimmermann et al., 1998; Xiao et al., 2000; Bajrovic et al., 2001; Boonrod et al., 2004; Prins 
et al., 2005 and Villani et al., 2005). 
To study accumulation levels and functionality two different approaches were chosen: the 
first was the production of the specific scFvLR2cp-35 using the constitutive 35S promoter 
from the Cauliflower mosaic virus. This promoter was used as a model promoter since it is 
very well characterized and can produce high levels of expression in all plant tissues 
including the phloem. Since GLRaV-2 is restricted to the phloem the second approach 
consisted in producing the scFvLR2cp-35 under the control of the phloem-specific promoter 
of the Coconut foliar decay virus (CFDV) which restricts protein accumulation only into the 
phloem tissue. This approach will limit scFv production to the plant tissue where the virus is 
more vulnerable. 
Grapevine transformation is laborious, time-consuming and sometimes difficult to achieve, so 
transient assays in detached tobacco leaves were performed because it can provide a rapid and 
reliable method to evaluate protein expression, there is no transgene integration and 
expression levels are thus not influenced by position effects (Kapila et al., 1996). 
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In this study, the antibody fragment scFvLR2cp-35 was cloned separately into the plant 
expression vector pTRA containing the CaMV 35S or CFDV promoter, respectively. The 
transient production of the scFv fragment was achieved by vacuum assisted agro-infiltration 
of agrobacterium cultures containing the different constructs into detached tobacco leaves. 
Immunoblot analysis of transiently produced scFvLR2cp-35 was negative for both construct 
indicating that accumulation levels were below detection limits. 
Previous studies have shown that both the overall levels and the activities of scFv antibodies 
accumulating in the plant cytosol are highly dependent on the intrinsic properties of the 
expressed scFv fragment (De Jaeger et al., 2000). High accumulation levels of scFv fragments 
in the cytosol is very difficult to achieve for most of the cases due to the reducing conditions 
of this environment, the absence of protein disulphide isomerases and chaperones. Preclusion 
of the scFv intradomain disulfide bridges often results in a loss of stability and antigen 
binding activity of the scFvs in the plant cytosol. In most of the cases levels were found to be 
very low or at the detection limits, only few exceptions were previously reported (De Jaeger 
et al., 1999; Makvandi-Nejad et al., 2005; Nölke et al., 2005).  
Since both expressed scFvLR2cp-35 constructs could not be detected by immunoblot analysis 
a capture ELISA using extracts from N. benthamiana leaves infected by GLRaV-2 was 
carried out. This was the method of choice because it is a sensitive and reliable assay to 
evaluate the binding specificity and to quantify the amount of transiently produced scFv 
fragment. 
The capture ELISA results confirmed that the antigen binding reactivity and specificity was 
retained in both transiently produced scFvLR2cp-35 construct. Moreover, accumulation levels 
ranged between 2.2 and 2.9 μg per g fresh weight for the cytosolic construct driven by the 
constitutive CaMV 35S promoter. 
The low accumulation level of the transiently produced scFvLR2cp-35 in the plant cytosol is 
in agreement with most of the reported scFvs produced in transgenic plants that have been 
cloned directly from a hybridoma cell line (Fecker et al., 1996; Zimmermann et al., 1998; 
Schillberg et al., 1999; Shimada et al., 1999; Ramirez et al., 2002; Eto et al., 2003; Esteban et 
al., 2003). Although hybridoma technology enables the selection of highly specific 
monoclonal antibodies from culture supernatants, their cloned and expressed genes in the 
form of cytosolic intrabodies often perform very poorly or not at all. 
A significant difference in the level of production was observed for the scFvLR2cp-35 with 
the phloem specific promoter; accumulation level was at least 10 times lower. This difference 
between the levels of production using both promoters was previously reported by Hehn and 
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Rohde (1998); where the activity of the CFDV promoter with the reporter gene β-
glucuronidase reached 30% of the activity when compared to the CaMV 35S promoter in 
transient expression experiments using N. tabacum protoplasts. The reason for this difference 
is related with the restricted accumulation of β-glucuronidase or scFvLR2cp-35 into the 
phloem tissue when expressed under the control of the CFDV promoter. 
Zimmermann et at. (1998) reported that cytosolic expression of a scFv fragment specific to 
TMV coat protein conferred resistance against this virus even though the level of 
accumulation was approximately 20.000-fold lower than in plants accumulating full-length 
immunoglobulin in the apoplast. This study showed that even very small amounts of cytosolic 
scFv were able to neutralize invading virions. Therefore, although the accumulation levels of 
the transiently produced scFvLR2cp-35 were rather low in the plant cytosol the possibility of 
conferring GLRaV-2 resistance was further investigated. Consequently, stable transformed N. 
benthamiana plants were generated by leaf disc transformation using recombinant A. 
tumefaciens carrying either the CaMV 35S promoter or the CFDV promoter. 
Immunoblot and capture ELISA analysis of regenerated T0 plant for each of the two 
constructs indicated that the accumulation level of scFvLR2cp-35 were below detection 
limits. These data confirmed that the stability of this scFv fragment appears to be low in the 
plant cytosol. The possibility that misfolded scFv fragment accumulated in the cytosol, and 
was not detectable by the capture ELISA was excluded because cytosolic scFvLR3cp-35 were 
not detected using anti c-myc antibody in immunoblot analysis (data not shown). 
Voss et al. (1995) could demonstrate that N. tabacum plants secreting full-size antibodies 
binding to intact TMV particles displayed a reduced number of necrotic local lesions when 
challenge with TMV. The results indicated that the number of infection events was directly 
correlated to the amount of secreted full-size antibodies. Furthermore, recent studies suggest 
that the degree of resistance is mainly dependent on the level of the transgene expression 
rather than affinity of the recombinant antibodies (Villani et al., 2005). Unfortunately it was 
impossible to correlate scFv accumulation levels with potential biological effect; therefore, it 
was decided not to perform bioassays studies. 
It appears that the primary sequence of the variable domains determines the folding efficiency 
of scFv fragments (Cattaneo and Biocca, 1997). Different strategies for stabilizing 
cytosolically expressed antibodies have been reported. Schouten et al. (1996, 1997) have 
demonstrated that the addition of a C-terminal KDEL peptide increased the cytosolic 
expression level of a scFv fragment. Maximum expression levels of up to 0.2% of the total 
soluble protein were measured, whereas the same scFv fragment without KDEL did not show 
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any accumulation in the cytosol of transgenic plants. They suggested that short polypeptides 
such as the KDEL sequence may protect the scFv antibody from proteolytic degradation. 
Cytosolic antibody expression may be further enhanced in the future by the identification of 
intrinsic structural features or fusion protein partners that stabilize the antibodies (Spiegel et 
al., 1999; Worn et al., 2000). 
In summary, these results clearly demonstrate that scFvLR2cp-35 could be successfully 
transiently produced into the plant cytosol. Furthermore, although accumulation level was 
low, the transiently produced scFv fragment retained the functionality and antigen binding 
capacity to the GLRaV-2 coat protein antigen. 
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IV.2 GRLaV-3 coat protein specifics scFv-fragments 
GLRaV-3 like the rest of the closterovirus family is restricted to the phloem tissue (Turturo et 
al., 2005), therefore virus purification is time consuming and rather difficult to achieve 
because yields are low (Zee et al., 1987; Hu et al., 1990; Zimmermann et al., 1990; Boscia et 
al., 1995; Choueri et al., 1996). Since recombinant GLRaV-3 coat protein was successfully 
expressed and purified in E. coli to produce polyclonal antisera (Ling et al., 2000a), this was 
the method of choice for large scale production of GLRaV-3 coat protein. 
 
IV.2.1 Bacterial expression and purification of GLRaV-3 coat protein 
In order to obtain GLRaV-3 coat protein for mice immunization and subsequently for 
antibody titer determination and scFv characterization, the cDNA of the GLRaV-3 coat 
protein was C-terminally fused to the MBP (III.3.1.1). Over expression of this fusion protein 
in bacteria produced large quantities of soluble MBP-GLRaV-3 in approximately 12.5 mg/l 
culture. The SDS-PAGE analysis showed occasionally degradation, most probably derived by 
the expression condition used during the induction. 
The pTYB1 expression vector was chosen to express the full-length GLRaV-3 coat protein. 
The strategy of expressing the protein in a second expression system relies on avoiding cross-
reactivity against MBP during the antibody titer determination and to select only scFvs 
specific to GLRaV-3 coat protein epitopes during the panning procedure. The full length 
protein was C-terminally fused to a self-cleavable intein tag in which a chitin binding domain 
(CBD) allows affinity purification of the fusion precursor on a chitin column. The advantage 
of the C-terminal tag IMPACT system is that only fully translated proteins can be purified 
since the affinity tag (CBD) is downstream of the protein of interest. Truncated proteins, 
which do not bear the intein–CDB domain, will not be affinity purified (Zhang et al., 1999). 
The use of fusion proteins such as MBP or GST can improve the solubility of the expressed 
protein and protect it from proteolysis as previously described by Frangioni and Neel (1993), 
Fang  and Ewald (2004), Lichty et al. (2005), Kataeva et al. (2005). The fusion of GLRaV-3 
coat protein to MBP increased the level of protein expression 5 fold higher than to intein-
CDB domain; however, the chitin binding domain seems to protect better the GLRaV-3 coat 
protein from degradation as minor degradation bands were observed on the immunoblot 
(Figure III-10). 
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IV.2.2 Mice immunization and antibody titer determination 
Knowing the antibody titer provides a basis for making changes in the injection schedule or 
quantity of immunogen if necessary. Once the titer reaches an appropriate level, the spleen is 
harvested and antibody libraries can be prepared. 
The titer of specific antibodies raised against the coat protein was evaluated using the full-
length GLRaV-3 coat protein and ranged between 1:140,000-150,000 as revealed by ELISA, 
indicating a clear enrichment of specific polyclonal antibodies against the antigen. The 
specific antibody titer obtained after the last boost was similar or even higher than reported 
values obtained in our lab or in the literature (De Jaeger et al., 1997; Majidi et al., 2005; 
Valderrama-Aguirre et al., 2005; Zhao and Liu, 2005). 
This result is also in agreement with a previous performed study where GLRaV-3 coat protein 
was used as antigen for the generation of the mAb LRE (P. Saldarelli, personal 
communication) indicating that GLRaV-3 coat protein is a potent antigen. Since a high 
immunoresponse is strictly necessary for a successful isolation of specific scFvs against the 
GLRaV-3 coat protein the chances of success were improved considerable. 
 
IV.2.3 Phage display antibody selection using full-length GLRaV-3 coat protein 
One of the most successful applications of phage display has been the isolation of specific 
antibodies from large phage antibody libraries (Winter and Griffiths, 1994). Repertoires may 
be created from the IgG genes of spleen B-cells of mice immunized with the antigen. The 
rational is that an immune phage antibody repertoire will be enriched in antigen-specific 
antibodies, some of which will have been affinity matured by the immune system (Clakson et 
al., 1991). One of the most important factors that can determine the successful isolation of 
specific scFv-fragments is the quality and complexity of the library (Rader and Barbas, 1997). 
The larger libraries, the greater the chance of finding antibodies that bind to any given 
epitope. It is also important to empirically check the diversity of libraries before starting any 
screen because of the possibility that instabilities in libraries can lead to loss of insert. 
A library with a number of 5.8x106 independent clones using the pHENHi vector (Appendix 
VII.2) was generated for the GLRaV-3 coat protein. The phage display system based on the 
pHENHi vector was the method of choice, since it has proven to be robust and reliable in 
previous experiments in our lab both in library stablishment and for hybridoma cloning. 
The number of independent clones of this phagemid scFv library was similar to others 
reported values (De Jaeger et al., 1997; Eeckhout et al., 2000; Paus et al., 2003; Nölke et al., 
2005; Peschen et al. 2004). The library size was not very large; however it was constructed 
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from immunized animal exhibiting a high specific immunoresponse. Consequently, the 
probability of selecting high-affinity antibodies is significantly increased since affinity 
maturation occurred in vivo. 
Phage antibody selections involve the sequential enrichment of specific binding phage from a 
large excess of non-binding clones. This is achieved by multiple rounds of phage binding to 
the target, washing to remove non-specific phages and elution to retrieve specific binding 
phages. This procedure is another important parameter for the successful isolation of 
monoclonal scFv fragments which depends on the quality and purity of the protein used 
during the selection of the specifics scFv. Selections using impure targets are significantly 
more difficult, because of the limited amount of the target protein in the mixture, and of the 
enrichment of phage antibodies specific for unrelated proteins (Hoogenboom et al., 1998). 
The simplest and most widely used approach is to immobilise target molecules to a support 
and then to expose solutions containing phage to the immobilised target. Many variations to 
this theme have been successfully used including immobilisation onto coated tubes or plates, 
within columns or on the surface of magnetic beads. Immobilization of many bio-molecules 
can be achieved by passive adsorption onto polystyrene tubes with an appropriate surface 
modification such as MaxisorpTM (Willats 2002). Passive adsorption has the convenience that 
a wide range of molecules can be immobilised without any prior treatment. More innovative 
screening methods have also been employed including panning against whole fixed or living 
cells, tissue section or even within living animal (Johns et al., 2000; Wang and Shusta, 2005). 
Passive adsorption on a plastic surface (immunotubes) was the method of choice for the 
panning of the library in the present study since it is easy to perform, does not require antigen 
biotinylation and has been used for successful isolation of different antigens (Paus et al., 
2003; Eeckhout et al., 2004; Fomitcheva et al., 2005; Nölke et al., 2005; Peschen et al., 2004; 
Villani et al., 2005). After each round of panning the stringency of the washing step was 
increased because it was observed that this can minimize the presence of phages without scFv 
fragment (Tur et al., 2001). The obtained result after the third round of panning supported this 
finding since the presence of full-size scFv fragments increased from 79% in the first round to 
96% in the last round. Moreover, there was a significant enrichment of 1508-fold of specific 
binding clones after the last round of panning. 
A soluble expression assay was used to select specific clones against MBP-GLRaV-3 coat 
protein. As previously reported (Eeckhout et al., 2000; Paus et al., 2003; Fomitcheva et al., 
2005; Nölke et al., 2005) the selection of this procedure as a first screening method was based 
on the simplicity of the technique that allows the growing of a large number of clones. It may 
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be necessary to screen large numbers of antibodies to identify those variants with the most 
optimal characteristic. The screening assay analyzed the binding of the soluble antibodies 
fragments from the bacterial supernatant on a 96-well high binding microtiter plate directly 
coated with the antigen. The selected screening strategy successfully revealed the presence of 
thirteen positives clones reacting specifically to the GLRaV-3 without cross-reacting to MBP. 
This result supports the idea that the use of a high purified sample of the full-length GLRaV-3 
coat protein for the panning procedure was a very important factor that probably improved the 
chances for the selection of scFv-fragments specific against the coat protein. 
The sequence analysis of the thirteen specific scFv fragment revealed the presence of three 
different sequences groups. The most abundant sequence was represented by the clone 
scFvLR3cp-1 presented in nine of the thirteen clones sequenced, followed by scFvLR3cp-2 
and scFvLR3cp-6 which were presented twice each. 
Interestingly, the comparison of the scFvLR3cp-1 VH fragment with its nearest V germline 
gene fragments (V00774) showed only three differences in the amino acid sequences. Two of 
them were located at the N-terminus and were introduced most likely by the degenerated 
primers used for the cloning, meanwhile the only internal variation was found in the CDRH2 
region and may have resulted from a somatic mutation or introduced by the PCR 
amplification since low fidelity Taq polymerase was used to amplify the variable fragments 
(Eckert and Kunkel, 1991). In any case, these mutations probably had a positive effect in the 
stability and affinity of this specific antibody considering that scFvLR3cp-1 reached the 
highest levels of expression in bacteria and also scFvLR3cp-1-like antibodies dominated the 
mouse immunoresponse been the most abundant specific scFv fragment present after the 
panning. 
The variable heavy chain of the scFvLR3cp-2 and -6 presented 19 and 17 mutations, 
respectively, distributed between CDRH1, CDRH2, FR2 and FR3 suggesting that the 
differences from the closest germline sequence are possible to have arisen due to somatic 
mutations of the V genes in the B cell and random rearrangement of antibody gene fragment. 
These mutations could have a negative effect on both antibody affinity and stability in view of 
scFvLR3cp-2 and -6 were produced in bacteria mainly as inclusion bodies. Nevertheless, is 
very difficult to predict how these mutations can affect the level of production, stability and 
binding properties of these specific scFvs. 
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IV.2.4 Expression of functional antibody fragments in E. coli 
Periplasmic expression was also the method of choice for the expression of the GLRaV-3 coat 
protein specific scFv fragments. Therefore, scFvLR3cp-1, -2 and -6 were directly subcloned 
in the pSyn vector proceeded by a pelB leader sequence. Soluble scFv fragments were 
produced by addition of IPTG in E. coli BL21(DE3) strain and purified by IMAC. 
The level of expression of these three scFv was very different, scFvLR3cp-2 and scFvLR3cp-
6 presented serious difficulties to be expressed because of the high level of accumulation of 
inclusion bodies. The high level of expression of a recombinant protein with a bacterial signal 
peptide in E. coli often results in the accumulation of insoluble antibody fragments after 
transport to the periplasmic, presumably via the aggregation of a folding intermediate 
(Whitlow and Filpula 1991; Kipriyanov et al., 1994). Lowering the bacterial growth and 
induction temperature has been show to decrease periplasmic aggregation and increase the 
yield of soluble antibody protein (Skerra and Plückthun, 1991) but different attempts to 
improve the expression conditions were unsuccessful (III.2.5.2). However, success of 
expressing antibody fragments in E. coli depends on the properties of the variable domain 
sequence and structure (Plückthun et al., 1996). scFvLR3cp-1 on the other hand, presented 
the highest level of expression. The yield of this bacterially purified scFv fragment was 
relatively high and ranged between 2.5 and 4 mg/l culture considering that the level of 
expression described in the literature for bacterial expression systems secreting scFv fragment 
into the periplasmic space give typical yields of 0.1-2 mg/l (Plückthun et al., 1996). 
Surprisingly, scFvLR3cp-1 presented a Glu residue at position 6 and even though showed a 
high level of expression in bacterial periplasm, whereas scFvLR3cp-2 and scFvLR3cp-6 
shared a Gln at this position but tended to accumulate as inclusion bodies. Therefore, as 
mentioned before the stability of scFvs is generally most probably due to an exquisite balance 
between the local sequence and the global structure being dependent on the overall sequence 
context determined by the germ line clan (Jung et al., 2001). 
 
IV.2.5 Characterization of GLRaV-3 coat protein specific scFv 
The functionality of scFvLR3cp-1 could be confirmed by direct and capture ELISA 
demonstrating high specific binding against the GLRaV-3 coat protein, furthermore 
electrophoretic mobility shift assay confirmed soluble interaction in a dose dependent manner 
between the scFv fragment and it antigen. 
The sensogram obtained by surface plasmon resonance studies (III.2.5.6) revealed that the 
kinetic of scFvLR3cp-1 binding to immobilized MBP-GLRaV-3 coat protein was dose-
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dependent with a slow association constant of 4.89 x 104 and a relatively fast dissociation of 
1.98 x 19-3. The dissociation constant (KD) determined from the ratio of theses two kinetics 
constants was calculated in the range of 10-8 M. The binding kinetic of scFvLR3cp-1 was 10-
100 folds higher in comparison with scFvs fragments obtained from naïve libraries of similar 
size (Griffiths et al., 1993; Krebs et al., 1998; Griep et al., 1999; Villani et al., 2005). The 
obtained result reflects that even though naïve antibody libraries overcome the use of animals, 
the importance of the utilization of immuno phage antibody repertoire affinity mature in vivo 
definitively leads to the generation of scFvs with higher affinities. Furthermore, it also 
circumvents the use of in vitro affinity maturation techniques (I.1.6.1) to improve the binding 
properties of scFvs selected from naïve libraries. 
The immunogold electron microscopy (III.2.5.7) revealed that the scFvLR3cp-1 binds to the 
entire length of the purified GLRaV-3 virus particles, moreover, the binding of this specific 
scFv fragment to the denatured antigen by immunoblot analysis (III.2.5.8) demonstrated that 
scFvLR3cp-1 recognizes a linear epitope. This speculation was finally confirmed by epitope 
mapping (III.2.5.9) revealing the presence of the linear epitope AQEPPRQ located between 
the amino acids 69 and 75 of the GLRaV-3 coat protein. 
This is finding is not surprising and may be attributed to the following reasons:  
• Passive adsorption of the GLRaV-3 coat protein used during the panning of scFv 
library relies on establishing a large number of relatively weak bonds between the 
target molecule and the immunotube which can result in the immobilized molecule 
being forced out of its functional configuration (Wilson and Nock, 2002). This can 
result in the complete denaturation of the bound protein and loss of the conformational 
epitopes. Under these conditions, 95% of adsorbed proteins are not functional (Butler 
et al., 1992; Davies et al., 1994). 
• The full length GLRaV-3 coat protein used during the panning procedure was eluted 
from the chitin column using DTT to promote the self specific cleavage from the 
intein-fusion. The use of this specific reagent could probably cause a partial-total 
denaturation of the eluted protein. Therefore, only phage antibodies binding to 
epitopes present in denatured molecules could be selected (Chames et al., 2001).  
 
IV.2.6 Cross-reactivity of scFvLR3cp-1 to related GLRaVs 
The specificity of affinity purified scFvLR3cp-1 to a number of different GLRaVs from 
Closteroviridae family was evaluated by direct ELISA. The result proved that this specific 
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scFv fragment recognized GLRaV-1, GLRaV-6 and GLRaV-7 in leaf extracts of grapevine 
infected plants. No cross-reactivity to GLRaV-2 was observed. 
Cross-reactivity between GLRaV-3 and GLRaV-1 was previously reported by Seddas, et al. 
(2000) who described a mAb raised against GLRaV-1 that did cross-react with GLRaV-3 in 
ELISA, immunoblot and electron microscopy. Both ampeloviruses are phylogenetically 
closer than the other GLRaVs from the Closteroviridae family. This is in agreement with the 
amino acids sequence homology that can be observed in the RNA-dependent RNA 
polymerase domain (POL), which is considered to be a reliable region for phylogeny analysis  
and also in the heat shock protein-70 homologue (HSP70) (Koonin and Dolja, 1993). The 
phylogenetically proximity in amino acid sequence identity is 66% and 43.1% for the POL 
and HSP70, respectively. 
Furthermore, the heptapeptide (AQEPPRQ) shares three identical and a similar fourth amino 
acid with the GLRaV-1 coat protein sequence. This similarity suggests that residues E71, P72, 
P73 and R74 from the putative scFVLR3cp-1 epitope may play an essential role in the binding 
to different GLRaVs coat proteins. There is no information available for the amino acid 
sequences of GLRaV-6 and -7 coat proteins that could explain the cross-reactivity by direct 
comparison. But we can speculate the presence of a highly conserved epitope in both viruses 
where the scFvLR3cp-1 is binding with different affinities especially considering that 
GLRaV-6 and 7 are members of the Closteroviridae family. 
 
IV.2.7 Expression of scFvLR3cp-1 in plants 
Previous studies have indicated that viral infection can be blocked in the cytosol, which 
would be expected because most steps of viral replication take place there (Tavladoraki et al., 
1993; Zimmermann et al., 1998; Xiao et al., 2000; Bajrovic et al., 2001; Boonrod et al., 2004; 
Prins et al., 2005 and Villani et al., 2005). GLRaV-3 like the rest of the grapevine leafroll-
associated virus types replicate in the cytosol. 
To study accumulation levels and functionaly the same approaches as indicated for 
scFvLR2cp-35 were choosen (IV.1.4). First the scFvLR3cp-1 cDNA was subcloned into the 
plant expression vector pTRA containing the CaMV 35S promoter to enable GLRaV-3-
specific scFv accumulation in the plant cell cytosol, the compartment where the viral 
pathogens replicates. Since GLRaV-3 is restricted to the phloem (Turturo et al., 2005), the 
second approch consisted in using a plant expression vector containing the phloem-specific 
CFDV promoter which restricts scFvLR3cp-1 accumulation only into the phloem tissue 
where the virus is present and more vulnerable. 
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As mention before, accumulation of scFv fragment in the cytosol are not straightforward due 
to the reducing condition of this environment and the absence of protein disulphide 
isomerases and chaperones, but despite this observation the transient assay using detached 
tobacco leaves showed that the scFvLR3cp-1 accumulated to high levels in the cytosol of 
tobacco leaves, ranging between ~40-60 μg/g fresh weight, when driven by the constitutive 
35S promoter (III.2.6.2). A considerable difference in the level of production was observed 
for the phloem-specific promoter; accumulation levels were at least 10 times lower, reaching 
values between ~1-4 μg per g fresh weight. Interestingly, there was a significant correlation 
between the levels of expression for both constructs with those obtained with scFvLR2cp-35 
confirming that the different expression levels are correlated with the promoter specificity. 
Furthermore, capture ELISA of the transiently expressed scFv fragments indicated that the 
antigen-binding capacity to the virus particles was completely retained in the reducing 
environment of the plant cytosol. Nevertheless, the results of the capture ELISA in 
combination with high accumulation levels of functional scFv in the plant cytosol make 
scFvLR3cp-1 a suitable candidate to evaluate the corresponding biological effects in the 
cytosol of stable transformed plants. Since grapevine transformation is laborious, time-
consuming and sometimes difficult to achieve, N. benthamiana was transformed with the 
scFvLR3cp-1 construct under the control of the 35S promoter. The accumulation levels, 
integrity and functionality of the T2 generation were analyzed by immunoblot analysis and 
capture ELISA. The obtained results were comparable with those previous performed with the 
transiently produced scFvLR3cp-1. This result demonstrated that the GLRaV-3 coat protein 
specific scFv fragment could be stable transformed in N. benthamiana and accumulated to 
high level in the plant cytosol retaining its functionality. Unfortunately, N. benthamiana can 
not be infected by GLRaV-3 virus; therefore, bioassays studies could not be performed. 
Overall the accumulation level of scFvLR3cp-1 in the plant cytosol was up to 25 fold higher 
when compared with scFvLR2cp-35 derived from a hybridoma cell line. So far, most reports 
indicate that high-level of cytosolic expression were mainly achieved only by scFvs generated 
through phage display (De Jaeger et al. 1999; Nölke et al, 2005; Zhang et al., unpublished 
data). This result suggests that phage display technology, in contrast to construction of scFvs 
from hybridoma clones, allows selection of functional scFv fragments with improved stability 
and expression levels in the cytosol. Phage display technology may favour the selection of 
scFv fragments that are robust and tolerate the cytosolic reducing conditions because the 
selection procedure is usually performed for several rounds in bacteria leading to enrichment 
of more stable scaffolds. 
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In summary, the high level of scFvLR3cp-1 accumulation not only in bacteria but also in the 
plant cell cytosol of stable transformed plants together with its ability to recognise with high 
specificity at least four different GLRaVs from the Closteroviridae family could make this 
scFv fragment a very useful tool to engineer resistance against a broad spectrum of grapevine 
viruses. 
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IV.3 Future prospects 
 
Antibody based resistance by the ectopic expression of scFv has a great potential for 
interfering with physiological or pathological function in vivo in a highly specific manner. It 
has been demonstrated that enhanced virus resistance can be achieved by heterologous 
expression of virus-specific recombinant antibodies in transgenic plants (Boonrod et al., 
2004; Nölke et al., 2004; Prins et al., 2005; Villani et al., 2005; Zimmermann et al., 2006). 
The success of this approach requires highly stable molecules, correct folding, high affinity 
and specificity, proper subcellular targeting and high expression levels. 
Within this thesis the generation and characterization of highly specific antibody fragments 
for antibody-based pathogen resistance in grapevine to GLRaV-2 and -3 viruses is reported. 
These scFvs were successfully produced transiently in N. tabacum driven by the enhanced 
CaMV 35S or the CFDV phloem-specific promoter. Moreover, scFvLR3cp-1 accumulated at 
high level in the plant cytosol of stable transformed N. benthamiana plants retaining its 
functionality. 
To test the biological effect of anti-GLRaV-2 and 3 scFvs in plants, bioassay studies should 
be performed. GLRaV-2 is the only member of the Closteroviridae family that can be 
mechanically transmitted to herbaceous plant species (e.g. N. benthamiana). However, 
bioassays studies were not performed since it was impossible to correlate scFvLR2cp-35 
accumulation level in the plant cytosol of stable transformed N. benthamiana with a potential 
biological effect. To circumvent this problem scFvLR2cp-35 accumulation levels may be 
improved by modulating the primary sequence, specially of the framework regions (Hoet et 
al., 2005), for instance by random mutation in vitro, by random prone PCR (Harvey et al., 
2006) or by molecular evolution (Razai et al., 2005; Riano-Umbarila et al., 2005). 
To evaluate the biological effect in planta of the ampelovirus specific scFvLR3cp-1 upon 
virus inoculation, grapevine plants are currently been transformed with the vector containing 
the phloem-specific CFDV promoter (G. Reustle, RLP AgroScience GmbH, AlPlanta, 
Neustadt-Germany, personal communication). Transgenic plants will be analyzed for the 
presence of this specific scFv transgene by PCR, Southern and Northern blot analysis and 
accumulation of the recombinant scFv fragment by immunoblot and ELISA. In addition, scFv 
producing transgenic lines will be evaluated for potential resistance or tolerance to GLRaV-3 
virus. Infection and virus spread will be monitored by the evaluation of symptom 
development and by ELISA and PCR. Moreover, since scFvLR3cp-1 possesses a broad 
specificity against at least four different GLRaVs it is a promising candidate to engineer 
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resistance not only to GLRaV-3 in grapevine but also against a different spectrum of virus 
from the Closteroviridae family. Additionally, this specific scFv fragment could also be used 
for establishment of a fully recombinant ELISA kit able to detect mixed infections in 
grapevine plants ensuring reproducibility and comparability of these assays and 
circumventing the traditionally used polyclonal antibodies. The use of scFvLR3cp-1 may 
contribute to the standardization as it binds to only one epitope and because batch to batch 
variation is absent. The goal is to fuse scFvLR3cp-1 to alkaline phosphatase for detection of 
GLRaV-3 and to evaluate the virus under routine assay conditions. Previous reports indicated 
that engineered antibodies were successfully used for Citrus tristeza virus (CTV) and Tomato 
spotted wilt virus (TSWV) diagnosis in plant by capture ELISA showing the usefulness of 
recombinant scFv antibodies for routine detection of a virus in plants (Terrada et al., 2000; 
Griep et al., 2000). Furthermore, this diagnosis strategy can be a suitable method for 
certification of pathogen-free planting material. In addition, binding of the scFvLR3cp-1 to 
the conserved AQEPPRQ epitope would help to clarify structure-function relationships in 
vivo in the infection cycle of the GLRaV-3 virus by using scFvLR3cp-1 expressing plants. 
 
Antibody engineering and phage display technology are valuable tools that can be used to 
create plants with enhanced resistance not only to virus but also to other pathogens, such as 
bacteria, fungi, insect and nematode pests (Nölke et al., 2004, Zimmermann et al., 2006). By 
the use of this phage display technology it may be possible to isolate high affinity antibodies 
that bind to almost any crucial protein involved in the pathogenesis conferring immunity or 
resistance to the pathogen. Another important property is that multiple antibodies with 
different target specificities can be expressed in a single plant to engineering ‘pyramided’ 
resistance against individual or multiple pathogens. The latest will be more difficult to break 
because simultaneous adaptations will be required in different genes. Alternatively, bispecific 
antibodies can be expressed (Fischer et al., 1999c); raising the interesting possibility of 
neutralizing two pathogen proteins simultaneously in the same cell, such as a viral coat 
protein and a replicase (Boonrod et al., 2004) or movement protein. 
The integration of transgenic and antibody-based resistance breeding will lead to develop a 
new generation of plants that can contribute to circumvent the problems originated by the use 
of environmental unfriendly chemical and reducing risk for the consumers. 
 
V Summary 
__________________________________________________________________________________________ 
 104
V Summary 
 
The GLRaV-2 and -3 are one of the most economically damaging and widespread viral 
diseases of wine grapes world-wide. These two viruses were chosen as target for generation 
of specific scFv recombinant antibody fragments by recombinant DNA technology binding to 
the corresponding coat proteins. 
The first part of this thesis comprise the generation of the scFvLR2cp-35. The variable 
domains that constitute the specific scFv fragment were derived from the mouse mAb R19 
raised against GLRaV-2 coat protein. The scFvLR2cp-35 fragment was successfully 
expressed in bacteria and the specific reactivity of the purified scFv fragment to GLRaV-2 
coat protein was confirmed by capture ELISA. The cDNA encoding the scFvLR2cp-35 was 
subcloned into pTRA plant expression vectors containing either the constitutive CaMV 35S 
promoter or the phloem-specific CFDV promoter and transiently produced in tobacco leaves 
by agro-infiltration. ScFvLR2cp-35 accumulation levels ranged between 2.2 and 2.9 μg per g 
fresh leaf tissue for the cytosolic construct produced with the constitutive 35S promoter and 
approximately 10-fold lower for the scFv transiently produced with the phloem-specific 
promoter. ELISA results confirmed significant binding to GLRaV-2 particles for both 
transiently produced scFvLR2cp-35 samples indicating that scFvLR2cp-35 was functional in 
the plant cytosol. Since GLRaV-2 can be mechanically transmissible to N. benthamiana, 
bioassay studies using stable transformed plant expressing scFvLR2cp-35 can be performed. 
Consequently, 120 independent transgenic N. benthamiana lines were generated and tested 
for both constructs by leaf disc transformation. Unfortunately, immunoblot and capture 
analyses revealed that the expression levels of the scFvLR2cp-35 were below detection limit 
for both constructs. Since it was impossible to correlate potential observed biological effects 
with scFv accumulation levels it was decided not to perform bioassay studies. 
The second part of this work includes the generation of GLRaV-3 coat protein specific scFvs 
by phage display technology. Mice were immunized with the bacterial produced and affinity 
purified MBP-GLRaV-3 coat protein. High antibody titers showed successful immunization. 
A phagemid-scFv library was constructed using the immunized mice repertoire and specific 
scFvs were selected by solid phase panning using recombinant full-length GLRaV-3 coat 
protein. Further characterization using bacterially expressed scFvs confirmed that isolated 
antibody fragments showed GLRaV-3 coat protein-binding capacities. Three scFvs, 
scFvLR3cp-1, -2 and 6, were expressed in bacteria and affinity purified by IMAC. Based on 
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the highest yields and solubility scFvLR3cp-1 was selected for further characterization. The 
direct ELISA confirmed that the scFvLR3cp-1 binds highly specific to the recombinant coat 
protein of GLRaV-3. Moreover the capture ELISA demonstrated a high binding specificity of 
the selected scFv to the viral particles present in infected grapevine material. Electrophoretic 
mobility shift assay (EMSA) confirmed interactions between the scFv and the antigen 
demonstrating the functionality in soluble form of the affinity purified scFvLR3cp-1. The 
binding kinetic to the immobilized antigen was determined by surface plasmon resonance 
demonstrating that the specific scFv fragment binds to the antigen in a dose dependent 
manner with a dissociation constant of 4 x 10-8 M. Immunogold electron microscopy analysis 
reflected that the scFvLR3cp-1 binds over the entire surface of the virus particle. The putative 
binding epitope of the scFvLR3cp-1 to the GLRaV-3 coat protein was determined by studying 
the reactivity of the affinity purified scFv fragment to truncated versions of GLRaV-3 coat 
protein by ELISA and immunoblot analysis. PEPSCAN analysis confirmed that scFvLR3cp-1 
binds to the linear epitope AQEPPRQ comprising the amino acids 69 to 75 of the GLRaV-3 
coat protein. The reactivity of the affinity purified scFvLR3cp-1 to related GLRaVs was 
evaluated by direct ELISA demonstrating a broad specificity against at least four different 
GLRaVs from the Closteroviridae family. 
scFvLR3cp-1 was subcloned into the pTRA plant expression vectors containing either the 
constitutive CaMV 35S promoter or the phloem-specific CFDV promoter. Immunoblot 
analysis of transiently produced tobacco leaves indicated high levels of functional scFv 
fragment in the plant cytosol when driven by the 35S constitutive promoter (up to 60 μg per g 
fresh weight) and approximately 10 fold lower when driven by the CFDV promoter. Capture 
ELISA with the transiently produced scFvLR3cp-1 confirmed that the antigen-binding 
capacity was retained. Finally, stable transformed plants expressing scFvLR3cp-1 in the 
cytosol were generated. Again the immunoblot analysis and capture ELISA demonstrated that 
scFvLR3cp-1 was produced to high levels (up to 70 μg per gram fresh tissue) in the cell 
cytosol of stable transformed N. benthamiana lines and the antigen binding activity to 
GLRaV-3 particles was retained in the reducing environment of the plant cytosol. Since N. 
benthamiana can not be infected by GLRaV-3 bioassays studies could not be performed. 
The data presented in this study proved that specifics scFvs against GLRaV-2 and 3 coat 
proteins have been successfully generated and functionally expressed not only in bacteria but 
also in the cytosol of tobacco plants. The simultaneous expression of these specifics scFv-
fragments could be a very powerful strategy to engineered ‘pyramided’ resistance to different 
GLRaVs in grapevine transgenic plants. 
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VII Appendices 
 
VII.1 List of abbreviations 
 
ABTS  2,2’-Azino-di-(3-ethylbenzthiazoline sulphonate) 
Ab  Antibody 
Ag Antigen 
AMCV Artichoke mottled crinkle virus 
Amp  Ampicillin 
AP  Alkaline phosphatase 
ArMV Arabis mosaic virus 
Avr Avirulance genes 
B  cell Bone-marrow-derived lymphocyte 
BCIP  5-bromo-4-chloro-3-indolyl phosphate 
bp  Base pair 
BSA  Bovine serum albumin 
CaCl2  Calcium chloride 
CaMV  Cauliflower mosaic virus 
Carb  Carbenicillin 
CDR  Complementary determining region 
cDNA  Complementary DNA 
CFDV Coconut Foliar Decay Virus 
CHS  Chalcone synthase 
CI  Chloroform/isoamyl alcohol (24:1) 
CH/CL  Heavy/Light constant domains 
CP Coat protein 
Cys  Cysteine 
cv.  Cultivar 
D  Diversity gene segments 
DEPC  Diethylpyrocarbonate 
DNA  Deoxyribonucleic acid 
dNTP  Deoxyribonucleoside triphosphate 
dsRNA Double stranded RNA 
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DTT  1,4-dithiothreitol 
E. coli  Escherichia coli 
EDC/NHS  N-Ethyl-N′-(Dimethylaminopropyl) 
EDTA  Ethylenediamine tetraacetic acid 
ELISA  Enzyme-linked immunosorbent assay 
EMSA  Electrophoretic mobility shift assay 
ER  Endoplasmatic reticulum 
EtOH  Ethanol 
Fab  Fragment antigen binding 
Fc  Fragment crystalline 
FRs  Framework regions 
g  Relative centrifugal force (RCF) 
GFLV Grapevine fanleaf virus 
GLV Grapevine leafroll 
GLRaVs Grapevine leafroll-associated viruses  
GST  Glutathione S-transferase 
GSM  Agrobacteria glycerol stock media 
GSP Gene specific primers 
h  Hour(s) 
HCl  Hydrochloride 
HEL Helicase 
his  Histidine 
HRP  Horse radish peroxidase 
HSP Heat shock protein 
IPTG  Isopropyl B-D-thiogalactopyranoside 
IMAC  Immobilized metal ion affinity chromatography 
J  Joining gene segments 
L Litre  
Lys  Lysine 
kb  Kilobase pair 
kDa  Kilodalton 
KDEL  ER retention signal 
Km  Kanamycin 
M  Molarity 
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MBP Maltose binding protein 
MeBr Methyl bromide 
MES  2-(N-morpholino)-ethanesulphonic acid 
min  Minute(s) 
MPBS  Non-fat skim milk powder in PBS 
MgSO4  Magnesium sulfate 
mRNA  Messenger RNA 
MT Methyltransferase 
NaCl  Sodium chloride 
Nt Nucleotide 
OD  Optical density 
o/n  Overnight 
ORF  Open reading frame 
Ori  Origin of replication 
PAT Bialaphos resistance gene 
PBS  Phosphate buffered saline 
PBST  0.1% Tween-20 in PBS 
PCR  Polymerase chain reaction 
poly A  Polyadenylation signal 
pH  A logarithmic measure of hydrogen ion concentration 
pIII  Phage minor protein III 
pVI  Phage minor coat protein VI 
pVIII  Phage major protein VIII 
pNPP  p-nitrophenyl phosphate 
PR Pathogenesis-related 
PTGS Post-transcriptional gene silencing  
Pw  Tobacco mosaic virus RNA termination sequence 
rAb Recombinant antibody  
RdRP RNA-dependent RNA-polymerase 
Rif  Rifampicilin 
RNA  Ribonucleic acid 
RNase  Ribonuclease 
rpm  Rounds per minute 
S  Svedberg 
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SAR Systemic acquire resistance 
scFv  Single-chain variable fragment 
SDS-PAGE  Sodium dodecyl sulphate-polyacrylamide gel electrophoresis 
ssRNA Single stranded RNA 
TBE  Tris- buffered saline electrophoresis buffer 
TEMED  N,N,N′, N′-tetramethylene-ethylenediamine 
TMV  Tobacco mosaic virus 
UTR  untranslated region 
Ω  Omega leader region of TMV 
V  Volt; variable region 
VH/VL  Heavy/Light chain variable region 
v/v  Volume per volume 
w/v  Weight per volume 
w/w  Weight per weight 
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VII.2 Schematic presentation of vectors maps 
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pMAL c2X polylinker 
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pMALc2X 
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pelB  VH VL 
Gene III Sfi I Not I
c-myc218 His6
BstEII AscI 
pHENHi 
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Figure VII-1: Schematic representation of vector maps. A: pMAL c2X, the nucleotide sequence of the multiple 
cloning site is indicated; B: pTYB1; C: pHENHi; D: pSynI; E and F: pTRA. 
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